Yayınlar & Eserler

Yayın Ağı
Makaleler 416
Tümü (416)
SCI-E, SSCI, AHCI (387)
SCI-E, SSCI, AHCI, ESCI (401)
ESCI (14)
Scopus (395)
TRDizin (17)
Diğer Yayınlar (7)

1. Association of rheumatoid factor with vasculitic manifestations and distinct clinical patterns in eosinophilic granulomatosis with polyangiitis: a multicenter observational study

Ince B., Bektaş E., YAĞIZ B., BEKTAŞ M., Ocak T., Bes C., et al.
Rheumatology International , cilt.46, sa.7, 2026 (SCI-Expanded, Scopus)

2. EULAR recommendations for the management of Behçet’s syndrome: 2025 update

HATEMİ G., Ramiro S., ÖZGÜLER Y., ESATOĞLU S. N., Tomasson G., Barete S., et al.
Annals of the Rheumatic Diseases , cilt.85, sa.6, ss.1010-1025, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis

ALİBAZ F., Kara M., ESATOĞLU S. N., KENAR ARTIN G., Uzun G. S., Ünlü B., et al.
Clinical and Experimental Rheumatology , cilt.44, sa.4, ss.647-662, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Reply to "Correspondence on: EULAR/PRES endorsed recommendations for the management of FMF: 2024 update"

ÖZEN S., GÜL A., Santos C. S., SAĞ E., Lachmann H. J., Deschner J. K., et al.
Annals of the rheumatic diseases , cilt.85, sa.3, 2026 (SCI-Expanded, Scopus)

5. Is it a secondary cause of vasculitis or a mimic? A case of retinal vasculopathy with cerebral leukoencephalopathy

Çöpür S., Senturk Y. E., Kok Y. B., Kucukkaya R., Kanıtez N. A.
Modern Rheumatology Case Reports , cilt.10, sa.1, 2026 (ESCI, Scopus)

6. Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

Amikishiyev S., Deniz R., GÜNVER M. G., Aghamuradov S., Koca N., Ince B., et al.
Frontiers in Immunology , cilt.17, 2026 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

7. International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders

Alkwai H. M., Almaghlouth I. A., Mendonça L. O., Elkhalifa S., Abolhassani H., Aljumaah S., et al.
Pediatric Rheumatology , cilt.23, sa.1, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

8. Reply to ‘Inborn errors of immunity and AAV: a complex picture’

GÜL A., Aksentijevich I., Brogan P., Gattorno M., Grayson P. C., ÖZEN S.
Nature Reviews Rheumatology , cilt.21, sa.12, ss.753, 2025 (SCI-Expanded, Scopus)

9. Cell-Based Investigation of the Association of the rs4402765 Variant with IL1A and IL1B Genes in Behçet’s Disease

tüzün B., Coşkuntan İ., Yaylaz B. S., GÜNVER M. G., ABACI N., GÜL A.
EXPERIMED , cilt.0, 2025 (ESCI, Scopus, TRDizin)

10. Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritis.

ALİBAZ ÖNER F., Kaymaz-Tahra S., Ince B., BÖLEK E. Ç., Yüce Inel T., Öz H. E., et al.
Clinical and experimental rheumatology , cilt.43, sa.11, ss.1928-1944, 2025 (SCI-Expanded, Scopus)

11. Interim Results of a Randomized Placebo Controlled Study of IL-1 Inhibitor Goflikicept in Patients With Familial Mediterranean Fever

Uhanova O., UĞURLU S., Kostik M., Sarkisyan T., Yeghiazaryan A., Lysenko L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.1519-1521, 2025 (SCI-Expanded, Scopus)

12. Immunogenetics of Behçet's disease: Is there a link to recent phenotypic changes?

Kirino Y., Takeuchi M., GÜL A.
Saudi Journal of Ophthalmology , cilt.39, sa.4, ss.323-328, 2025 (ESCI, Scopus)

13. Avascular necrosis in patients with systemic lupus erythematosus: Prevalence, associations, risk factors and outcome

Çetin Ç., Seyithanoğlu D., Mert L., Yalçınkaya Y., GÜL A., İnanç M., et al.
LUPUS , cilt.34, sa.12, ss.1240-1250, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Behçet disease: A unique systemic vasculitis with a distinct form of ocular involvement

Tugal-Tutkun I., GÜL A.
Saudi Journal of Ophthalmology , cilt.39, sa.4, ss.287-289, 2025 (ESCI, Scopus)

15. Nationwide Historical Cohort Study on the Primary Prophylactic Effects of Colchicine in Cardiovascular Events

Satis H., KALYONCU U., Ayan G., Fidanci A. A., Ulgu M. M., Ata N., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.1939-1940, 2025 (SCI-Expanded, Scopus)

16. The relationship between NETosis findings and disease activity in Behçet's disease: an exploratory study.

Bektas E., Deniz R., Emrence Z., Sirma Ekmekci S., Abaci N., Amikishiyev S., et al.
Clinical and experimental rheumatology , cilt.43, sa.10, ss.1772-1781, 2025 (SCI-Expanded, Scopus)

17. NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis

Guliyeva V., DEMİRKAN F. G., Bektas E., Deniz R., EMRENCE Z., AKGÜN Ö., et al.
RHEUMATOLOGY , cilt.64, ss.5509-5517, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Integrated stress response in Behçet disease: expression analyses in peripheral blood and synovial monocytes

Coşkuntan İ., Paçal F., Coşan F., Çetin E., Deniz G., Üstek D., et al.
Rheumatology International , cilt.45, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Colchicine Modulates the Actin Cytoskeleton by Direct Binding to the Monomer and Facilitating Polymerization

HACIOSMANOĞLU ALDOĞAN E., GÜNÇER B., Baday S., ÖZERMAN EDİS B., Martonfalvi Z., Agocs G., et al.
FASEB JOURNAL , cilt.39, sa.19, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Evaluation of therapeutic plasma exchange in anti-neutrophil cytoplasmic antibody-associated vasculitis in real-life settings: long-term results of propensity score matching analysis in high-risk patients

I Nce B., Bektas M., Gülseren Ü. A., Ük E., Çelik B., Yüce S., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.54, sa.4, ss.282-291, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Transient elastography measurements of the liver and transplanted kidney in patients with AA amyloidosis: a cross-sectional comparative study

Bektaş M., Çavuş B., Ağargün B. F., Şenkal İ. V., Koca N., İnce B., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.45, sa.7, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. The pathogenesis, clinical presentations and treatment of monogenic systemic vasculitis

GÜL A., Aksentijevich I., Brogan P., Gattorno M., Grayson P. C., ÖZEN S.
Nature Reviews Rheumatology , cilt.21, sa.7, ss.414-425, 2025 (SCI-Expanded, Scopus)

23. Discontinuation of hydroxychloroquine due to suspected retinal toxicity in systemic lupus erythematosus and the role of multimodal imaging.

İnce B., Oğure M. B., Cebeci Z., Tor Y. B., Yalçinkaya Y., GÜL A., et al.
Turkish journal of medical sciences , cilt.55, sa.4, ss.837-845, 2025 (SCI-Expanded, Scopus, TRDizin)

24. Potential Predictors of the Outcome of Tocilizumab Treatment in Patients with COVID-19-Associated Hyperinflammation

AMIKISHIYEV S., BEKTAŞ M., GÜNVER M. G., İNCE B., Aghamuradov S., Koca N., et al.
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , cilt.7, sa.2, ss.185-194, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

25. EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update

ÖZEN S., SAĞ E., Oton T., GÜL A., Sieiro Santos C., Bayraktar D., et al.
Annals of the Rheumatic Diseases , cilt.84, sa.6, ss.899-909, 2025 (SCI-Expanded, Scopus)

26. Role of Mutual Information Profile Shifts in Assessing the Pathogenicity of Mutations on Protein Functions: The Case of Pyrin Variants Associated With Familial Mediterranean Fever

Hacisuleyman A., GÜL A., Erman B.
Proteins: Structure, Function and Bioinformatics , cilt.93, sa.5, ss.1035-1053, 2025 (SCI-Expanded)

27. Budd Chiari syndrome associated with antiphospholipid syndrome: Clinical characteristics and prognosis of 17 patients from single center.

Uludağ Ö., Işık A., Torun E. S., Alkaç B., Yalçınkaya Y., GÜL A., et al.
Lupus , cilt.34, sa.5, ss.484-491, 2025 (SCI-Expanded, Scopus)

28. Highlights from the breakout session: management of special situations in systemic vasculitis

GÜL A., Langford C. A.
Rheumatology , cilt.64, 2025 (SCI-Expanded, Scopus)

29. Filaggrin Gene Variants Among Patients With Atopic Dermatitis in Turkey: A Multicenter Study Investigating Its Relationship With Disease Severity and Clinical/Laboratory Findings

Erdem Y., Özkaya E., Erbilgin Y., Saritas M., Sayitoğlu M., Kucuk O. S., et al.
DERMATITIS , 2025 (SCI-Expanded, Scopus)

30. The decline of AA amyloidosis in familial Mediterranean fever is significant, but the story is not over

GÜL A., Ben-Chetrit E.
Clinical and Experimental Rheumatology , cilt.43, sa.10, ss.1715-1717, 2025 (SCI-Expanded)

31. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study

Satiş H., Gül A., Ayan G., Babaoğlu H., Armağan B., ERDEN A., et al.
Clinical and Experimental Rheumatology , cilt.43, sa.10, ss.1709-1714, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Cytokine Signature Differences in Major Phenotypic Groups of Behçet Disease

Deniz R., EMRENCE Z., Punar Ş., İleri B., ARGA K. Y., ALİBAZ ÖNER F., et al.
Journal of Clinical Rheumatology , cilt.30, sa.8, 2024 (SCI-Expanded)

33. Evaluation of ACR/EULAR 2022 ANCA associated vasculitis classification criteria: The impact of reclassification in a large cohort with long-term follow-up ACR/EULAR 2022 ANCA ilişkili vaskülit sınıflandırma kriterlerinin değerlendirilmesi ve mevcut kriterler ile karşılaştırılması

İnce B., Koca N., Bektaş M., Altunok D., Yalçınkaya Y., GÜL A., et al.
Journal of Turkish Society For Rheumatology , cilt.16, sa.3, ss.134-140, 2024 (Scopus, TRDizin) Creative Commons License

34. Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study

AMIKISHIYEV S., YALÇINKAYA Y., Mammadova K., Aliyeva N., DURAK G., Artim-Esen B., et al.
MODERN RHEUMATOLOGY , 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. ABO blood groups and increased risk for the development of vascular involvement in Behçet's disease.

Bektas E., Büyükdemir A., Yalcinkaya Y., Artim Esen B., Inanc M., GÜL A.
Clinical and experimental rheumatology , cilt.42, sa.10, ss.2071-2075, 2024 (SCI-Expanded, Scopus) Creative Commons License

36. AA Amyloidosis: A Contemporary View

Mirioglu Ş., Uludag O., Hurdogan Ö., KUMRU G., Berke I., Doumas S. A., et al.
CURRENT RHEUMATOLOGY REPORTS , cilt.26, sa.7, ss.248-259, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

37. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.

Bektaş M., Işık E. G., Oğuz E., Kemik F., Abbasgholizadeh A., İnce B., et al.
Clinical and experimental rheumatology , cilt.42, sa.2, ss.358-366, 2024 (SCI-Expanded, Scopus)

38. Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey

Bektas M., Koca N., Oguz E., Sari S., Dagci G., Ince B., et al.
RHEUMATOLOGY , cilt.63, sa.2, ss.319-328, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study

BEKTAŞ M., IŞIK E. G., Oguz E., Kemik F., Abbasgholizadeh A., İNCE B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.42, sa.2, ss.358-366, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis

İnce B., Işik E. G., Özkan Z. G., Yalçinkaya Y., Artim Esen B., GÜL A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.54, sa.1, ss.69-75, 2024 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

41. Intracranial granuloma in a patient with granulomatosis with polyangiitis under rituximab maintenance: A case report

Ince B., Eroğlu E., BARBUROĞLU M., Yalçinkaya Y., Artim-Esen B., GÜL A., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus

Mirioğlu Ş., Çınar S., Uludağ Ö., Gürel E., Varelci S., Özlük Y., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.54, sa.2, ss.391-400, 2024 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

43. Minimal disease activity and associated factors in patients with psoriatic arthritis: cross-sectional study from a single center.

Bektas M., Çelik B., İnce B., Yalçınkaya Y., Esen B. A., GÜL A., et al.
Reumatologia , cilt.62, sa.5, ss.330-337, 2024 (Scopus)

44. Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials

Tesser J., GÜL A., Olech E., Oelke K., Lukic T., Kwok K., et al.
Arthritis Research and Therapy , cilt.25, sa.1, 2023 (SCI-Expanded, Scopus) Creative Commons License

45. Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system

Azar L. M., KARAMAN E., Beyaz B., Goektan I., Eyuepoglu A. E., Kizilel S., et al.
BMC BIOTECHNOLOGY , cilt.23, sa.1, 2023 (SCI-Expanded) Creative Commons License

46. 5-Fluoro/(trifluoromethoxy)-2-indolinone derivatives with anti-interleukin-1 activity

Soylu-Eter Ö., Sevinçli Z. Ş., Ersoy B., Hasanusta B., Gatfar U., Lack N. A., et al.
Archiv der Pharmazie , cilt.356, sa.12, 2023 (SCI-Expanded, Scopus)

47. The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus

Cetin Ç., Sarac-Sivrikoz T., Ates-Tikiz M., Zarali S., Ersoy A., YALÇINKAYA Y., et al.
LUPUS , cilt.32, sa.13, ss.1509-1517, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Phenotypes of the Patients with More Than One Autoinflammatory Gene Variant: Classified Diseases and Mixed Autoinflammatory Disorders (MAID)

Amıkıshıyev S., Kalaycı T., Soltanova L., Yalçınkaya Y., Artim-Esen B., İnanç M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.506-508, 2023 (SCI-Expanded, Scopus)

49. Clinical Features of the Patients with NLRP1 Gene Variants and a Systemic Autoinflammatory Phenotype

AMIKISHIYEV S., KALAYCI T., Deniz R., YALÇINKAYA Y., ARTIM ESEN B., İNANÇ M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3800-3802, 2023 (SCI-Expanded, Scopus)

50. Behçet disease, familial Mediterranean fever and MEFV variations: More than just an association

SEYAHİ E., UĞURLU S., Amikishiyev S., GÜL A.
Clinical Immunology , cilt.251, 2023 (SCI-Expanded)

51. Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behcet disease

Deniz R., Emrence Z., Yalçınkaya Y., Esen B. A., İnanç M., Ocal M. L., et al.
RHEUMATOLOGY , cilt.62, sa.5, ss.1903-1909, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic

Amikishiyev S., Gunver M. G., Bektas M., Aghamuradov S., Ince B., Koca N., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.75, sa.5, ss.664-672, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study

Mirioglu Ş., Dirim A. B., Bektas M., Demir E., Tor Y. B., Ozluk Y., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.38, sa.5, ss.1327-1336, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?

Uludağ Ö., ÇINAR S., McDonnell T., ÇENE E., Yalçinkaya Y., GÜL A., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1067-1074, 2023 (SCI-Expanded, Scopus, TRDizin)

55. Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?

Fragoulis G. E., Bertsias G., Bodaghi B., Gul A., van Laar J., MUMCU G., et al.
Clinical Immunology , cilt.246, 2023 (SCI-Expanded)

56. Performances of different classification criteria for systemic lupus erythematosus in a single-center cohort from Turkey

TORUN E. S., BEKTAŞ E., KEMİK F., BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., et al.
LUPUS , cilt.31, sa.12, ss.1536-1543, 2022 (SCI-Expanded)

57. Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behcet's disease

Sallakci N., Tahralı İ., Küçüksezer U. C., Çetin E., Gül A., Deniz G.
IMMUNOLOGIC RESEARCH , cilt.70, sa.5, ss.654-666, 2022 (SCI-Expanded, Scopus)

58. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center.

İnce B., Bektaş M., Koca N., Ağargün B. F., Zarali S., Güzey D. Y., et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.28, sa.6, ss.300-304, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Immune modulation as a consequence of SARS-CoV-2 infection

Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.
FRONTIERS IN IMMUNOLOGY , cilt.13, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

60. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.

Oztas M., Bektas M., Karacan I., Aliyeva N., Dag A., Aghamuradov S., et al.
Journal of medical virology , cilt.94, ss.3431-3437, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Course and Prognosis of AA Amyloidosis in Patients with Psoriatic Arthritis: Report of Three Cases from a Single Center Cohort and Review of the Literature.

Bektaş M., Koca N., Ince B., Yalçınkaya Y., Esen B. A., Öcal M. L., et al.
Mediterranean journal of rheumatology , cilt.33, sa.2, ss.185-195, 2022 (Scopus)

62. VASCULAR EVENTS AND ASSOCIATED FACTORS IN ANCA-ASSOCIATED VASCULITIS: ANALYSIS OF 237 PATIENTS WITH LONG-TERM FOLLOW-UP

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., YALÇINKAYA Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1432-1433, 2022 (SCI-Expanded) Creative Commons License

63. SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Mirioglu S., Cinar S., Uludag O., Gurel E., Varelci S., Ozluk Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1374, 2022 (SCI-Expanded, Scopus) Creative Commons License

64. AMYLOID STORM DEVELOPS IN PATIENTS WITH AA AMYLOIDOSIS AND ASSOCIATED WITH HIGHER AMYLOID BURDEN AND INCREASED MORTALITY

BEKTAŞ M., SARI S., KOCA N., OĞUZ E., İNCE B., YALÇINKAYA Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1001, 2022 (SCI-Expanded) Creative Commons License

65. AMYLOID BURDEN AND ASSOCIATED FACTORS PREDICT HIGHER MORTALITY AND POOR OUTCOME IN FAMILIAL MEDITERRANEAN FEVER-ASSOCIATED AA AMYLOIDOSIS: DATA FROM A TERTIARY REFERRAL AMYLOIDOSIS CENTER WITH 137 PATIENTS

BEKTAŞ M., KOCA N., OĞUZ E., İNCE B., SARI S., ŞENTÜRK N., et al.
ANNALS OF THE RHEUMATIC DISEASES , ss.348, 2022 (SCI-Expanded, Scopus) Creative Commons License

66. DIFFERENCES IN THE CLINICAL SPECTRUM OF HAPLOINSUFFICIENCY OF A20 (HA20) CASES DIAGNOSED DURING ADULTHOOD

Amikishiyev S., Aliyeva N., Bektas M., Koca N., Soltanova L., Yalcinkaya Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1756, 2022 (SCI-Expanded, Scopus) Creative Commons License

67. FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS

Aliyeva N., Sari S., Amikishiyev S., Dulundu B. C. Y., Suleymanova V., Telli P., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.976-977, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

68. DEVELOPMENT OF MALIGNANCY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., AĞARGÜN B. F., et al.
ANNALS OF THE RHEUMATIC DISEASES , ss.1430-1431, 2022 (SCI-Expanded) Creative Commons License

69. ANTI-FIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS ASSOCIATED WITH SYTEMIC SCLEROSIS: CHARACTERISTICS OF SSC-IAH PATIENTS RECEIVING NINTEDANIB AND ADVERS EVENTS DURING TREATMENT

Yalcinkaya Y., Amikishiyev S., Aliyeva N., Artim-Esen B., Gul A., Bingol Z., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1499, 2022 (SCI-Expanded, Scopus) Creative Commons License

70. A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt

Torun E. S., Erciyestepe M., Yalcinkaya Y., Gul A., Inanc M., Ocal L., et al.
CLINICAL MEDICINE INSIGHTS-CASE REPORTS , cilt.15, 2022 (ESCI, Scopus)

71. Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.

Kalayoglu Besisik S., Ozbalak M. M., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research , cilt.12, sa.2, ss.54-59, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

72. The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus.

Sari S., Cinar S., Yalcinkaya Y., Artim-Esen B., Ozluk Y., Gul A., et al.
Lupus , cilt.31, sa.5, ss.555-564, 2022 (SCI-Expanded, Scopus)

73. Description of damage in different clusters of patients with antiphospholipid syndrome.

Uludağ Ö., Çene E., Gurel E., Çetin Ç., Bektaş M., Yalçınkaya Y., et al.
Lupus , cilt.31, sa.4, ss.433-442, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

Mert A., VAHABOĞLU H., ARSLAN F., Batirel A., Saracoglu K. T., Bastug A., et al.
RHEUMATOLOGY INTERNATIONAL , sa.3, ss.457-467, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Budd-Chiari syndrome in Behcet's disease: a retrospective multicenter study

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D., Yigit M., et al.
CLINICAL RHEUMATOLOGY , cilt.41, sa.1, ss.177-186, 2022 (SCI-Expanded)

76. Ankilozan spondilit ve psöriyatik artritte sekukinumab deneyimi: Tek merkezden 44 hastanın analizi

BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., ESEN B. A., ÖCAL L., GÜL A., et al.
Ulusal Romatoloji Dergisi , cilt.13, sa.3, ss.116-120, 2021 (TRDizin) Creative Commons License

77. Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab

ALİBAZ ÖNER F., Kaymaz-Tahra S., Bayindir O., YAZICI A., Ince B., Kalkan K., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , sa.6, ss.1224-1229, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Pure Red Cell Aplasia in IgG4-Related Disease: Successful Treatment With Cyclosporine.

Bektaş M., Ağargün B. F., Torun E. S., Çatma Y., Beşişik S. F., Nalçaci M., et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.27, sa.8S, 2021 (SCI-Expanded, Scopus)

79. Transient Elastography (fibroscan); As a New Non-invasive Diagnostic Method for Detecting Hepatic Involvement of Amyloidosis

BEKTAŞ M., ÇAVUŞ B., AĞARGÜN B. F., Senkal V., KOCA N., İNCE B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.2306-2308, 2021 (SCI-Expanded, Scopus)

80. A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls

Ince B., Kamali S., Bektas M., Ogret Y., Savran F., Yalcinkaya Y., et al.
RHEUMATOLOGY INTERNATIONAL , sa.9, ss.1667-1672, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

81. Adamantiades-Behcet's disease (Behcet's disease) and COVID-19

Zouboulis C. C., van Laar J. A. M., Schirmer M., Emmi G., Fortune F., Gul A., et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.35, sa.9, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

82. Reinfection with SARS-CoV-2 in a kidney transplant recipient

Amikishiyev S., Demir E., Aghamuradov S., Garayeva N., Artan A. S., Gül A., et al.
TRANSPLANT INFECTIOUS DISEASE , cilt.23, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

83. An Algorithm for the Diagnosis of Behcet Disease Uveitis in Adults

Tugal-Tutkun I., Onal S., Stanford M., AKMAN M., Twisk J. W. R., Boers M., et al.
OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.29, sa.6, ss.1154-1163, 2021 (SCI-Expanded, Scopus)

84. NK17 and NKreg responses in patients with active Behcet's uveitis

ESEN F., Kokoglu A., ÇETİN Ç., Turkyilmaz O., AKSU CEYLAN N., ORAY M., et al.
EUROPEAN JOURNAL OF IMMUNOLOGY , ss.315, 2021 (SCI-Expanded)

85. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach

ÖZEN S., SAĞ E., Ben-Chetrit E., Gattorno M., Gül A., Hashkes P. J., et al.
RHEUMATOLOGY , cilt.60, sa.8, ss.3799-3808, 2021 (SCI-Expanded, Scopus)

86. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease

Gelmez M. Y., Cinar S., Cetin E., Ozcit-Gürel G., Babuna-Kobaner G., Erdugan M., et al.
IMMUNOLOGY LETTERS , cilt.235, ss.1-8, 2021 (SCI-Expanded, Scopus)

87. ANALYSIS OF 5-YEAR HOSPITALIZATION DATA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DAMAGE IS A RISK FACTOR FOR FREQUENT AND LONGER STAYS

Çetin Ç., Can M. G., Öztaşkın S., Yalçınkaya Y., Gül A., İnanç M., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.604-605, 2021 (SCI-Expanded) Creative Commons License

88. FAVOURABLE SHORT-TERM COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS

Aliyeva N., Dulundu B. C. Y., Amikishiyev S., Aghamuradov S., BEKTAŞ M., Ince B., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.913-914, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma

89. MORE FREQUENT AND EARLIER HIP INVOLVEMENT IN SPONDYLOARTHRITIS ASSOCIATED WITH FAMILIAL MEDITERRANEAN FEVER

BEKTAŞ M., SARI S., ÇETİN Ç., Dulundu B. C. Y., KOCA N., İNCE B., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.951-952, 2021 (SCI-Expanded, Scopus) Creative Commons License

90. PULMONARY INVOLVEMENT IN A SINGLE CENTER COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Senkal N., Kiyan E., Kocasoy-Orhan E., Demir A., Aydoğan S. M., Yalcinkaya Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1191, 2021 (SCI-Expanded)

91. CLUSTER ANALYSIS AND COMPARISON OF CUMULATIVE DAMAGE BY DIAPS IN A SINGLE CENTER COHORT OF APS PATIENTS

ULUDAĞ Ö., GÜREL E., ÇETİN Ç., ÇENE E., YALÇINKAYA Y., GÜL A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.636-637, 2021 (SCI-Expanded, Scopus) Creative Commons License

92. HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FOR MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND COVID-19

İNCE B., BEKTAŞ M., KOCA N., AĞARGÜN B. F., ZARALI S., Guzey D. Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.912-913, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma

93. SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: PREDOMINANCE OF PULMONARY FIBROSIS AS A RISK FACTOR FOR MORTALITY IN A SINGLE CENTER COHORT

Amikishiyev S., Yalcinkaya Y., Aliyeva N., Mammadova K., Artim-Esen B., Gul A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1251-1252, 2021 (SCI-Expanded, Scopus)

94. EVALUATION OF BASELINE POSITRON EMISSION TOMOGRAPHY IN THE DIAGNOSIS AND ASSESSMENT OF GIANT CELL ARTERITIS

Ince B., Isik E. G., Ozkan Z. G., Yalcinkaya Y., Artim-Esen B., Gul A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1210-1211, 2021 (SCI-Expanded, Scopus)

95. RETINOL BINDING PROTEIN 4 AS AN ACUTE PHASE REACTANT AND BIOMARKER IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AMYLOIDOSIS COMPARED TO INFECTIONS

Koca N., Deniz R., Erdugan M., Yalcinkaya Y., Artim-Esen B., Ocal M. L., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1006-1007, 2021 (SCI-Expanded, Scopus)

96. PERFORMANCES OF DIFFERENT CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN A SINGLE CENTER COHORT FROM TURKEY

TORUN E. S., BEKTAŞ E., KEMİK F., BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.602-603, 2021 (SCI-Expanded, Scopus) Creative Commons License

97. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response

Başaran S., Şimşek-Yavuz S., Meşe S., Çağatay A., Medetalibeyoğlu A., Öncül O., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.105, ss.756-762, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

98. Tümör nekrozis faktör-alfa inhibitörü tedavisi gereken aksiyal spondiloartritli kadın hastalarda klinik özellikler ve tedavi sonuçları

YALÇINKAYA Y., PEHLİVAN Ö., HÜSEYİNSİNOĞLU N., ALİYEVA N., AMIKISHIYEV S., ESEN B. A., et al.
Ulusal Romatoloji Dergisi , cilt.13, sa.3, ss.100-106, 2021 (Hakemli Dergi)

99. Initial complete blood count score and predicting disease progression in COVID-19 patients.

Ozbalak M. M., Kalayoglu Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research , cilt.11, sa.1, ss.77-83, 2021 (ESCI) Sürdürülebilir Kalkınma

100. Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage

Ince B., Artan S., Yalcinkaya Y., Artim-Esen B., Gül A., Ocal L., et al.
RHEUMATOLOGY INTERNATIONAL , sa.2, ss.439-448, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.

Uludağ Ö., Bektaş M., Cene E., Sezer M., Sahinkaya Y., Gül A., et al.
Journal of thrombosis and thrombolysis , cilt.51, sa.2, ss.466-474, 2021 (SCI-Expanded, Scopus)

102. mRNA Expression Levels of NKp30, NKp46, NKG2D, Perforin and Granzyme in the Behcet's Disease

GELMEZ M. Y., ÇINAR S., ÇETİN E., ÖKTELİK F. B., Babuna-Kobaner G., Erdugan M., et al.
TURKISH JOURNAL OF IMMUNOLOGY , cilt.9, sa.2, ss.80-85, 2021 (ESCI, Scopus)

103. A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic

Ince B., Bektaş M., Koca N., Ağargün B. F., Zarali S., Güzey D. Y., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , sa.5, ss.2243-2247, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

104. Initial complete blood count score and predicting disease progression in COVID-19 patients

Ozbalak M. M., Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.1, ss.77-83, 2021 (ESCI) Sürdürülebilir Kalkınma

105. Antifosfolipid sendromunda kardiyovasküler risk: Trombotik ve obstetrik hastalık alt gruplarının karşılaştırılması

ULUDAĞ Ö., YALÇINKAYA Y., GÜL A., İNANÇ M., ÖCAL L., ESEN B. A.
Ulusal Romatoloji Dergisi , cilt.12, sa.3, ss.83-87, 2020 (Hakemli Dergi)

106. Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review

KARA B., Ekinci Z., Sahin S., GÜNGÖR M., Gunes A. S., Ozturk K., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.11, ss.1903-1910, 2020 (SCI-Expanded, Scopus)

107. Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus

Senkal N., KIYAN E., Kocasoy-Orhan E., Demir A., AYDOĞAN M., YALÇINKAYA Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.72, 2020 (SCI-Expanded, Scopus)

108. The Correlation Between Pregnancy, Disease Activity and Adverse Pregnancy Outcomesin Patients with Systemic Lupus Erythematosus

ÇETİN Ç., Sivrikoz T. S., Tikiz M. A., TORUN E. S., ZARALI S., YALÇINKAYA Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.72, 2020 (SCI-Expanded, Scopus)

109. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis

Ozdogan H., UĞURLU S., UYGUNOĞLU U., TÜTÜNCÜ M., Gül A., Akman G., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.45, 2020 (SCI-Expanded)

110. Letter: is pneumococcal vaccination safe during the COVID-19 pandemic?

Deniz R., Cagatay A. A., Gül A.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.52, sa.5, ss.919-920, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

111. Ancient familial Mediterranean fever mutations in human pyrin and resistance toYersinia pestis

Park Y. H., Remmers E. F., Lee W., Ombrello A. K., Chung L. K., Zhao Shilei Z. S., et al.
NATURE IMMUNOLOGY , cilt.21, sa.8, ss.857-876, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

112. Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behcet's disease pathogenesis

Gür M., Golcuk M., Gül A., Erman B.
CHEMICAL BIOLOGY & DRUG DESIGN , cilt.96, sa.1, ss.644-658, 2020 (SCI-Expanded, Scopus)

113. COVID-19 is a Real Headache!

Bolay H., GÜL A., Baykan B.
HEADACHE , cilt.60, sa.7, ss.1415-1421, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

114. Common genetic susceptibility loci link PFAPA syndrome, Behcet's disease, and recurrent aphthous stomatitis

Manthiram K., Preite S., Dedeoglu F., DEMİR S., ÖZEN S., Edwards K. M., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.117, sa.25, ss.14405-14411, 2020 (SCI-Expanded)

115. Genetic Susceptibility Loci for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Syndrome

Manthiram K., Preite S., Dedeoglu F., Demir S., Ozen S., Edwards K., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.72, ss.26-27, 2020 (SCI-Expanded, Scopus)

116. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus

Mirioğlu Ş., Çınar S., Yazıcı H., Özlük Y., Kılıçaslan I., Gül A., et al.
LUPUS , sa.4, ss.379-388, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

117. Genetics of Behcet's Disease

GÜL A., Wallace G. R.
BEHCET SYNDROME, 2ND EDITION , ss.223-233, 2020 (SCI-Expanded)

118. Treatment of Libman-Sacks endocarditis by combination of warfarin and immunosuppressive therapy

Sonsoz M. R., Tekin R. D., Gül A., Bugra Z., Atilgan D.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.47, sa.8, ss.687-690, 2019 (ESCI, Scopus, TRDizin)

119. Recommendation on Colchicine Dosing and Definition of Colchicine Resistance/Intolerance in the Management of Familial Mediterranean Fever

ÖZEN S., SAĞ E., Ben-Chetrit E., Gattorno M., Gül A., Hashkes P., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus)

120. AGBL3 as a Novel Gene Associated with Hereditary Hypocomplementemic Urticarial Vasculitis and Favorable Response to Rituximab

Gül A., Abaci N., Sirma-Ekmekci S.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus)

121. Association of Serum and Urine Levels of TWEAK, MCP-1 and NGAL with Disease Activity in Systemic Lupus Erythematosus

Mirioglu S., ÇINAR S., YAZICI H., GÜL A., Ocal L., İNANÇ M., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus)

122. Genetic Evidence for Recent Positive Selection of the HLA-B*51:01 Allele in the Turkish Population, a Population with a High Prevalence of HLA-B*51-Associated Behcet's Disease

Remmers E., Gül A., Kastnerl D.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

123. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival

Artim-Esen B., Çene E., Sahinkaya Y., Erdugan M., Oguz E., Gül A., et al.
LUPUS , cilt.28, sa.12, ss.1480-1487, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

124. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin S. Z., Robson J. C., Sreih A. G., Hill C., Alibaz-Oner F., Mackie S., et al.
JOURNAL OF RHEUMATOLOGY , cilt.46, sa.9, ss.1198-1201, 2019 (SCI-Expanded, Scopus)

125. Classification criteria for autoinflammatory recurrent fevers

GATTORNO M., Hofer M., FEDERICI S., VANONI F., BOVIS F., AKSENTIJEVICH I., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.78, sa.8, ss.1025-1032, 2019 (SCI-Expanded, Scopus)

126. Clinical course of abdominal aortic aneurysms in Behcet disease: a retrospective analysis

Sahutoglu T., Esen B. A., Aksoy M., Kurtoglu M., Poyanli A., Gül A.
RHEUMATOLOGY INTERNATIONAL , cilt.39, sa.6, ss.1061-1067, 2019 (SCI-Expanded)

127. An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome

FEDERICI S., VANONI F., Ben-Chetrit E., CANTARINI L., Frenkel J., GOLDBACH-MANSKY R., et al.
JOURNAL OF RHEUMATOLOGY , cilt.46, sa.4, ss.429-436, 2019 (SCI-Expanded, Scopus)

128. Management of skin, mucosa and joint involvement of Behcet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behcet's syndrome

LECCESE P., Ozguler Y., Christensen R., Esatoglu S. N., BANG D., BODAGHI B., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.48, sa.4, ss.752-762, 2019 (SCI-Expanded)

129. Phenotypic variability including Behcet's disease-like manifestations in DADA2 patients due to a homozygous c.973-2A > G splice site mutation

van Well G. T. J., Kant B., van Nistelrooij A., Ekmekci S. S., Henriet S. S. V., Hoppenreijs E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.142-146, 2019 (SCI-Expanded, Scopus)

130. Pseudodominance of autoinflammatory disease in a single Turkish family explained by co-inheritance of haploinsufficiency of A20 and familial Mediterranean fever

Horita N., Gul A., Aksentijevich I., Kastner D. L., Remmers E. F.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.89-92, 2019 (SCI-Expanded, Scopus)

131. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behcet Disease Uveitis

Albayrak O., Oray M., Can F., Kirimli G. U., Gül A., Tugal-Tutkun I., et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.60, sa.1, ss.52-63, 2019 (SCI-Expanded, Scopus)

132. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behcet's disease

Cosan F., Oku B., Gedar Totuk O. M., Abaci N., Ustek D., Diz Kucukkaya R., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, sa.12, ss.2175-2179, 2018 (SCI-Expanded, Scopus)

133. Management of major organ involvement of Behcet's syndrome: a systematic review for update of the EULAR recommendations

Ozguler Y., LECCESE P., Christensen R., Esatoglu S. N., BANG D., BODAGHI B., et al.
RHEUMATOLOGY , cilt.57, sa.12, ss.2200-2212, 2018 (SCI-Expanded)

134. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

Ben-Chetrit E., GATTORNO M., Gül A., KASTNER D. L., Lachmann H. J., TOUITOU I., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.11, ss.1558-1565, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

135. Dynamics of Inflammatory Response in Autoinflammatory Disorders: Autonomous and Hyperinflammatory States

Gül A.
FRONTIERS IN IMMUNOLOGY , cilt.9, 2018 (SCI-Expanded, Scopus)

136. The Omeract Core Domain Set for Clinical Trials in Behcet's Syndrome

HATEMİ G., Meara A., ÖZGÜLER Y., DİRESKENELİ R. H., Mahrs A., Shea B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

137. Non-Aphthous Beginning As an Independent Risk Factor for the Course of Behcet's Disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gül A.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

138. Classification of Idiopathic Inflammatory Myopathies: Assessment of 123 Patients According to 2017 Acr/EULAR Criteria Followed up By a Single Center from Turkey

Oguz E., Sahin E., Erdugan M., Artim-Esen B., Gül A., Ocal L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

139. Favourable Response to Rituximab for the Treatment of IgG4-Related Disease: Long-Term Follow-up of 10 Patients Resistant to Glucocorticoids and Immunosuppressives

Oguz E., Dagci G., Erdugan M., Artim-Esen B., Gül A., Ocal L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

140. IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis

Arthur V. L., Shuldiner E., Remmers E. F., Hinks A., Grom A. A., Foell D., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, sa.8, ss.1319-1330, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

141. 2018 update of the EULAR recommendations for the management of Behcet's syndrome

Hatemi G., CHRISTENSEN R., BANG D., BODAGHI B., Celik A. F., Fortune F., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.6, ss.808-818, 2018 (SCI-Expanded)

142. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

DE BENEDETTI F., GATTORNO M., ANTON J., Ben-Chetrit E., Frenkel J., HOFFMAN H. M., et al.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.378, sa.20, ss.1908-1919, 2018 (SCI-Expanded, Scopus)

143. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Aeschlimann F. A., Batu E. D., CANNA S. W., GO E., Gül A., HOFFMANN P., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.5, ss.728-735, 2018 (SCI-Expanded, Scopus)

144. Binding stability of peptides on major histocompatibility complex class I proteins: role of entropy and dynamics

Gül A., Erman B.
PHYSICAL BIOLOGY , cilt.15, sa.2, 2018 (SCI-Expanded, Scopus)

145. Ailevi Akdeniz Ateşinde Moleküler Tanı Deneyimi: MEFV Geninde Sık Görülen Mutasyonlar

Coşkunpınar E., Özvarnalı A., Çefle K., PALANDUZ A., GÜL A., Öztürk D., et al.
HASEKİ TIP BÜLTENİ , cilt.56, sa.1, ss.42-49, 2018 (Scopus, TRDizin)

146. Molecular Diagnosis Experience in Familial Mediterranean Fever: The Most Frequent Mutations in the MEFV Gene

Coskunpinar E., Ozvarnali A., Cefle K., Palanduz A., Gül A., Ozturk D., et al.
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.56, sa.1, ss.42-49, 2018 (ESCI, Scopus, TRDizin)

147. IDIOPATHIC INFLAMMATORY MYOPATHIES: CLINICAL CHARACTERISTICS, SURVIVAL AND POOR PROGNOSTIC FACTORS OF 110 PATIENTS FROM TURKEY

Oguz E., Erdugan M., Esen B. A., Gul A., Ocal L., Inanc M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded)

148. The important role of non-oral aphthous beginning and demographic factors on poor prognosis of Behcet disease

Dilsen N., Konice M., Aral O., Ocal L., Inanc M., Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

149. The OMERACT core set of domains for outcomes measures in Behcet's syndrome

Meara A., Hatemi G., Ozguler Y., Dreskeneli H., Mahr A., Gul A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

150. Whole-genome imputation study implicates TLR2 locus variants that confer risk for Behcet's disease by increasing innate immune response against microbes

Remmers F., Takeuchi M., Meguro A., Ombrello M. J., Kirino Y., Horita N., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

151. Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study

Tugal-Tutkun I., PAVESIO C., DE CORDOUE A., BERNARD-POENARU O., Gül A.
OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.26, sa.7, ss.1023-1033, 2018 (SCI-Expanded, Scopus)

152. ASSESMENT OF ORGAN DAMAGE ACCORDING TO IMACS (INTERNATIONAL MYOSITIS ASSESMENT AND CLINICAL STUDIES) MYOSITIS DAMAGE INDEX IN 92 PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOSITIS

Oguz E., Sahin E., Erdugan M., Esen B. A., Gul A., Ocal L., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded, Scopus)

153. GENETIC, EPIGENETIC AND ENVIRONMENTAL FACTORS AND THE VASCULITIS RISK IN THE MEDITERRANEAN

Gül A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded, Scopus)

154. Influence of smoking on the manifestations at the onset and course of Behcet disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

155. THE ROLE OF 21-HYDROXYLASE DEFICIENCY IN THE PATHOGENESIS OF BEHCET DISEASE

Gul N., Gül A., Inanc M., Ocal L., Aral O., Alagol F.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.81, sa.1, ss.11-16, 2018 (ESCI, TRDizin)

156. Non-aphthous beginning as an independent risk factor for the prognosis of Behcet's disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

157. Novel association of human leukocyte antigen class I allele with ocular Behcet's disease by imputation of dense genotype data

Takeuchi M., Remmers E., Meguro A., GÜL A., Kastner D., Mizuki N.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

158. Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016

Sreih A. G., Alibaz-Oner F., Kermani T. A., Aydin S. Z., Cronholm P. F., Davis T., et al.
JOURNAL OF RHEUMATOLOGY , cilt.44, sa.12, ss.1933-1937, 2017 (SCI-Expanded, Scopus)

159. Behcet's disease (or syndrome) - an update

Gul A.
REVUE DE MEDECINE INTERNE , cilt.38, 2017 (SCI-Expanded)

160. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M., et al.
RHEUMATOLOGY , cilt.56, sa.12, ss.2102-2108, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

161. Developing a Core Set of Outcome Measures for Behcet Disease: Report from OMERACT 2016

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., et al.
JOURNAL OF RHEUMATOLOGY , cilt.44, sa.11, ss.1750-1753, 2017 (SCI-Expanded, Scopus)

162. Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Prior Therapies

Tesser J., Gül A., Olech E., Oelke K., Lukic T., Murray C. W., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

163. New Autoinflammatory Phenotype Associated with Homozygous AGBL3 Variant

Gül A., Abaci N., Ekmekci S. S.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

164. A20 Haploinsufficiency: Clinical Phenotypes and Disease Course of Patients with This Newly Recognized Autoinflammatory Disease

Aeschlimann F. A., Batu E. D., Go E., Gül A., Hoffmann P. M., Leavis H. L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

165. A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

Gül A., Ulker S., Senturk R. S., Turk U. O., GÜRGÜN C., Lavrovsky Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded)

166. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments

ÖZEN S., KONE-PAUT I., Gül A.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.47, sa.1, ss.115-120, 2017 (SCI-Expanded, Scopus)

167. Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function

Takata K., Kozaki T., Lee C. Z. W., Thion M. S., Otsuka M., Lim S., et al.
IMMUNITY , cilt.47, sa.1, ss.183-204, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

168. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)

KUEMMERLE-DESCHNER J. B., ÖZEN S., Tyrrell P. N., KONE-PAUT I., GOLDBACH-MANSKY R., Lachmann H., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.76, sa.6, ss.942-947, 2017 (SCI-Expanded, Scopus)

169. Reply to: Behcet's disease: an MHC-I-opathy?

McGonagle D., Aydin S. Z., Gül A., MAHR A., Direskeneli H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.2, 2017 (SCI-Expanded, Scopus)

170. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

OMBRELLO M. J., ARTHUR V. L., REMMERS E. F., Hinks A., TACHMAZIDOU I., Grom A. A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.76, sa.5, 2017 (SCI-Expanded)

171. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.

Artim-Esen B., Sahin S., Çene E., Sahinkaya Y., Barut K., Adrovic A., et al.
The Journal of rheumatology , cilt.44, sa.5, ss.619-625, 2017 (SCI-Expanded, Scopus)

172. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome

ÖZEN S., KUEMMERLE-DESCHNER J. B., CIMAZ R., Livneh A., QUARTIER P., KONE-PAUT I., et al.
ARTHRITIS CARE & RESEARCH , cilt.69, sa.4, ss.578-586, 2017 (SCI-Expanded, Scopus)

173. Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.

Omma A., Erer B., KARADAĞ Ö., YILMAZ N., Alibaz-Oner F., YILDIZ F., et al.
Clinical and experimental rheumatology , sa.1, ss.77-82, 2017 (SCI-Expanded, Scopus)

174. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility

TAKEUCHI M., MIZUKI N., MEGURO A., OMBRELLO M. J., KIRINO Y., SATORIUS C., et al.
NATURE GENETICS , cilt.49, sa.3, ss.438-443, 2017 (SCI-Expanded, Scopus)

175. Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., et al.
OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.25, sa.1, ss.62-70, 2017 (SCI-Expanded)

176. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behcet's disease in HLA-B(star)51 carriers

TAKEUCHI M., OMBRELLO M. J., KIRINO Y., Erer B., Tugal-Tutkun I., Seyahi E., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.12, ss.2208-2211, 2016 (SCI-Expanded, Scopus)

177. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behcet's disease

ERER B., TAKEUCHI M., Ustek D., Tugal-Tutkun I., Seyahi E., Ozyazgan Y., et al.
GENES AND IMMUNITY , cilt.17, sa.7, ss.396-399, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

178. PET/CT IMAGING IN PATIENTS WITH VASCULAR BEHCET DISEASE

Toz B., Erer B., Ozkan Z. G., Esen B. A., Kamali S., Inanc M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

179. A BEHCET'S DISEASE PATIENT WITH PERCARDIAL TAMPONADE RELATED TO RIGHT CORONARY PSEUDOANEURYSM

Erer B., Toz B., Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

180. HOMOZYGOSITY FOR A SINGLE ERAP1 ALLOTYPE GREATLY INCREASES BEHCET'S DISEASE RISK IN HLA-B*51 CARRIERS

Remmers E. F., Takeuchi M., Ombrello M. J., Kirino Y., Erer B., Tugal-Tutkun I., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

181. IDENTIFYING CORE DOMAINS FOR BEHCET'S SYNDROME TRIALS: AN INTERNATIONAL PHYSICIAN AND PATIENT DELPHI EXERCISE

Meara A., Ozguler Y., Maher A., Direskeneli H., Gul A., Yazici Y., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

182. DENSE GENOTYPING OF IMMUNE-RELATED LOCI IMPLICATES HOST RESPONSES TO MICROBIAL EXPOSURE IN BEHCET'S DISEASE SUSCEPTIBILITY

Takeuchi M., Mizuki N., Meguro A., Ombrello M., Kirino Y., Satorius C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

183. CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

Gul A., Demir G. A., Kurtuncu M., Erer B., Sevgi S., Turgay S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

184. Identifying Core Domains for BehcEt's Syndrome Trials: An International Physician and Patient Delphi Exercise

Meara A., Ozguler Y., Mahr A., Direskeneli H., Gül A., Yazici Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

185. a Singlecenter Experience of Rituximab Treatment in 86 Patients with Systemic Lupus Erythematosus

Artim-Esen B., Toz B., Erer B., Kamali S., Gül A., Ocal L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

186. Utility of Vascular Findings By PET/CT Scan in the Diagnosis and Activity Assesment of Takayasu Arteritis

Toz B., Ozkan Z. G., Artim-Esen B., Erer B., Kamali S., Gül A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

187. Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial

Frenkel J., Anton J., Livneh A., Ben-Chetrit E., Brogans P., Bujan-Rivas S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

188. Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis

Toz B., Tecer S., Oguz E., Erdugan M., Artim-Esen B., Kamali S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

189. Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities.

Kanitez N. A., Toz B., Gulluoglu M., Erer B., Esen B. A., Omma A., et al.
Clinical rheumatology , cilt.35, sa.10, ss.2495-9, 2016 (SCI-Expanded, Scopus)

190. Novel Susceptible Genes for Behcet's Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Kirino Y., Satorius C., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

191. a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

192. PET/CT Imaging in Patients with Vascular Behcet Disease

Toz B., Erer B., Kamali S., Inanc M., Ocal L., Gül A.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

193. Efficacy and Safety of IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever Who Underwent Kidney Transplantation

Toz B., Caliskan Y. K., Erer B., Ocal L., Gül A.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

194. Asia Minor, Genes, and Fever

Gül A.
ACTA PHYSIOLOGICA , cilt.218, ss.2, 2016 (SCI-Expanded)

195. DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

Esen B. A., Pehlivan O., Sahinkaya Y., Yuce T., Kamali S., Gul A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.4, 2016 (SCI-Expanded, Scopus)

196. AUTOIMMUNE HEMOLYTIC ANEMIA AND THROMBOCYTOPENIA IN A SINGLE CENTRE COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM TURKEY: CLINICAL ASSOCIATIONS AND EFFECT ON DISEASE DAMAGE AND SURVIVAL

ESEN B., Kamali S., GÜL A., Ocal L., İNANÇ M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.4, 2016 (SCI-Expanded, Scopus)

197. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)

Demirkaya E., Acikel C., Hashkes P., Gattorno M., Gül A., Ozdogan H., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.6, ss.1051-1056, 2016 (SCI-Expanded, Scopus)

198. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

WINTHROP K. L., PARK S., Gül A., CARDIEL M. H., GOMEZ-REINO J. J., TANAKA Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.6, ss.1133-1138, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

199. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever

Gül A.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , cilt.30, sa.2, ss.296-303, 2016 (SCI-Expanded)

200. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

Kisacik B., Pamuk O. N., Onat A. M., Erer S. B., Hatemi G., Ozguler Y., et al.
JOURNAL OF RHEUMATOLOGY , cilt.43, sa.3, ss.524-529, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

201. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients

Demir S., Artim-Esen B., Sahinkaya Y., Pehlivan Ö., Alpay-Kanitez N., Omma A., et al.
LUPUS , cilt.25, sa.2, ss.177-184, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

202. MEFV gene p.Met694Val variation is not associated with subacute thyroiditis in Turkish patients

Gul N., Soyluk Ö., Sariman M., Abaci N., Sirma-Ekmekci S., Aral F., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.14758-14761, 2016 (SCI-Expanded) Creative Commons License

203. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

ZHOU Q., WANG H., SCHWARTZ D. M., STOFFELS M., PARK Y. H., ZHANG Y., et al.
NATURE GENETICS , cilt.48, sa.1, ss.67-75, 2016 (SCI-Expanded, Scopus)

204. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

Ombrello M. J., Remmers E. F., Tachmazidou I., Grom A., Foell D., Haas J., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.112, sa.52, ss.15970-15975, 2015 (SCI-Expanded, Scopus)

205. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behcet Syndrome: Report from OMERACT 2014

Hatemi G., Ozguler Y., Direskeneli H., Mahr A., Gul A., Levı V., et al.
JOURNAL OF RHEUMATOLOGY , cilt.42, ss.2436-2441, 2015 (SCI-Expanded, Scopus)

206. 'MHC-I-opathy'-unified concept for spondyloarthritis and Behcet disease

McGonagle D., Aydin S. Z., Gül A., Mahr A., Direskeneli H.
NATURE REVIEWS RHEUMATOLOGY , cilt.11, sa.12, ss.731-740, 2015 (SCI-Expanded)

207. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

AYDIN S. Z., DIRESKENELI H., SREIH A., ALIBAZ-ONER F., Gul A., Kamali S., et al.
JOURNAL OF RHEUMATOLOGY , cilt.42, sa.12, ss.2465-2469, 2015 (SCI-Expanded, Scopus)

208. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.

Kucuksezer U. C., Aktas-Cetin E., Bilgic-Gazioglu S., Tugal-Tutkun I., Gül A., Deniz G.
Clinical and experimental rheumatology , cilt.33, sa.6 Suppl 94, 2015 (SCI-Expanded, Scopus)

209. Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF)

Fidan K., Kavaklioglu G., Ebrahimi A., Ozlu C., Ay N. Z., Ruacan A., et al.
STEM CELL RESEARCH , cilt.15, sa.3, ss.694-696, 2015 (SCI-Expanded)

210. Natural killer cells dominate a Th-1 polarised response in Behcet's disease patients with uveitis

Kucuksezer U. C., Aktas-Cetin E., Bilgic-Gazioglu S., Tugal-Tutkun I., Gül A., Deniz G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)

211. Development and Validation of Diagnostic Criteria for Cryopyrin Associated Periodic Syndromes

Kuemmerle-Deschner J. B., ÖZEN S., Tyrrell P. N., Kone-Paut I., Goldbach-Mansky R., Lachmann H., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

212. Salivary IL-1 Alpha and IL-1 Beta Levels Are Associated with Oral Mucosal Activity in Behcet's Disease

Kanitez N. A., Toz B., Berktas F., Ergun S., Koray M., Polat N. G., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

213. High Rate and Bimodal Pattern of Severe Infection in a Selected ANCA Associated Vasculitis Cohort

Aydin E., Toz B., Erer B., Erelel M., Gocmez A., Gül A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

214. 'Epistatic interactions between autoimmunity and genetic thrombophilia' Reply

Bakir-Gungor B., Remmers E. F., Meguro A., Mizuki N., Kastner D. L., Gül A., et al.
EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.23, sa.10, ss.1279-1280, 2015 (SCI-Expanded)

215. Prenatal diagnosis and postnatal outcome of persistent right ductus arteriosus: a report of three cases

Ekiz A., GÜL A., Uludogan M., Bornaun H.
JOURNAL OF MEDICAL ULTRASONICS , cilt.42, sa.4, ss.571-574, 2015 (SCI-Expanded)

216. Budd-Chiari Syndrome in Behcet's Disease: a Retrospective Multicenter Study

Akyol L., Toz B., Bayndar O., Zengin O., ÜSKÜDAR CANSU D., Yigit M., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

217. Cogan Syndrome: Differential Response to Biologic Agents and Role of PET-CT in the Increased Diagnosis of Aortitis

Toz B., Erer B., Kamali S., Tugal-Tutkun I., Ocal L., GÜL A.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

218. Autoimmune Hemolytic Anemia and Thrombocytopenia in a Single Centre Cohort of Patients with Systemic Lupus Erythematosus from Turkey : Clinical Associations and Effect on Disease Damage and Survival

Artim-Esen B., Kamali S., GÜL A., Ocal L., İNANÇ M.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

219. Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab

Toz B., İNANÇ M., Erer B., ŞENTÜRK N., Kamali S., Ocal L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

220. Lung Damage in ANCA Associated Vasculitis Assessed By Vasculitis Damage Index: Recurrent Pulmonary Infections Have a Significant Contribution

Aydin E., Toz B., Erer B., Kanitez N. A., Erelel M., Gocmez A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

221. Quality of Life Changes with Canakinumab Therapy in Adults with Colchicine Resistant FMF

Gül A., Ozdogan H., Kasapcopur O., Erer B., Ugurlu S., SEVGI S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

222. HA20: A Novel Autoinflammatory Disease Caused By Haploinsufficiency of A20, Encoded By TNFAIP3

Zhou Q., Wang H., Schwartz D. M., Stoffels M., Park Y. H., Zhang Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

223. The perceptions of pediatricians regarding their self-efficacy in child neglect and abuse

Gul H., YÜRÜMEZ E., Yaylali F. H., Gul A.
TURKISH JOURNAL OF PEDIATRICS , cilt.57, sa.5, ss.475-481, 2015 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

224. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey

Akkoc N., Direskeneli H., Erdem H., Gül A., KABASAKAL Y., KİRAZ S., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.35, sa.9, ss.1473-1478, 2015 (SCI-Expanded)

225. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

Gül A., Ozdogan H., Erer B., Ugurlu S., Kasapcopur O., Davis N., et al.
ARTHRITIS RESEARCH & THERAPY , cilt.17, 2015 (SCI-Expanded)

226. Pathogenesis of Beh double dagger et's disease: autoinflammatory features and beyond

Gul A.
SEMINARS IN IMMUNOPATHOLOGY , cilt.37, sa.4, ss.413-418, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

227. SALIVARY IL-1 ALPHA AND IL-1 BETA LEVELS ASSOCIATED WITH ORAL MUCOSAL DISEASE ACTIVITY IN BEHCET'S DISEASE

Alpay-Kanitez N., Toz B., Berktas F., Guzel M., Ergun S., Koray M., et al.
ANNALS OF THE RHEUMATIC DISEASES , ss.403-404, 2015 (SCI-Expanded, Scopus)

228. MATHEMATICAL MODELING OF BEHCET'S DISEASE: A DYNAMICAL SYSTEMS APPROACH

Erdem C., Bozkurt Y., Erman B., Gül A., Demir A.
JOURNAL OF BIOLOGICAL SYSTEMS , cilt.23, sa.2, ss.231-257, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

229. A VERY HIGH PREVALANCE OF AVASCULAR NECROSIS IN TURKISH PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S): PRELIMINARY RESULTS FROM A SINGLE CENTRE

Toz B., Erer B., Kanitez N. A., Esen B. A., GÜL A., İNANÇ M., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1110-1111, 2015 (SCI-Expanded, Scopus)

230. VALIDITY AND RELIABILITY OF MEDICATION ADHERENCE SCALE IN FMF (ADULT VERSION)

Fidanci B. E., Yesilkaya S., Acikel C., Ozden A., Simsek D., Yildiz F., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1274-1275, 2015 (SCI-Expanded)

231. LUNG DAMAGE IN ANCA ASSOCIATED VASCULITIS ASSESSED BY VASCULITIS DAMAGE INDEX: RECURRENT PULMONARY INFECTIONS HAVE A SIGNIFICANT CONTRIBUTION

Aydin E., Toz B., Erelel M., Gocmez A., Erer B., Kanitez N. A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.513, 2015 (SCI-Expanded, Scopus)

232. HIGH RATE AND BIMODAL PATTERN OF SEVERE INFECTION IN A SELECTED ANCA ASSOCIATED VASCULITIS COHORT

Aydin E., Toz B., Erelel M., Erer B., Esen B. A., Gul A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.525-526, 2015 (SCI-Expanded, Scopus)

233. Identification of possible pathogenic pathways in Behcet's disease using genome-wide association study data from two different populations

Bakir-Gungor B., Remmers E. F., Meguro A., Mizuki N., Kastner D. L., Gül A., et al.
EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.23, sa.5, ss.678-687, 2015 (SCI-Expanded)

234. Favourable pregnancy outcome in Takayasu arteritis: a single-centre experience

Alpay-Kanitez N., Omma A., Erer B., Artim-Esen B., Gül A., Inanc M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.2, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

235. Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a

Aydinoglu-Candan O., Araz-Ersan B., Gül A., Badur S., Tugal-Tutkun I.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.253, sa.3, ss.457-465, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

236. Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes

Bozkurt Y., Demir A., Erman B., Gül A.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE , 2015 (SCI-Expanded, Scopus)

237. The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis

ÇETİN G. Y., Ganiyusufoglu E., Solmaz D., Cagatay Y., Oner S. Y., Erer B., et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , cilt.22, sa.3, ss.207-208, 2015 (SCI-Expanded, Scopus)

238. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded, Scopus)

239. Familial Mediterranean fever phenotype and MEFV variations

Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.6, 2014 (SCI-Expanded, Scopus)

240. HLA-DRB1*1101, Regulatory Variants of the MHC, and a Regulatory Region Near an Intergenic Long Noncoding RNA on Chromosome 1 Are Risk Factors for Systemic Juvenile Idiopathic Arthritis.

Ombrello M. J., Remmers E. F., Tachmazidou I., Grom A., Foell D., Martini A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

241. Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

Kisacik B., Pamuk O., Onat A. M., Erer B., Hatemi G., Ozguler Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

242. Evaluation of KIR3DL1/KIR3DS1 Association with Behcet's Disease in Turkish Individuals.

Erer B., Remmers E. F., Takeuchi M., Satorius C., Ustek D., Tugal-tutkun I., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

243. Genetic susceptibility to Behcet's disease

Gul A.
ORAL DISEASES , cilt.20, ss.2, 2014 (SCI-Expanded)

244. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center.

Artim-Esen B., Çene E., Sahinkaya Y., Ertan S., Pehlivan O., Kamali S., et al.
The Journal of rheumatology , cilt.41, sa.7, ss.1304-10, 2014 (SCI-Expanded, Scopus)

245. Increased IL-23 receptor, TNF-alpha and IL-6 expression in individuals with the IL23R-IL12R132 locus polymorphism

Cavus F., Ulusoy C., Orcen A., Gül A., Tuzun E., Vural B.
IMMUNOLOGY LETTERS , cilt.160, sa.1, ss.96-98, 2014 (SCI-Expanded, Scopus)

246. Impact of rheumatoid arthritis in Turkey: a questionnaire study

Direskeneli H., Akkoc N., Bes C., CAKIR N., ÇEFLE A., Cobankara V., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, ss.477-483, 2014 (SCI-Expanded, Scopus)

247. Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity

OMBRELLO M. J., KIRINO Y., de Bakker P. I. W., Gül A., KASTNER D. L., REMMERS E. F.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.111, sa.24, ss.8867-8872, 2014 (SCI-Expanded)

248. Does FMF gene exist in multiple sclerosis and contribute to the progression?

Ozaras N., Akman-Demir G., Ustek D., Eraksoy M., Abaci N., Gül A.
NEUROLOGY ASIA , cilt.19, sa.2, ss.235-236, 2014 (SCI-Expanded, Scopus) Creative Commons License

249. Üveitli Behçet Hastalarında Atak Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırıması

KÜÇÜKSEZER U. C., TAHRALI İ., BİLGİÇ GAZİOĞLU S., ÇETİN E., GÜL A., Tuğal Tutkun İ., et al.
Deneysel Tıp Dergisi , cilt.3, sa.6, ss.23-28, 2014 (Hakemli Dergi)

250. Treatment of Familial Mediterranean Fever: Colchicine and Beyond

Gul A.
ISRAEL MEDICAL ASSOCIATION JOURNAL , cilt.16, sa.5, ss.281-284, 2014 (SCI-Expanded, Scopus)

251. FMF50: a score for assessing outcome in familial Mediterranean fever

ÖZEN S., Demirkaya E., DÜZOVA A., Erdogan O., ERKEN E., Gül A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.73, sa.5, ss.897-901, 2014 (SCI-Expanded, Scopus)

252. Identification of multiple genetic susceptibility loci for Behcet's disease

Takeuchi M., Mizuki N., Meguro A., Tugal-Tutkun I., Ozyazgan Y., Ohno S., et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.55, sa.13, 2014 (SCI-Expanded, Scopus)

253. Genetics of Behcet's disease: lessons learned from genomewide association studies

Gul A.
CURRENT OPINION IN RHEUMATOLOGY , cilt.26, sa.1, ss.56-63, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

254. MEFV gene variations in patients with systemic lupus erythematosus

Erer B., Cosan F., Oku B., Ustek D., Inanc M., Aral O., et al.
MODERN RHEUMATOLOGY , cilt.24, sa.1, ss.93-96, 2014 (SCI-Expanded, Scopus)

255. Comparative Analysis of Spondyloarthritis (SPA) Associated with Familial Mediterranean Fever (FMF) and Behcet Disease (BD): 50 Year-Experience

Dilsen N., Konice M., Aral O., Ocal L., Inanc M., Gül A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

256. Effects of Smoking in Patients with Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis Receiving TNF Inhibitors

Pehlivan O., YALÇINKAYA Y., HÜSEYİNSİNOĞLU N., Kanitez N. A., Esen B. A., Erer B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

257. Behcet's Syndrome According to Classical and Population Genetics

Meguro A., Mizuki N., Gül A., Kitaichi N., Ohno S.
BEHCET'S SYNDROME: FROM PATHOGENESIS TO TREATMENT , ss.25-37, 2014 (SCI-Expanded)

258. Üvietli Behçet Hastalarında Atak Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırılması.

KÜÇÜKSEZER U. C., Tahrali I., Gazioglu S. B., ÇETİN E., GÜL A., Tugal-Tutkun I., et al.
Deneysel Tıp Dergisi , cilt.3, sa.6, ss.23-38, 2013 (Hakemli Dergi)

259. Üveitli Behçet Hastalarında Atak-Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırılması

KÜÇÜKSEZER U. C., TAHRALI İ., BİLGİÇ GAZİOĞLU S., ÇETİN E., GÜL A., TUTKUN N. İ., et al.
Deneysel Tıp Araştırma Enstitüsü Dergisi , cilt.3, sa.6, ss.23-28, 2013 (Hakemli Dergi)

260. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behcet's disease

Vural B., Sehitoglu E., Cavus F., Yalcinkaya N., Haytural H., Kucukerden M., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.139-144, 2013 (SCI-Expanded, Scopus)

261. PRODUCTIVITY LOSS DUE TO SICK LEAVE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.662-663, 2013 (SCI-Expanded, Scopus)

262. POOR IMMUNIZATION WITH HEPATITIS B VACCINATION IN PATIENTS WITH GRANULOMATOSIS WITH POLIANGIITIS (WEGENER'S) AND MORE FAVORABLE ANTIBODY RESPONSE IN FEMALES

Kara E., Erer B., Esen B. A., Omma A., Sahinkaya Y., Kanitez N., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.385, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

263. INDIRECT COSTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.1029, 2013 (SCI-Expanded, Scopus)

264. CROSS-SECTIONAL ASSESSMENT OF DAMAGE IN TAKAYASU ARTERITIS WITH A VALIDATED TOOL

Omma A., Erer B., KARADAĞ Ö., YILMAZ N., Oner F. A., YILDIZ F., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.224, 2013 (SCI-Expanded, Scopus)

265. ANKYLOSING SPONDYLITIS HEALTH CARE COSTS AND ASSOCIATED DISEASE ACTIVITY SCORES IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.
VALUE IN HEALTH , cilt.16, sa.3, 2013 (SCI-Expanded, SSCI, Scopus)

266. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease

Kirino Y., Zhou Q., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.20, ss.8134-8139, 2013 (SCI-Expanded, Scopus)

267. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey

Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.3, 2013 (SCI-Expanded, Scopus)

268. A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases

Cosan F., YAZICI A., Yilmazer B., Gül A., Ustek D., ÇEFLE A.
CLINICAL RHEUMATOLOGY , cilt.32, 2013 (SCI-Expanded, Scopus)

269. Beh‡et's disease: immunological relevance with arthritis of ankylosing spondylitis

Cetin E., Cosan F., Kucuksezer U. C., Bilgic S., Cagatay Y., Gül A., et al.
RHEUMATOLOGY INTERNATIONAL , sa.3, ss.733-741, 2013 (SCI-Expanded, Scopus)

270. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1

Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.
NATURE GENETICS , cilt.45, sa.2, ss.202-207, 2013 (SCI-Expanded, Scopus)

271. Expression of regulatory receptors on γδ T Cells and their cytokine production in Behcet's disease

Parlakgul G., Guney E., Erer B., Kilicaslan Z., Direskeneli H., Gül A., et al.
Arthritis Research and Therapy , cilt.15, sa.1, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

272. INDIRECT COSTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.
VALUE IN HEALTH , cilt.15, sa.7, 2012 (SCI-Expanded, SSCI, Scopus)

273. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

Alpay N., Sumnu A., Caliskan Y., Yazici H., Turkmen A., Gül A.
RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.10, ss.3277-3279, 2012 (SCI-Expanded)

274. Behçet Hastalarında SWAP70 Antikorunun İncelenmesi

uğurel e., karabulut a., GÜL A., güre a. o., TÜZÜN E., ÖZBEK U., et al.
Deneysel Tıp Dergisi , cilt.2, sa.2, ss.22-29, 2012 (Hakemli Dergi)

275. PRODUCTIVITY LOSS OF ANKYLOSING SPONDYLITIS PATIENTS IN TURKEY DUE TO SICK LEAVE

Akkoc N., Hamuryudan V., Durguner B., Direskeneli H., Gul A., Kabasakal Y., et al.
VALUE IN HEALTH , cilt.15, sa.4, 2012 (SCI-Expanded, SSCI, Scopus)

276. Investigation of Swap70 antibody in patients with Behcet’s disease

Uğurel E., Karabulut A., Gül A., Güre A., Shugaiv E., Tüzün E., et al.
EXPERIMED , cilt.2, sa.4, ss.22-29, 2012 (Hakemli Dergi)

277. Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

Gül A., Tugal-Tutkun I., Dınarello C. A., Reznıkov L., Esen B. A., Mırza A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.563-566, 2012 (SCI-Expanded, Scopus)

278. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology

Kamali S., Artim-Esen B., Erer B., Ozdener L., Gül A., Ocal L., et al.
CLINICAL RHEUMATOLOGY , cilt.31, sa.2, ss.325-328, 2012 (SCI-Expanded, Scopus)

279. HLA-B*51 and Behcet Disease

Gül A., Ohno S.
OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.20, sa.1, ss.37-43, 2012 (SCI-Expanded, Scopus)

280. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.

SAYARLIOGLU M., YUZBASIOGLU N., Inanc M., KAMALI S., CEFLE A., KARAMAN O., et al.
Rheumatology international , cilt.32, ss.177-82, 2012 (SCI-Expanded, Scopus)

281. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study

Esen B. A., Yilmaz G., Uzun S., Ozdamar M., Aksozek A., Kamali S., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.1, ss.79-83, 2012 (SCI-Expanded, Scopus)

282. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

KUEMMERLE-DESCHNER J. B., HACHULLA E., CARTWRIGHT R., Hawkins P. N., TRAN T. A., Bader-Meunier B., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.70, sa.12, ss.2095-2102, 2011 (SCI-Expanded, Scopus)

283. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease

Vural B., Ugurel E., Tuzun E., Kurtuncu M., Zuliani L., Cavus F., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.91-97, 2011 (SCI-Expanded, Scopus)

284. Familial Mediterranean Fever and Seronegative Arthritis

AKKOÇ N., Gül A.
CURRENT RHEUMATOLOGY REPORTS , cilt.13, sa.5, ss.388-394, 2011 (SCI-Expanded, Scopus)

285. The regulation of MEFV expression and its role in health and familial Mediterranean fever

Grandemange S., Aksentijevich I., Jeru I., Gul A., Touitou I.
GENES AND IMMUNITY , cilt.12, sa.7, ss.497-503, 2011 (SCI-Expanded)

286. TNF-alpha antagonist therapy modify the tuberculin skin test response

Cagatay T., Kilicaslan Z., Cagatay P., Mertsoylu M., Gulbaran Z., Yildiz R., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.31, sa.9, ss.1147-1151, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

287. Genome-wide association studies in Behcet's disease: expectations and promises

Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.29, sa.4, 2011 (SCI-Expanded, Scopus)

288. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome

Yildirim G., Gungoruduk K., Aslan H., GÜL A., Bayraktar M., Ceylan Y.
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION , cilt.12, sa.2, ss.90-96, 2011 (ESCI, Scopus, TRDizin)

289. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

CEFLE A., Inanc M., SAYARLIOGLU M., KAMALI S., Gul A., Ocal L., et al.
Rheumatology international , cilt.31, ss.183-9, 2011 (SCI-Expanded, Scopus)

290. Association of Familial Mediterranean Fever-Related MEFV Variations With Ankylosing Spondylitis

Cosan F., Ustek D., Oku B., Duymaz-Tozkir J., Cakiris A., Abaci N., et al.
ARTHRITIS AND RHEUMATISM , cilt.62, sa.11, ss.3232-3236, 2010 (SCI-Expanded, Scopus)

291. Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis

Cagatay T., Aydin M., Sunmez S., Cagatay P., Gulbaran Z., Gül A., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.11, ss.1459-1463, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

292. HSP 60 expression in recurrent oral ulcerations of Behcet's disease

Deniz E., Guc U., Buyukbabani N., Gül A.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY , cilt.110, sa.2, ss.196-200, 2010 (SCI-Expanded, Scopus)

293. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease

REMMERS E. F., Cosan F., KIRINO Y., OMBRELLO M. J., Abaci N., SATORIUS C., et al.
NATURE GENETICS , sa.8, ss.698-704, 2010 (SCI-Expanded, Scopus)

294. Recurrent anterior uveitis in Henoch Schonlein's vasculitis

Erer B., Kamali S., Cingu K., Kilicaslan I., Gül A., Inanc M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.10, ss.1377-1379, 2010 (SCI-Expanded, Scopus)

295. HOMOZYGOUS 3.1KB DELETION IN LEPREL1 INTRON1 PROTECTS FROM BEHCET'S DISEASE

Kirino Y., Ombrello M. J., Gül A., Cosan F., Miss B. Y., Gadina M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

296. EXPRESSION OF TRANSCRIPTION FACTORS OF CD4+T HELPER CELLS IN BEHCET'S DISEASE

Parlakgul G., Yilmaz V., Guney E., Guner H. A., Erer B., Direskeneli H., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

297. ROLE OF GAMMA DELTA plus T CELLS IN BEHCET'S DISEASE

Guney E., Parlakgul G., Erer B., Direskeneli H., Gül A., Direskeneli G. S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

298. AUTOANTIBODY RESPONSES AGAINST PINK1 AND SWAP70 ANTIGENS IN BEHCET'S DISEASE

Ugurel E., Vural B., Cavus F., Ozbek U., Gül A., GÜRE A. O.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

299. GENETIC PREDISPOSITION FOR LOW IL-10 EXPRESSION IS ASSOCIATED WITH BEHCET'S DISEASE

Gül A., Kirino Y., Ustek D., Ombrello M. J., Cosan F., Yang B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

300. Predicting Important Residues and Interaction Pathways in Proteins Using Gaussian Network Model: Binding and Stability of HLA Proteins

HALİLOĞLU T., Gül A., Erman B.
PLOS COMPUTATIONAL BIOLOGY , cilt.6, sa.7, 2010 (SCI-Expanded, Scopus)

301. SAFE, RAPID-ONSET, AND SUSTAINED BIOLOGICAL ACTIVITY OF IL-1BETA REGULATING ANTIBODY XOMA 052 IN RESISTANT UVEITIS OF BEHCET'S DISEASE: PRELIMINARY RESULTS OF A PILOT TRIAL

Gül A., Artim-Esen B., Solinger A., Giustino L., Tugal-Tutkun I.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

302. A GENOME-WIDE ASSOCIATION STUDY IDENTIFIES COMMON VARIANTS OF THE IL10 AND IL23R GENES THAT CONTRIBUTE TO BEHCET'S DISEASE SUSCEPTIBILITY

Remmers E. F., Cosan F., Kirino Y., Ombrello M. J., Yang B., Kaklamani V. G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

303. EXPRESSION OF NK RECEPTORS ON GD T CELLS IN BEHCET'S DISEASE

Parlakgul G., Guney E., Erer B., Ergen A., Gül A., Direskeneli G. S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

304. PULMONARY PERFUSION SCINTIGRAPHY FINDINGS IN BEHCET'S DISEASE

Cosan F., Adalet I., Artim-esen B., Aral O., Gül A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

305. Comment on the article by Durmus et al. "Clinical significance of MEFV mutations in ankylosing spondylitis"

AKKOÇ N., Gül A.
JOINT BONE SPINE , cilt.77, sa.3, ss.281, 2010 (SCI-Expanded, Scopus)

306. AB0413] THE DETERMINATION OF ANTI-TOPOISOMERASE I, ANTI-CENP-B AND ANTI-RNA POLYMERASE III AUTOANTIBODIES BY ELISA AND COMPARISON WITH CLINICAL PARAMETERS IN SYSTEMIC SCLEROSIS

Cagatay Y., Gurel-Polat N., Artim-Esen B., Kamali S., Gul A., Ocal L., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.2, 2010 (SCI-Expanded)

307. Predictors of Damage and Survival in Patients with Wegener's Granulomatosis: Analysis of 50 Patients

Kamali S., Erer B., Artim-Esen B., Gül A., Ocal L., Konice M., et al.
JOURNAL OF RHEUMATOLOGY , cilt.37, sa.2, ss.374-378, 2010 (SCI-Expanded, Scopus)

308. Comparison of argon laser photocoagulation-induced cutaneous inflammation and skin pathergy test in Behcet's disease

Sayarlioglu M., Calka O., Cinal A., Sayarlioglu H., Akdeniz N., Topcu N., et al.
CLINICAL RHEUMATOLOGY , cilt.29, sa.1, ss.59-63, 2010 (SCI-Expanded, Scopus)

309. Genetics of Behcet's Disease

Guel A., Ohno S.
BEHCET'S SYNDROME , ss.265-276, 2010 (SCI-Expanded)

310. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

HOUSSIAU F. A., VASCONCELOS C., D'CRUZ D., SEBASTIANI G. D., DE RAMON GARRIDO E., DANIELI M. G., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.69, sa.1, ss.61-64, 2010 (SCI-Expanded, Scopus)

311. Amyloid arthropathy mimicking seronegative rheumatoid arthritis in multiple myeloma: case reports and review of the literature

Alpay N., Artim-Esen B., Kamali S., Gül A., Kalayoglu-Besisik S.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , cilt.16, sa.4, ss.226-231, 2009 (SCI-Expanded, Scopus)

312. Low-dose natural human interferon-alpha lozenges in the treatment of Behcet's syndrome

Kilic H., Zeytin H. E., KORKMAZ C., Mat C., Gül A., Cosan F., et al.
RHEUMATOLOGY , cilt.48, sa.11, ss.1388-1391, 2009 (SCI-Expanded, Scopus)

313. Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gül A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.68, sa.10, ss.1528-1534, 2009 (SCI-Expanded, Scopus)

314. A novel TNFRSF1gene mutation in a Turkish family: a report of three cases

Cosan F., YAZICI A., ÇEFLE A., GÜL A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.27, sa.5, ss.715, 2009 (SCI-Expanded, Scopus)

315. Adult-onset Still's disease.

Cagatay Y., Gül A., Cagatay A., Kamali S., Karadeniz A. N., Inanc M., et al.
International journal of clinical practice , cilt.63, sa.7, ss.1050-5, 2009 (SCI-Expanded, Scopus)

316. Rosai-Dorfman disease with factor XII deficiency

Gunal E. K., Kamali S., Akdogan M. F., Cimen A. O., Ocal L., Agan M., et al.
CLINICAL RHEUMATOLOGY , cilt.28, sa.6, ss.733-736, 2009 (SCI-Expanded, Scopus)

317. No association of granzyme B gene polymorphism with Behcet's disease

Kucuksezer U. C., Duymaz-Tozkir J., Gül A., Saruhan-Direskeneli G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.27, sa.2, 2009 (SCI-Expanded, Scopus)

318. Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Behçet's disease.

Vural B., Demirkan A., Ugurel E., Kalaylioglu-Wheeler Z., Esen B., Gure A. O., et al.
Clinical and experimental rheumatology , cilt.27, sa.2, 2009 (SCI-Expanded, Scopus)

319. Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis

Gunal E. K., Kamali S., Gül A., Ocal L., Konice M., Aral O., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.29, sa.4, ss.365-370, 2009 (SCI-Expanded, Scopus)

320. No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behçet's disease

Cosan F., Oku B., Cakiris A., Duymaz-Tozkir J., Mercanoglu F., Saruhan-Direskeneli G., et al.
Clinical Rheumatology , cilt.28, sa.12, ss.1385-1388, 2009 (SCI-Expanded)

321. Investigation of Genomic Instability in Patients with Sjogren's Syndrome by Using Sister Chromatid Exchange Analysis

ERGUN S., Tanyeri H., Ozturk Ş., Duman N., Kamal S., GÜL A., et al.
ACTA STOMATOLOGICA CROATICA , cilt.42, sa.4, ss.318-325, 2008 (ESCI, Scopus) Sürdürülebilir Kalkınma

322. EULAR recommendations for the management of Behcet disease

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gül A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.67, sa.12, ss.1656-1662, 2008 (SCI-Expanded)

323. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet's disease

Takemoto Y., NARUSE T., Namba K., Kitaichi N., OTA M., SHINDO Y., et al.
TISSUE ANTIGENS , cilt.72, sa.4, ss.347-353, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

324. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behcet uveitis

Tugal-Tutkun I., Cingu K., Kir N., Yeniad B., Urgancioglu M., Gül A.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.246, sa.8, ss.1169-1177, 2008 (SCI-Expanded, Scopus)

325. Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis

Gunal E. K., Kamali S., Gül A., Ocal L., Konice M., Aral O., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.28, sa.10, ss.959-964, 2008 (SCI-Expanded, Scopus)

326. MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever

Uestek D., Ekmekci C., Oku B., Cosan F., Cakiris A., Abaci N., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

327. PULMONARY ARTERY ANEURYSM SCREENING IN PATIENTS WITH BEHCET'S DISEASE

Cosan F., Esen B. A., Cagatay Y., Tunaci A., Guel A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

328. PULMONARY ARTERY ANEURYSMS IN FEMALE PATIENTS WITH BEHCET'S DISEASE: REPORT OF 4 CASES

Cosan F., Esen B. A., Cagatay Y., Tunaci A., Gül A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

329. PEDIATRIC NEURO-BEHCET'S SYNDROME

Akman-Demir G., Saip S., Uluduz D., Kurtuncu M., Seyahi E., Tugal-Tutkun I., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2008 (SCI-Expanded, Scopus)

330. PARENCHYMAL INFLAMMATORY INFILTRATIONS PRECEDING PULMONARY ARTERY ANEURYSMS IN BEHCET'S DISEASE

Cosan F., Esen B. A., Cagatay Y., Kamali S., Tunaci A., Gül A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

331. EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S DISEASE: REPORT OF A TASK FORCE OF THE EUROPEAN STANDING COMMITTEE FOR INTERNATIONAL CLINICAL STUDIES INCLUDING THERAPEUTICS (ESCISIT)

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gul A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

332. MANAGEMENT OF BEHCET'S DISEASE: A SYSTEMATIC LITERATURE REVIEW FOR THE EULAR EVIDENCE BASED RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S DISEASE

Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gul A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

333. P SELECTIN GLYCOPROTEIN LIGAND I GENE VNTR POLYMORPISM AND RISK OF THROMBOSIS IN BEHCET'S DISEASE

Cosan F., Ustek D., Abaci N., Cakiris A., Kucukkaya R. D., Gül A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

334. DISTRIBUTION OF KILLER IMMUNOGLOBIN-LIKE RECEPTOR 3DL1/3DS1 ALLELES IN BEHCET'S DISEASE

Duymaz-Tozkir J., Ugurlu A., Uyar F. A., Norman P., Parham P., Saruhan-Direskeneli G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

335. Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey

Gunal E. K., Sarvan F., Karnali S., Gül A., Inanc M., Carin M., et al.
JOINT BONE SPINE , cilt.75, sa.3, ss.299-302, 2008 (SCI-Expanded, Scopus)

336. MEFV gene mutations and inflammatory bowel disease: Is there any effect?

AKYÜZ F., Besisik F., Pinarbasi B., DEMİR K., KAYMAKOĞLU S., Ozdil S., et al.
GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded, Scopus)

337. Cryopyrin associated periodic fever syndromes and a new CIAS1 mutation in Turkish patients

Ozdogan H., Hatemi G., Ustek D., Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.2, ss.203, 2008 (SCI-Expanded, Scopus)

338. The MEFV gene 3 '-UTR alu repeat polymorphisms in patients with Familial Mediterranean Fever

Ustek D., Ekmekci C., Oku B., Cosan F., Cakiris A., Abaci N., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.2, ss.176, 2008 (SCI-Expanded, Scopus)

339. Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behcet's disease in Turkey

MIZUKI N., MEGURO A., TOHNAI I., Guel A., Ohno S., MIZUKI N.
JAPANESE JOURNAL OF OPHTHALMOLOGY , cilt.51, sa.6, ss.431-436, 2007 (SCI-Expanded)

340. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.

Tufan F., Kamali S., ERER B., Gul A., Inanc M., OCAL L., et al.
Clinical rheumatology , cilt.26, sa.11, ss.1913-5, 2007 (SCI-Expanded, Scopus)

341. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis

Hazenberg B. P. C., Bijzet J., Limburg P. C., Skinner M., Hawkins P. N., Butrimiene I., et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , cilt.14, sa.2, ss.133-140, 2007 (SCI-Expanded, Scopus)

342. Anti-TNF therapy in the management of Behcet's disease - review and basis for recommendations

Sfikakis P. P., Markomichelakis N., Alpsoy E., Assaad-Khalil S., Bodaghi B., Gul A., et al.
RHEUMATOLOGY , cilt.46, sa.5, ss.736-741, 2007 (SCI-Expanded, Scopus)

343. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation

Ustek D., EKMEKCI C. G., Selcukbiricik F., Cakiris A., OKU B., Vural B., et al.
ARTHRITIS AND RHEUMATISM , cilt.56, sa.1, ss.345-350, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

344. Standard and novel therapeutic approaches to Behcet's disease

Gul A.
DRUGS , cilt.67, sa.14, ss.2013-2022, 2007 (SCI-Expanded, Scopus)

345. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?

Akman-Demir G., Gul A., Gurol E., Ozdogan H., Bahar S., Oge A. E., et al.
JOURNAL OF NEUROLOGY , cilt.253, sa.7, ss.928-934, 2006 (SCI-Expanded, Scopus)

346. Distribution of common CARD15 variants in patients with sporadic Crohn's disease: Cases from Turkey

Uyar F. A., Over-Hamzaoglu H., Ture F., Gul A., Tozun N., Saruhan-Direskeneli G.
DIGESTIVE DISEASES AND SCIENCES , cilt.51, sa.4, ss.706-710, 2006 (SCI-Expanded, Scopus)

347. Selective pressures for the high prevalence of MEFV variants induced by smallpox infection in the "Old World": A hypothesis

Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.24, sa.2, ss.213, 2006 (SCI-Expanded, Scopus)

348. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjogren's syndrome, and Wegener's granulomatosis

KAMALI S., POLAT N., KASAPOGLU E., GUL A., OCAL L., ARAL O., et al.
CLINICAL RHEUMATOLOGY , cilt.24, sa.6, ss.673-676, 2005 (SCI-Expanded, Scopus)

349. Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients

KAMALI S., INANC M., GUL A., OCAL L., POLAT N., Kilicaslan I., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.26, sa.1, ss.16-20, 2005 (SCI-Expanded, Scopus)

350. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis

CEFLE A., KAMALI S., SAYARLIOGLU M., Inanc M., Ocal L., Aral O., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.25, sa.6, ss.442-446, 2005 (SCI-Expanded, Scopus)

351. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease - An open-label trial

Tugal-Tutkun I., MUDUN A., URGANCIOGLU M., Kamali S., KASAPOGLU E., Inanc M., et al.
ARTHRITIS AND RHEUMATISM , cilt.52, sa.8, ss.2478-2484, 2005 (SCI-Expanded, Scopus)

352. Impaired endothelium-dependent flow-mediated dilation in Behcet's disease: more prominent endothelial dysfunction in patients with vascular involvement

OFLAZ H., MERCANOGLU F., KARAMAN O., KAMALI S., ERER B., GENCHELLAC H., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.59, sa.7, ss.777-781, 2005 (SCI-Expanded, Scopus)

353. Whole-genome screening for susceptibility genes in multicase families with Behcet's disease

KARASNEH J., Gul A., OLLIER W., SILMAN A., WORTHINGTON J.
ARTHRITIS AND RHEUMATISM , cilt.52, sa.6, ss.1836-1842, 2005 (SCI-Expanded, Scopus)

354. Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behcet's disease

KARASNEH J., HAJEER A., SILMAN A., WORTHINGTON J., OLLIER W., Gul A.
RHEUMATOLOGY , cilt.44, sa.5, ss.614-617, 2005 (SCI-Expanded, Scopus)

355. Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

KAMALI S., CEFLE A., SAYARLIOGLU M., Gul A., Inanc M., Ocal L., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.25, sa.3, ss.211-214, 2005 (SCI-Expanded, Scopus)

356. Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases

SAYARLIOGLU M., CEFLE A., Inanc M., KAMALI S., DALKILIC E., Gul A., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.59, sa.2, ss.202-205, 2005 (SCI-Expanded, Scopus)

357. Characteristics of patients with late onset systemic lupus erythematosus in Turkey

SAYARLIOGLU M., CEFLE A., KAMALI S., GUL A., Inanc M., OCAL L., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.59, sa.2, ss.183-187, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

358. Familial Mediterranean fever (FMF) in Turkey - Results of a nationwide multicenter study

Tunca M., Akar S., Onen F., Ozdogan H., KASAPÇOPUR Ö., Yalcinkaya F., et al.
MEDICINE , cilt.84, sa.1, ss.1-11, 2005 (SCI-Expanded, Scopus)

359. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behcet's disease

Duymaz-Tozkir J., Yilmaz V., Uyar F., Hajeer A., Saruhan-Direskeneli G., Gul A.
JOURNAL OF RHEUMATOLOGY , cilt.32, sa.1, ss.93-97, 2005 (SCI-Expanded, Scopus)

360. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial - Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

HOUSSIAU F., VASCONCELOS C., D'CRUZ D., SEBASTIANI G., GARRIDO E., DANIELI M., et al.
ARTHRITIS AND RHEUMATISM , cilt.50, sa.12, ss.3934-3940, 2004 (SCI-Expanded)

361. Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome

MERCANOGLU F., ERDOGAN D., OFLAZ H., KUCUKKAYA R., SELCUKBIRICIK F., GUL A., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.58, sa.11, ss.1003-1007, 2004 (SCI-Expanded, Scopus)

362. Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus

ALANSARI A., GUL A., Inanc M., ORDI J., TEH L., OLLIER W., et al.
SAUDI MEDICAL JOURNAL , cilt.25, sa.10, ss.1445-1448, 2004 (SCI-Expanded, Scopus)

363. Necrotizing crescentic glomerulonephritis with granulomatous vasculitis in a patient with familial Mediterranean fever and renal amyloidosis

CEFLE A., Kilicaslan I., GUL A., KAMALI S., INANC M., KONICE M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.22, sa.4, 2004 (SCI-Expanded, Scopus)

364. An unusual overdose of leflunomide in a patient with rheumatoid arthritis

KAMALI S., KASAPOGLU E., UYSAL M., Inanc M., Gul A.
ANNALS OF PHARMACOTHERAPY , cilt.38, ss.1320-1321, 2004 (SCI-Expanded, Scopus)

365. Common Crohn's disease-predisposing variants of the CARD15/NOD2 gene are not associated with Behcet's disease in Turkey

Uyar F. A., Saruhan-Direskeneli G., Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.22, sa.4, 2004 (SCI-Expanded, Scopus)

366. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behcet's disease

Sayarlioglu M., Kotan M., Topcu N., Bayram I., Arslanturk H., Gul A.
ANNALS OF PHARMACOTHERAPY , cilt.38, sa.5, ss.808-811, 2004 (SCI-Expanded, Scopus)

367. Expression of KIR and C-type lectin receptors in Behcet's disease

SARUHAN-DIRESKENELI G., UYAR F. A., CEFLE A., ONDER S., EKSIOGLU-DEMIRALP E., KAMALI S., et al.
RHEUMATOLOGY , cilt.43, sa.4, ss.423-427, 2004 (SCI-Expanded, Scopus)

368. Genetic heterogeneity in familial Mediterranean fever: Comment on the article by Cazeneuve et al

GÜL A.
ARTHRITIS AND RHEUMATISM , cilt.50, sa.4, ss.1355, 2004 (SCI-Expanded, Scopus)

369. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization

SAYARLIOGLU M., Inanc M., KAMALI S., CEFLE A., KARAMAN O., GUL A., et al.
LUPUS , cilt.13, sa.4, ss.274-278, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

370. Colchicine-induced myopathy in a teenager with familial editerranean fever

Sayarlioglu M., Sayarlioglu H., Ozen S., Erkoc R., Gul A.
ANNALS OF PHARMACOTHERAPY , cilt.37, sa.12, ss.1821-1824, 2003 (SCI-Expanded, Scopus)

371. Prevalence of Behçet's disease in Istanbul, Turkey.

Azizlerli G., Kose A., Sarica R., Gul A., Tutkun I., KULAC M., et al.
International journal of dermatology , cilt.42, sa.10, ss.803-6, 2003 (SCI-Expanded, Scopus)

372. Eosinophilia and hyperimmunoglobulinemia E as the presenting manifestations of Wegener's granulomatosis.

Kamali S., Kasapoglu E., Akturk F., Gul A., Inanc M., Ocal L., et al.
Clinical rheumatology , cilt.22, sa.4-5, ss.333-5, 2003 (SCI-Expanded, Scopus)

373. Human genome and diseases: Review immunology and functional genomics of Behcet's disease

Zierhut M., Mizuki N., Ohno S., Inoko H., Gul A., Onoe K., et al.
CELLULAR AND MOLECULAR LIFE SCIENCES , cilt.60, sa.9, ss.1903-1922, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

374. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease

KARASNEH J., HAJEER A., BARRETT J., OLLIER W., THORNHILL M., Gul A.
RHEUMATOLOGY , cilt.42, sa.7, ss.860-864, 2003 (SCI-Expanded, Scopus)

375. Tumour necrosis factor-alpha gene promoter region-308 and -376 G -> A polymorphisms in Behcet's disease

DUYMAZ-TOZKIR J., Gul A., UYAR F. A., OZBEK U., SARUHAN-DIRESKENELI G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.21, sa.4, 2003 (SCI-Expanded, Scopus)

376. IMPAIRED ENDOTHELIUM DEPENDENT FLOW-MEDIATED DILATION IN BEHCET'S DISEASE

Oflaz H., Karaman O., Kamali S., Erer B., Mercanoglu F., İNANÇ M., et al.
RHEUMATOLOGY , cilt.42, ss.135-136, 2003 (SCI-Expanded)

377. WHOLE GENOME SCREENING OF MULTICASE FAMILIES WITH BEHCET'S DISEASE

Karasneh J., GÜL A., Ollier W. E. R., Silman A., Worthington J.
RHEUMATOLOGY , cilt.42, ss.5, 2003 (SCI-Expanded, Scopus)

378. A patient with classical polyarteritis nodosa evolving into end stage renal failure

Kamali S., Gul A., Poyanli A., Cefle A., Sayarlioglu M., Inanc M., et al.
RENAL FAILURE , cilt.25, sa.6, ss.1037-1041, 2003 (SCI-Expanded, Scopus)

379. A weak association of HLA-B*2702 with Behcet's disease

Gul A., Uyar F. A., Inanc M., Ocal L., Barrett J., Aral O., et al.
GENES AND IMMUNITY , cilt.3, sa.6, ss.368-372, 2002 (SCI-Expanded, Scopus)

380. Immunosuppressive therapy in lupus nephritis - The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

HOUSSIAU F., VASCONCELOS C., D'CRUZ D., SEBASTIANI G., GARRIDO E., DANIELI M., et al.
ARTHRITIS AND RHEUMATISM , cilt.46, sa.8, ss.2121-2131, 2002 (SCI-Expanded, Scopus)

381. Transforming growth factor-beta 2 polymorphism and systemic lupus erythematosus

Alansari A., Hajeer A., Teh L., Bayat A., Mysercough A., Gul A., et al.
JOURNAL OF RHEUMATOLOGY , cilt.29, sa.6, ss.1189-1191, 2002 (SCI-Expanded, Scopus)

382. Transforming growth factor-12 polymorphism and systemic lupus erythematosus.

Alansari A., Hajeer A., Teh L., Bayat A., Mysercough A., Gül A., et al.
The Journal of rheumatology , cilt.29, sa.6, ss.1189-91, 2002 (SCI-Expanded)

383. POLYMORPHISMS IN THE ENDOTHELIAL NITRIC OXIDE SYNTHASE (eNOS) GENE ASSOCIATED WITH BEHCET'S DISEASE

Karasneh J. A., Gul A., Amoli M. M., Hajeer A. H., Worthington J., Ollier W. E. R.
RHEUMATOLOGY , cilt.41, ss.127-128, 2002 (SCI-Expanded, Scopus)

384. Association of the A561C E-selectin polymorphism with systemic lupus erythematosus in 2 independent populations

El-Magadmi M., Alansari A., Teh L., Ordi J., Gul A., Inanc M., et al.
JOURNAL OF RHEUMATOLOGY , cilt.28, sa.12, ss.2650-2652, 2001 (SCI-Expanded, Scopus)

385. Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23

Gul A., Hajeer A., Worthington J., Ollier W., Silman A.
ARTHRITIS AND RHEUMATISM , cilt.44, sa.11, ss.2693-2696, 2001 (SCI-Expanded, Scopus)

386. Cytokine gene polymorphism in patients with graft-versus-host disease after HLA-matched bone marrow transplantion.

ÖZBEK U., GURSES N., KALAYOGLU-BESISIK S., Aydin M., BILGEN H., ONGOREN S., et al.
BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded, Scopus)

387. Behcet's disease: An update on the pathogenesis

Gul A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.19, sa.5, 2001 (SCI-Expanded, Scopus)

388. Polymorphisms in the endothelial nitric oxide synthase gene associated with Behcet's disease.

Karasneh J., GÜL A., Hajeer A., Worthington J., Ollier W.
ARTHRITIS AND RHEUMATISM , cilt.44, sa.9, 2001 (SCI-Expanded)

389. Pulmonary manifestations of Behcet's disease

ERKAN F., Gul A., TASALI E.
THORAX , cilt.56, sa.7, ss.572-578, 2001 (SCI-Expanded)

390. Lack of association of HLA-B*51 with a severe disease course in Behcet's disease

Gul A., UYAR F. A., Inanc M., Ocal L., Tugal-Tutkun I., Aral O., et al.
RHEUMATOLOGY , cilt.40, sa.6, ss.668-672, 2001 (SCI-Expanded, Scopus)

391. Clinical course of ocular Behcet's disease in siblings

Onal S., Tuga-Tutkun I., Urgancioglu M., Gul A.
OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.9, sa.2, ss.111-124, 2001 (SCI-Expanded, Scopus)

392. Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test

GÜL A., Hajeer A., Worthington J., Barrett J., Ollier W., Silman A.
ARTHRITIS AND RHEUMATISM , cilt.44, sa.1, ss.239-240, 2001 (SCI-Expanded, Scopus)

393. Amyopathic dermatomyositis associated with cervical cancer

Celebi S., Gul A., Kamali S., Inanc M., Ocal L., Aral O., et al.
CLINICAL RHEUMATOLOGY , cilt.20, sa.6, ss.438-440, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

394. Fc receptor gamma subunit polymorphisms in systemic lupus erythematosus (SLE).

Alansari A., Gul A., Inanc M., Ordi J., Teh L., Ollier B., et al.
ARTHRITIS AND RHEUMATISM , cilt.43, sa.9, 2000 (SCI-Expanded)

395. Familial aggregation of Behcet's disease in Turkey

Gul A., Inanc M., Ocal L., Aral O., Konice M.
ANNALS OF THE RHEUMATIC DISEASES , cilt.59, sa.8, ss.622-625, 2000 (SCI-Expanded, Scopus)

396. Cytomegalovirus retinitis in a patient with Wegener's granulomatosis

Tugal-Tutkun I., Kir N., Gul A., KONICE M., URGANCIOGLU M.
OPHTHALMOLOGICA , cilt.214, sa.2, ss.149-152, 2000 (SCI-Expanded, Scopus)

397. Organizing pneumonia associated with pulmonary artery aneurysms in Behçet's disease.

Gul A., Yilmazbayhan D., Buyukbabani N., Lie J., Tunaci M., Tunaci A., et al.
Rheumatology (Oxford, England) , cilt.38, sa.12, ss.1285-9, 1999 (SCI-Expanded, Scopus)

398. Procoagulant mutations and venous thrombosis in Behcet's disease

Gul A., Aslantas A., Tekinay T., Konice M., Ozcelik T.
RHEUMATOLOGY , cilt.38, sa.12, ss.1298-1299, 1999 (SCI-Expanded, Scopus)

399. An evidence for linkage of HLA-B locus in Behcet's disease by transmission disequilibrium test.

GÜL A., Hajeer A., John S., Worthington J., Konice M., Ollier W., et al.
ARTHRITIS AND RHEUMATISM , cilt.42, sa.9, 1999 (SCI-Expanded)

400. CT findings of pulmonary artery aneurysms during treatment for Behçet's disease.

Tunaci M., Ozkorkmaz B., Tunaci A., Gul A., Engin G., Acunas B.
AJR. American journal of roentgenology , cilt.172, sa.3, ss.729-33, 1999 (SCI-Expanded, Scopus)

401. The use of two different Health Assessment Questionnaires in Turkish rheumatoid arthritis population and assessment of the associations with disability

SENERDEM N., Gul A., Konice M., Aral O., Ocal L., Inanc M., et al.
CLINICAL RHEUMATOLOGY , cilt.18, sa.1, ss.33-37, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

402. Detection of HGV-RNA in patients with Behcet's disease

Ulgen S., Sayhan N., Basgul S., Demiralp E., Sonsuz A., Hamzaoglu H., et al.
HEPATOLOGY , cilt.26, sa.4, ss.1962, 1997 (SCI-Expanded, Scopus)

403. HLA-B51 negative monozygotic twins discordant for Behcet's Disease [2]

Gul A., Inanc M., Ocal L., Aral O., Carin M. N., Konice M.
British Journal of Rheumatology , cilt.36, sa.8, ss.922-923, 1997 (SCI-Expanded, Scopus)

404. HLA-B51 negative monozygotic twins discordant for Behcet's disease

Gul A., Inanc M., Ocal L., Aral O., Carin M., Konice M.
BRITISH JOURNAL OF RHEUMATOLOGY , cilt.36, sa.8, ss.922-923, 1997 (SCI-Expanded, Scopus)

405. Peripheral blood T cell expansions in patients with Behcet's disease

Esin S., Gul A., Hodara V., JeddiTehrani M., Dilsen N., Konice M., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.107, sa.3, ss.520-527, 1997 (SCI-Expanded, Scopus)

406. Migrating monopredominant arthritis in children of Assyrian ancestry - Comment

Gul A., Aral O., Konice M.
JOURNAL OF RHEUMATOLOGY , cilt.23, sa.11, ss.2003, 1996 (SCI-Expanded, Scopus)

407. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease

GUL A., OZBEK U., Inanc M., KONICE M., OZCELIK T.
BRITISH JOURNAL OF RHEUMATOLOGY , cilt.35, sa.11, ss.1178-1180, 1996 (SCI-Expanded, Scopus)

408. Antibodies reactive with HIV-1 antigens in systemic lupus erythematosus

Gul A., Inanc M., YILMAZ G., Ocal L., Konice M., Aral O., et al.
LUPUS , cilt.5, sa.2, ss.120-122, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

409. Primary antiphospholipid syndrome associated with mesenteric inflammatory veno-occlusive disease

Gul A., Inanc M., Ocal L., Konice M., Aral O., LIE J.
CLINICAL RHEUMATOLOGY , cilt.15, sa.2, ss.207-210, 1996 (SCI-Expanded, Scopus)

410. Female genital tract giant cell arteritis associated with occult temporal arteritis

Inanc M., Gul A., Tuzlali S., Buyru F., Konice M., Aral O., et al.
JOURNAL OF RHEUMATOLOGY , cilt.23, sa.2, ss.393-395, 1996 (SCI-Expanded, Scopus)

411. IMMUNOHISTOLOGY OF SKIN PATHERGY REACTION IN BEHCETS-DISEASE

GUL A., ESIN S., DILSEN N., KONICE M., WIGZELL H., BIBERFELD P.
BRITISH JOURNAL OF DERMATOLOGY , cilt.132, sa.6, ss.901-907, 1995 (SCI-Expanded, Scopus)

412. Tükürük PH değerinin klinik tanıdaki yeri

KOÇAK BERBEROĞLU H., ÖNER B., GÜRKAN KÖSEOĞLU B., ÇEBİ Z., İNANÇ M., GÜL A.
Dişhekimliğinde klinik , cilt.2, ss.45-47, 1994 (Hakemli Dergi)

413. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

Mege J., DILSEN N., SANGUEDOLCE V., Gul A., BONGRAND P., ROUX H., et al.
The Journal of rheumatology , cilt.20, sa.9, ss.1544-9, 1993 (Scopus)

414. OVERPRODUCTION OF MONOCYTE-DERIVED TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-(IL)-6, IL-8 AND INCREASED NEUTROPHIL SUPEROXIDE GENERATION IN BEHCETS-DISEASE - A COMPARATIVE-STUDY WITH FAMILIAL MEDITERRANEAN FEVER AND HEALTHY-SUBJECTS

MEGE J., DILSEN N., SANGUEDOLCE V., GUL A., BONGRAND P., ROUX H., et al.
JOURNAL OF RHEUMATOLOGY , cilt.20, sa.9, ss.1544-1549, 1993 (SCI-Expanded, Scopus)

415. TUMOR-NECROSIS-FACTOR IN PATHOGENESIS OF FAMILIAL MEDITERRANEAN FEVER

DILSEN N., GUL A., MEGE J., SANGUEDOLCE M.
AMERICAN JOURNAL OF MEDICINE , cilt.93, sa.5, ss.587, 1992 (SCI-Expanded, Scopus)

416. INCREASED TNF-ALPHA, IL-6 PRODUCTION AND SUPEROXIDE GENERATION IN BEHCETS-DISEASE

MEGE J., DILSEN N., SANGUEDOLCE V., GUL A., BONGRAND P., OCAL L., et al.
BRITISH JOURNAL OF RHEUMATOLOGY , cilt.31, ss.214, 1992 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 341

1. ADALİMUMABIN İNSAN NK HÜCRELERİNDE APOPTOZ, HÜCRE SAĞKALIMI,PROLİFERASYON, ALT-GRUP ORANLARI, SİTOKİN SALINIMI VE SİTOTOKSİTEYE ETKİLERİ

Esen F., Kökoğlu A., Direskeneli R. H., Tugal Tutkun İ., Gül A., Deniz G., et al.
XXVII. Ulusal İmmünoloji Kongresi, Bursa, Türkiye, 26 Nisan 2026, ss.47, (Özet Bildiri)

2. Valvular heart disease in systemic lupus erythematosus and antiphospholipid syndrome: long-term outcomes and prognostic factors

Uludağ Ö., Karaca D., Çelik A. O., Karaca Özer P., Baykız D., İnce B., et al.
15th European Lupus Meeting, Lisbon, Portekiz, 4 - 07 Mart 2026, cilt.13, sa.1, ss.126, (Özet Bildiri) Creative Commons License

3. Clinical and Radiological Mimicry of Renal Malignancy in IgG4-Related Kidney Disease: A Case Report and Comprehensive Literature Review

Ergül R. B., Erdem S., Aydınoğlu A. T., Şanlı M. Ö., Özcan F., Hürdoğan Ö., et al.
IURES 2025 Kongresi, Muğla, Türkiye, 6 - 09 Kasım 2025, ss.40-43, (Özet Bildiri)

4. PHENOTYPE-SPECIFIC IMMUNE SIGNATURES IN BEHÇET'S DISEASE: A TRANSCRIPTOMIC AND CYTOKINE BASED APPROACH

DENİZ R., Gülfidan G., BES C., EMRENCE Z., ALİBAZ ÖNER F., SIRMA EKMEKCİ S., et al.
EULAR 2025, 11 Haziran 2025, (Özet Bildiri)

5. Analysis genomic profiles of type 2 diabetes patients with COVID-19 by next-generation sequencing method in Turkish population

Cacına C., Çakiris A., Abacı N., Sırma Ekmekci S., Bayrak A. E., Medetalibeyoğlu A., et al.
49th FEBS Congress, İstanbul, Türkiye, 5 - 09 Temmuz 2025, cilt.15, sa.2, ss.112, (Özet Bildiri)

6. Phenotypic and Functional Analysis of NK Cell Subsets in Behçet's Uveitis: Effects of Adalimumab Treatment and Comperative Inflammatory Responses with Axial Ankylosing Spondylitis

ESEN F., Kokoglu A., ÇETİN Ç., TÜRKYILMAZ Ö., DİRESKENELİ R. H., GÜL A., et al.
6th INTERNATIONAL MOLECULAR IMMUNOLOGY & IMMUNOGENETICS CONGRESS (MIMIC-VI), 28 Nisan 2025, (Özet Bildiri)

7. Erişkin yaşta tanı alan immün sistemin doğuştan kusurları hastalarının yönetiminde karşılaşılan problemler: Gerçek yaşamda zor vaka serisi.

ÜNAL D., DEMİR S., TOPRAK İ. D., KORKMAZ P., Hörmet İğde M., KILINÇ Z., et al.
30. ULUSLARARASI KATILIMLI ULUSAL ALLERJİ VE İMMÜNOLOJİ KONGRESİ, 01 Aralık 2024, (Tam Metin Bildiri)

8. 5-FLORO-1-(NAFTALEN-1-İL/2-İL)METİL-2-İNDOLİNON TÜREVLERİNİN DİZAYNI, SENTEZİ VE ANTİ-İNTERLÖKİN-1 AKTİVİTELERİ

SEVİNÇLİ Z. Ş., SOYLU ETER Ö., ERSOY B., Hasanusta B., Gatfar U., ERMAN B., et al.
VII. Ulusal Farmasötik Kimya Kongresi, İzmir, Türkiye, 26 Ekim 2024, cilt.1, ss.26, (Tam Metin Bildiri)

9. Analysis of Relapses in a Single Center Cohort of Patients with Lupus Nephritis

Kemeç G., Varelci S., Gürel E., Kılıçaslan I., Özlük M. Y., Yalçınkaya Y., et al.
ACR Convergence 2024, Washington, Amerika Birleşik Devletleri, 14 - 19 Kasım 2024, cilt.76, ss.1343-1344, (Özet Bildiri)

10. Cytokine Signature Differences in Major Phenotypic Groups of Behçet’s Disease

DENİZ R., EMRENCE Z., Punar S., İleri B., ARĞA K. Y., ALİBAZ ÖNER F., et al.
20th International Conference on Behçet’s Disease, Fas, 18 Eylül 2024, (Özet Bildiri)

11. BIOMARKERS OF DYSFUNCTIONAL HDL IN LUPUS NEPHRITIS AND ITS ASSOCIATION WITH SUBCLINICAL ATHEROSCLEROSIS

Zaralı S., Cingöz E., Çınar S., Baykız D., Poyanlı A., Bilge A. K., et al.
The European Alliance of Associations for Rheumatology, EULAR (2024), Vienna, Avusturya, 12 - 15 Haziran 2024, ss.1829, (Özet Bildiri)

12. The Relationship Between the NETosis Findings and Disease Activity in Behcet Disease

Bektaş E., Deniz R., Emrence Z., Sırma Ekmekci S., Abacı N., Amikishiyev S., et al.
ACR 2023, California, Amerika Birleşik Devletleri, 10 - 15 Kasım 2023, ss.4988-5002, (Özet Bildiri) Creative Commons License

13. Behçet hastalığında oral ve sistemik hastalık aktivitesi ile netosis bulguları arasındaki ilişki

Bektaş E., Deniz R., Emrence Z., Sırma Ekmekci S., Abacı N., Amikishiyev S., et al.
23. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, ss.26, (Tam Metin Bildiri)

14. Evaluatıon Of The Effıcacy And Complıcatıons Of Plasma Exchange In Anca- Assocıated Vasculıtıs: Results Of Propensıty Score Matchıng Analysıs In Hıgh-Rısk Patıents

İNCE B., BEKTAŞ M., ÇELİK B., YÜCE S., YALÇINKAYA Y., ARTIM ESEN B., et al.
ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY 2023, 31 Mayıs - 03 Haziran 2023, (Özet Bildiri)

15. Extra-Axial Manifestations in Patients with Axial Spondyloarthritis: The Course and Response to Therapeutic Agents

Yılmaz A., Bektaş E., Canik A., Artım Esen B., İnanç M., Gül A., et al.
EULAR Congress 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1701, (Tam Metin Bildiri)

16. EXTRA-AXIAL MANIFESTATIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS:THE COURSE AND RESPONSE TO THERAPEUTIC AGENTS

YILMAZ A., Bektas E., CANİK A., Artim-Esen B., İNANÇ M., GÜL A., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1701-1702, (Özet Bildiri) Sürdürülebilir Kalkınma

17. SERUM/URINE LEVELS AND EXPRESSION OF CD163 IN LUPUS NEPHRITIS

GÜREL E., ÇINAR S., HÜRDOĞAN Ö., ÖZLÜK M. Y., KILIÇASLAN I., VARELCİ S., et al.
EULAR 2023 European Congress of Rheumatology, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1493, (Özet Bildiri)

18. ABO Blood Groups and Increased Risk for Vascular Involvement in the Patients with Behçet’s Disease

Bektaş E., Büyükdemir A., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.
EULAR Congress 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1954, (Tam Metin Bildiri)

19. SARKOİDOZUN NADİR OLMAYAN BİR TUTULUMU: KEMİK SARKOİDOZU

AĞARGÜN B. F., Aghazada N., GÖKSOY SOLAK Y., ALTINKAYNAK M., AKPINAR T. S., SAKA B., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.148-149, (Tam Metin Bildiri)

20. TEKRARLAYAN LAKÜNER İNFARKTLAR VE SOL RETİNAL ARTER OKLÜZYONU İLE PREZENTE OLAN BİR ADENOZİN DEAMİNAZ 2 MUTASYONU

Doğan D., Sezgin M., Alkaç B., Gül A., Ekizoğlu Turgut E., Yeşilot N., et al.
58. ULUSAL NÖROLOJİ KONGRESİ , Antalya, Türkiye, 19 - 24 Kasım 2022, ss.777, (Özet Bildiri)

21. Behçet hastalığında ABO kan gruplarına göre vasküler tutulum riskinin değerlendirilmesi

Bektaş E., Büyükdemir A., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.
XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, ss.115, (Özet Bildiri)

22. Lupus nefritinde serum ve idrarda çözünür CD163’ün ve böbrek biyopsilerinde CD163 doku ekspresyonunun hastalık aktivitesiyle ilişkisi

GÜREL E., ÇINAR S., HÜRDOĞAN Ö., ÖZLÜK M. Y., KILIÇASLAN I., VARELCİ S., et al.
22. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, cilt.14, ss.15-16, (Özet Bildiri)

23. COVID-19 aşılaması sonrası yeni gelişen iki vaskülit olgumuzun literatür taramasıyla birlikte değerlendirilmesi

Alkaç B., Bektaş E., Tezel S., Denizmen D., Sarı S., Şanlı Y., et al.
XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, ss.247, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Sistemik Lupus Eritematozus ve Antifosfolipid Sendromlu Gebelerde Kompleman Sistemi Aktivasyonu ile TNF-alfa'nın gebelik seyir ve sonuçlarına etkisi

IŞIK A., ÇINAR S., ÖNDER S., BAYRAM A., SARAÇ SİVRİKOZ T., TÜRELİ D., et al.
TÜRKİYE MATERNAL FETAL TIP VE PERİNATOLOJİ DERNEĞİ 13.ULUSAL KONGRESİ, İstanbul, Türkiye, 12 - 16 Ekim 2022, (Özet Bildiri)

25. COVID-19 ve aşıları ile ilişkili rekürren perikardit olguları

Yılmaz A., Çetin O., Alagöz G., Atalar S. C., Amikishiyev S., Göksoy Solak Y., et al.
XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, cilt.14, sa.89, ss.265, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

26. Aa Amyloıdosıs In A Patıent Wıth Mutatıons In Both Ada2 And A20 Genes

AMİKİSHİYEV S., İNCE B., BEKTAŞ M., YALÇINKAYA Y., ARTIM ESEN B., İNANÇ M., et al.
EULAR 2022, 1 - 04 Haziran 2022, ss.1756-1757, (Özet Bildiri)

27. Development Of Malıgnancy In Patıent Wıth Anca-Assocıated Vasculıtıs

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., AĞARGÜN B. F., et al.
EULAR 2022, 1 - 04 Haziran 2022, (Özet Bildiri)

28. Amyloid Burden And Associated Factors Predict Highermortality And Poor Outcome In Familial Mediterranean Fever-Associated Aa Amyloidosis

BEKTAŞ M., KOCA N., OĞUZ E., İNCE B., SARI S., ŞENTÜRK ÖZTAŞ N., et al.
EULAR 2022, 1 - 04 Haziran 2022, (Özet Bildiri)

29. Amyloıd Storm Develops In Patıents Wıth Aa Amyloıdosıs And Assocıated Wıth Hıgher Amyloıd Burden And Increased Mortalıty

BEKTAŞ M., SARI S., KOCA N., OĞUZ E., İNCE B., YALÇINKAYA Y., et al.
EULAR 2022, 1 - 04 Haziran 2022, (Özet Bildiri)

30. Dıfferences In The Clınıcal Spectrum Of Haploınsuffıcıency Of A20 (Ha20) Cases Dıagnosed Durıng Adulthood

AMİKİSHİYEV S., ALİYEVA N., BEKTAŞ M., KOCA N., SOLTANOVA L., YALÇINKAYA Y., et al.
EULAR 2022, 1 - 04 Haziran 2022, (Özet Bildiri)

31. Vascular Events And Assocıated Factors In Anca-Assocıated Vasculıtıs: Analysıs Of 237 Patıents Wıth Long-Term Follow-Up

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., YALÇINKAYA Y., et al.
EULAR 2022, 1 - 04 Haziran 2022, (Özet Bildiri)

32. POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME

AMIKISHIYEV S., Deniz R., GÜNVER M. G., Aghamuradov S., Koca N., İNCE B., et al.
Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, sa.73, ss.937-938, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

33. AA AMYLOIDOSIS IN A PATIENT WITH MUTATIONS IN BOTH ADA2 AND A20 GENES

Amikishiyev S., Ince B., Bektas M., Yalcinkaya Y., Artim-Esen B., Inanc M., et al.
EULAR European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1756-1757, (Özet Bildiri) Creative Commons License

34. FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE

Oztas M., BEKTAŞ M., Karacan I., Aliyeva N., Dag A., Aghamuradov S., et al.
EULAR European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1660-1661, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

35. Serum and Urine Galectin-9, Ip-10 and Siglec-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus Compared to Anca-Associated Vasculitis: A Longitudinal Study

MİRİOĞLU Ş., ÇINAR S., ULUDAĞ Ö., GÜREL E., VARELCİ S., ÖZLÜK M. Y., et al.
59th ERA Congress, Paris, Fransa, 19 - 22 Mayıs 2022, cilt.37, ss.830-831, (Özet Bildiri)

36. COVID-19 ENFEKSİYONU SONRASI TEKRARLAYAN, ANTİ-IL-1 TEDAVİSİNE YANITLI BİR PLÖROPERİKARDİT TABLOSU: OLGU SUNUMU

ATALAR S. C., ÇETİN O., GÖKSOY SOLAK Y., ALTINKAYNAK M., AMIKISHIYEV S., AKPINAR T. S., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme 2022, Sakarya, Türkiye, 24 - 27 Mart 2022, ss.93-94, (Tam Metin Bildiri)

37. Pfizer-BioNTech BTN162b2 mRNA COVİD-19 aşısı sonrası gelişen büyük damar vasküliti

Bektaş E., Sarı S., Gül A.
Multidisipliner Vaskülit Sempozyumu , İstanbul, Türkiye, 16 Nisan 2022, ss.11-12, (Özet Bildiri) Sürdürülebilir Kalkınma

38. SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT

Demir B., Yalçınkaya Y., Can M. G., Aliyeva N., Amikishiyev S., Gül A., et al.
7th Systemic Sclerosis World Congress, 10 - 12 Mart 2022, ss.1, (Özet Bildiri)

39. ASSOCIATIONS OF ANTI-CENTROMERE ANTIBODY WITH DISEASE SEVERITY AND FUTURE ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS

Can M. G., Yalçınkaya Y., Demir B., Amikishiyev S., Artım Esen B., Gül A., et al.
7th Systemic Sclerosis World Congress, 10 - 12 Mart 2022, ss.1, (Özet Bildiri)

40. Konvansiyonel İmmünsupresif Tedaviye Dirençli Aktif Behçet Üveit Hastalarında NK Hücre Alt Grupları ve Fonksiyonlarının Değerlendirilmesi

Esen F., Kökoğlu A., Çetin Ç., Türkyılmaz Ö., Aksu Ceylan N., Oray M., et al.
Cerrahpaşa Behçet Hastalığı Sempozyumu-II, İstanbul, Türkiye, 18 - 19 Şubat 2022, ss.4, (Özet Bildiri)

41. Behçet Hastalığında Entegre Stres Yanıtının Rolü

Coşkuntan İ., Paçal F., Gül A., Sırma Ekmekci S., Abacı N.
XVII. Tıbbi Biyoloji ve Genetik Kongresi, Ankara, Türkiye, 28 - 31 Ekim 2021, cilt.52, ss.59-60, (Özet Bildiri)

42. COVID-19 ilişkili makrofaj aktivasyon sendromlu hastalarda anakinra tedavisine yanıtı öngörebilecek bulguların araştırılması

Amikishiyev S., Deniz R., Günver M. G., Aghamuradov S., Koca N., İnce B., et al.
Romatolojide Hedef 2021, İstanbul, Türkiye, 27 Ekim - 30 Kasım 2021, ss.10-11, (Özet Bildiri) Creative Commons License

43. Serum and urine Galectin-9,IP-10 and Siglec-1 as biomarkers of disease activity in patients with systemic Lupus Erythematosus

Mirioğlu Ş., ÇINAR S., ULUDAĞ Ö., GÜREL E., VARELCİ S., ÖZLÜK M. Y., et al.
ACR (American College of Rheumatology) Convergence 2021, Amerika Birleşik Devletleri, 05 Kasım 2021, cilt.73, ss.687-689, (Özet Bildiri)

44. Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus

MİRİOĞLU Ş., ÇINAR S., ULUDAĞ Ö., GÜREL E., VARELCİ S., ÖZLÜK M. Y., et al.
ACR Convergence 2021, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.73, ss.687-689, (Özet Bildiri)

45. Sistemik skleroz hastalarında COVID-19 enfeksiyonu sıklığı ve seyri: Tek merkez deneyimi

Aliyeva N., Yalçınkaya Y., Amikshiyev S., Bektaş M., Demir B., Can M. G., et al.
Romatolojide Hedef 2021, İstanbul, Türkiye, 27 - 30 Ekim 2021, ss.12-13, (Özet Bildiri) Sürdürülebilir Kalkınma

46. Renal transplant alıcılarında AA amiloidoz nüksünü saptamada non-invazif bir yöntem olarak transient elastografi (fibroscan)

Bektaş M., Dirim A. B., Çavuş B., Sarı S., Şenkal İ. V., Ağargün B. F., et al.
Romatolojide Hedef 2021, İstanbul, Türkiye, 27 - 30 Ekim 2021, ss.1-2, (Özet Bildiri) Creative Commons License

47. Sistemik skleroz hastalarında COVID-19 enfeksiyonu sıklığı ve seyri: Tek merkez deneyimi

Aliyeva N., Yalçınkaya Y., Amikshiyev S., Bektaş M., Demir B., Can M. G., et al.
Romatolojide Hedef 2021, İstanbul, Türkiye, 27 - 30 Ekim 2021, ss.12-13, (Özet Bildiri) Creative Commons License

48. Sistemik skleroz hastalarında COVID-19 enfeksiyonu sıklığı ve seyri: Tek merkez deneyimi

Aliyeva N., Yalçınkaya Y., Amikshiyev S., Bektaş M., Demir B., Can M. G., et al.
Romatolojide Hedef 2021, İstanbul, Türkiye, 27 - 30 Ekim 2021, ss.12-13, (Özet Bildiri) Sürdürülebilir Kalkınma

49. Performances of Different Classification Criteria for Systemic Lupus Erythematosus in a Single Center Cohort from Turkey

Torun E. S., Bektaş E., Kemik F., Bektaş M., Çetin Ç., Yalçınkaya Y., et al.
American College of Rheumatology 2021, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.72, ss.1-2, (Özet Bildiri) Creative Commons License

50. Transient Elastography (fi broscan); As a New Non-invasiveDiagnostic Method for Detecting Hepatic Involvement ofAmyloidosis

Bektaş M., Çavuş B., Ağargün B. F., Şenkal İ. V., Koca N., İnce B., et al.
ACR, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-4, (Özet Bildiri) Creative Commons License

51. More Frequent, Earlier Hip Involvement and Poor Outcome in Spondyloarthritis Associated with Familial Mediterranean Fever

Bektaş M., Sarı S., Çetin Ç., Yalçın Dulundu B. Ç., Koca N., İnce B., et al.
American college of Rheumatology 2021, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-6, (Özet Bildiri) Creative Commons License

52. Preliminary Criteria for Macrophage Activation SyndromeAssociated with Coronavirus Disease-19

Amikishiyev S., Günver M. G., Bektaş M., Aghamuradov S., İnce B., Koca N., et al.
American College of Rheumatology 2021, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-4, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

53. Transient Elastography (Fibroscan) as a Non-InvasiveMethod for Detecting Amyloid Deposition in TransplantedKidneys in Patients with AA Amyloidosis

Bektaş M., Çavuş B., Dirim A. B., Sarı S., Şenkal İ. V., Koca N., et al.
ACR, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-5, (Özet Bildiri) Creative Commons License

54. Is It Useful to Assess Muscle Involvement with Positron Emission Tomography in Patients with Idiopathic Inflammatory Myositis? A Case-Control Study

Bektaş M., Işık E. G., Kemik F., Oğuz E., Abbasgholı Zadeh A., İnce B., et al.
American college of Rheumatology 2021, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-5, (Özet Bildiri) Creative Commons License

55. Sistemik lupus eritematozus’ta hastalık ilişkili hasar COVİD-19 enfeksiyonunun seyrini olumsuz etkiler

Çetin Ç., Alıyeva N., Gülseren Ü. A., Torun E. S., Sarı S., Uludağ Ö., et al.
XXI.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, ss.14, (Özet Bildiri) Sürdürülebilir Kalkınma

56. Sistemik lupus eritematozuslu hastalarda hastalık aktivitesinin tayini ve takibinde serum ve idrar Galektin-6, IP-10 ve SIGLET-1'in biyobelirteç olarak rolü

Mirioğlu Ş., Çınar S., Uludağ Ö., Gürel E., Varelci S., Özlük M. Y., et al.
XXI. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.13, sa.1, ss.19, (Özet Bildiri) Creative Commons License

57. Biyopsiyle Gösterilmiş Lupus Nefriti Kohortunda Renal Prognozu Belirleyen Klinik ve Histopatolojik Özellikler

VARELCİ S., GÜREL E., MİRİOĞLU Ş., ÖZLÜK M. Y., KILIÇASLAN I., YAZICI H., et al.
21. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.13, ss.23-24, (Özet Bildiri)

58. Pulmoner hipertansiyonlu sistemik lupus eritematozus ve antifosfolipid sendromu hastalarının özellikleri

TORUN E. S., BAYKIZ D., IŞIK A., GÜREL E., KEMİK F., AĞARGÜN B. F., et al.
XXI. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.13, ss.51-52, (Özet Bildiri)

59. Aynı tablonun iki farklı yüzü: Sistemik jüvenil idiyopatik artrit ve erişkin başlangıçlı Still hastalığı

KÖKER TURAN O., SARI S., BEKTAŞ M., GÜL A., AKTAY AYAZ N.
21. Ulusal Romatoloji Kongresi, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.13, ss.9, (Tam Metin Bildiri)

60. Sistemik lupus eritematozus sınıflandırma kriterlerinin (1997, 2012, 2019) performanslarının tek merkezli kohort hastalarında karşılaştırılması: 2019 ACR/EULAR kriterleri ne getirdi?

Torun E. S., Bektaş E., Kemik F., Bektaş M., Çetin Ç., Yalçınkaya Y., et al.
Ulusal Romatoloji 2021, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.1, ss.20-21, (Özet Bildiri) Creative Commons License

61. Sistemik Lupus Eritematozuslu Hastalarda Hastalık Aktivitesinin Tayini ve Takibinde Serum ve İdrar Galektin-9, IP-10 ve SIGLEC-1’in Biyobelirteç Olarak Rolü

MİRİOĞLU Ş., ÇINAR S., ULUDAĞ Ö., GÜREL E., VARELCİ S., ÖZLÜK M. Y., et al.
21. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.13, ss.19, (Özet Bildiri)

62. SARS-CoV-2’nin Gizli Tehlikesi, Erişkinde Multisistem İnflamatuar Sendrom: Olgu Serisi

Benli A., Tor Y. B., Yavuz S., Çağatay A. A., Özsüt H., Gül A., et al.
Klimik COVID-19 Simpozyumu , İstanbul, Türkiye, 10 - 12 Eylül 2021, ss.59-61, (Özet Bildiri) Sürdürülebilir Kalkınma

63. ANCA ilişkili vaskülitte COVID-19 sıklığı ve seyri: Hipogammaglobulinemi mortalite için önemli bir risk faktörüdür

İnce B., Bektaş M., Koca N., Ağargün B. F., Zaralı S., Güzey D. Y., et al.
Ulusal Romatoloji 2021, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.1, ss.98-99, (Özet Bildiri) Sürdürülebilir Kalkınma

64. NK17 and Nkreg responses in patients with active Behçet’s uveitis

Esen F., Kökoğlu A., Çetin Ç., Türkyılmaz Ö., Aksu Ceylan N., Oray M., et al.
6th European Congress of Immunology (ECI 2021), Belgrade, Sırbistan, 1 - 04 Eylül 2021, ss.1, (Özet Bildiri)

65. İdiyopatik enflamatuvar miyopati hastalarında pozitron emisyon tomografisi ile kas tutulumu değerlendirilebilir mi? 34 hastanın değerlendirilmesi

Bektaş M., Işık E. G., Oğuz E., Kemik F., Abbasgholı Zadeh A., İnce B., et al.
Ulusal Romatoloji 2021, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, cilt.1, ss.25-26, (Özet Bildiri) Creative Commons License

66. Skleroderma Renal Krizi: Tek Merkezden izlenen Sistemik Sklerozlu Hastalarda Sıklığı ve Klinik Özellikleri

Alıyeva N., Yalçınkaya Y., Amıkıshıyev S., Artım Esen B., Gül A., İnanç M.
21.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, (Yayınlanmadı)

67. Sistemik Skleroz Hastalarında COVID-19 İnfeksiyonu Sıklığı Ve Seyri: Hastaneye Yatış Riskini Artıran Faktörler

Alıyeva N., Yalçınkaya Y., Amıkıshıyev S., Bektaş M., Cömert R. G., Artım Esen B., et al.
21.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, (Yayınlanmadı) Sürdürülebilir Kalkınma

68. Biyolojik Tedavi Kullanan Ailevi Akdeniz Ateşi Hastalarında COVID-19 Seyri: Tek Merkez Deneyimi

Alıyeva N., Yalçın Dulundu B. Ç., Telli P., Suleymanova V., Artım Esen B., İnanç M., et al.
21.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, (Yayınlanmadı) Sürdürülebilir Kalkınma

69. Aa Amyloıdosıs In Patıents Wıth Psorıatıc Arthrıtıs: Clınıcal Features And Prognosıs Of Three Cases From A Sıngle Center Cohort

BEKTAŞ M., KOCA N., İNCE B., YALÇINKAYA Y., ARTIM ESEN B., ÖÇAL M. L., et al.
EULAR 2021, 2 - 05 Haziran 2021, (Özet Bildiri)

70. Performances of Different Classification Criteria for Systemic Lupus Erythematosus in a Single Center Cohort from Turkey

Torun E. S., Bektaş E., Kemik F., Bektaş M., Çetin Ç., Yalçınkaya Y., et al.
EULAR 2021 Virtual Congress, 2 - 06 Haziran 2021, ss.602-603, (Tam Metin Bildiri)

71. MORE FREQUENT AND EARLIER HIP INVOLVEMENT IN SPONDYLOARTHRITIS ASSOCIATED WITH FAMILIAL MEDITERRANEAN FEVER

Bektaş M., Sarı S., Çetin Ç., Yalçın Dulundu B. Ç., Koca N., İnce B., et al.
EULAR 2021, Zürich, İsviçre, 2 - 05 Haziran 2021, ss.951-952, (Özet Bildiri) Creative Commons License

72. SUCCESSFUL TEATMENT OF ANKYLOSING SPONDILITIS ASSOCIATED AA AMYLOIDOSIS WITH SECUKINUMAB: A CASE SERIES WITH THREE PATIENTS

BEKTAŞ M., KOCA N., OĞUZ E., ÇETİN Ç., İNCE B., YALÇINKAYA Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1409-1410, (Özet Bildiri) Creative Commons License

73. PRELIMINARY CRITERIA FOR MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH CORONAVIRUS DISEASE-19

AMIKISHIYEV S., Gunver M. G., BEKTAŞ M., AGHAMURADOV S., İNCE B., KOCA N., et al.
European Congress of Rheumatology, ELECTR NETWORK, 01 Ocak 2021, cilt.80, ss.191-192, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

74. HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FOR MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND COVID-19

İnce B., Bektaş M., Koca N., Ağargün B. F., Zaralı S., Güzey D. Y., et al.
EULAR 2021, Zürich, İsviçre, 2 - 05 Haziran 2021, ss.912-913, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

75. MINIMAL DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS AND ASSOCIATED FACTORS: REAL LIFE DATA FROM A SINGLE CENTER

BEKTAŞ M., ÇELİK B., İNCE B., YALÇINKAYA Y., Artim-Esen B., GÜL A., et al.
European Congress of Rheumatology, ELECTR NETWORK, 01 Ocak 2021, cilt.80, ss.282-283, (Özet Bildiri) Creative Commons License

76. COURSE OF COVID-19 INFECTION IN A SERIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

ÇETİN Ç., ALIYEVA N., YALÇINKAYA Y., GÜL A., İNANÇ M., Artim-Esen B.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1359, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

77. Psoriyatik artritte AA amiloidoz sıklığı: Tek merkez deneyimi

BEKTAŞ M., KOCA N., YALÇINKAYA Y., ARTIM ESEN B., İNANÇ M., Öcal M. L., et al.
ROMATOLOJİDE HEDEF 2020 SEMPOZYUMU, Türkiye, 18 Kasım 2020, (Tam Metin Bildiri) Creative Commons License

78. Ankilozan spondilit ilişkili AA amiloidozun sekukinumab ile başarılı tedavisi: üç hastalık olgu serisi

Bektaş M., Koca N., Oğuz E., Çetin Ç., İnce B., Yalçınkaya Y., et al.
Ulusal Romatoloji Buluşması 2020, Antalya, Türkiye, 12 - 17 Ekim 2020, ss.36-37, (Özet Bildiri) Creative Commons License

79. Deri paterji testinin behçet hastalığı tanısındaki duyarlılık ve özgüllüğünün geliştirilmesi

Deniz R., Emrence Z., Yalçınkaya Y., Artım Esen B., İnanç M., Öçal M. L., et al.
21. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 12 - 17 Ekim 2020, ss.10-11, (Özet Bildiri)

80. BAŞVURU ANI TAM KAN SAYIMI PUANLAMASININ COVID-19 HASTALARINDA İLERLEYİCİ HASTALIĞI GÖSTERMEDE ROLÜ

ÖZBALAK M. M., BEŞIŞIK S., TOR Y. B., MEDETALİBEYOĞLU A., KÖSE M., Şenkal N., et al.
46. Ulusal Hematoloji Kongresi, Türkiye, 28 - 31 Ekim 2020, (Özet Bildiri)

81. Aveolar Hemoraji ile Prezente Olan Sjögren Sendromu

KARATEKİN B., PIHTILI A., BİNGÖL Z., KIYAN E., OKUMUŞ N. G., GÜL A.
Türk Toraks Derneği 23. Yıllık Kongre, Türkiye, 15 - 18 Ekim 2020, (Özet Bildiri)

82. Ankilozan Spondilit İlişkili AA Amiloidozun Sekukinumab İle Başarılı Tedavisi Üç Hastalık Olgu Serisi

BEKTAŞ M., KOCA N., OĞUZ E., ÇETİN Ç., İNCE B., YALÇINKAYA Y., et al.
XXI. ULUSAL ROMATOLOJİ KONGRESİ, 12 - 17 Ekim 2020, ss.36-37, (Özet Bildiri)

83. Psöriyatik artrit (PsA) hastalarının minimal disease activity (MDA) oranları ve etki eden faktörler: Tek merkezli gerçek yaşam verileri

BEKTAŞ M., YALÇINKAYA Y., ARTIM ESEN B., GÜL A., Öcal M. L., İNANÇ M.
ULUSAL ROMATOLOJİ BULUŞMASI, Türkiye, 12 Ekim 2020, (Tam Metin Bildiri) Creative Commons License

84. İNFLİKSİMAB SONRASI DEMİYELİNİZAN POLİNÖROPATİ GELİŞEN BİR ANKİLOZAN SPONDİLİT İLİŞKİLİ AMİLOİDOZ VAKASINDA SEKUKİNUMAB DENEYİMİ

BEKTAŞ M., YALÇINKAYA Y., ARTIM ESEN B., Öcal M. L., GÜL A., İNANÇ M.
ANKARA ROMATOLOJİ TOPLANTISI 2020, Türkiye, 04 Eylül 2020, (Özet Bildiri)

85. Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients

BEŞIŞIK S., ÖZBALAK M. M., TOR Y. B., MEDETALİBEYOĞLU A., KÖSE M., Şenkal N., et al.
International Society on Thrombosis and Hemostasis Annual Congress 2020, 12 - 14 Temmuz 2020, (Özet Bildiri)

86. ANALYSIS OF 89 PATIENTS WITH GIANT CELL ARTERITIS FROM TURKEY: PET-CT AS AN EMERGING METHOD FOR DIAGNOSIS AND HIGH FLARE RATE WITH STANDARD CARE

İnce B., Artan S., Yalçınkaya Y., Artım Esen B., Gül A., Öçal M. L., et al.
European Congress of Rheumatology 2020, Frankfurt, Almanya, 3 - 07 Haziran 2020, cilt.79, sa.1, ss.1540, (Tam Metin Bildiri)

87. THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND SEVERITY IN SYSTEMIC SCLEROSIS: A PROSPECTIVE ANALYSIS OF 278 PATIENTS

Yalçınkaya Y., Alıyeva N., Amıkıshıyev S., Artım Esen B., Gül A., İnanç M.
european congress of rheumatology 2020, Frankfurt, Almanya, 3 - 07 Haziran 2020, ss.406, (Özet Bildiri)

88. The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus eryhtematosus

ÇETİN Ç., SARAÇ SİVRİKOZ T., ATEŞ M., TORUN E. S., ZARALI S., YALÇINKAYA Y., et al.
ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY EULAR 2020, Amsterdam, Hollanda, 3 - 06 Haziran 2020, (Özet Bildiri)

89. THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND SEVERITY IN SYSTEMIC SCLEROSIS: A PROSPECTIVE ANALYSIS OF 278 PATIENTS

Yalçınkaya Y., Aliyeva N., Amikishiyev S., Çağatay Y., Artım Esen B., Gül A., et al.
european congress of rheumatology 2020, Frankfurt, Almanya, 3 - 07 Haziran 2020, cilt.79, ss.406, (Tam Metin Bildiri)

90. EVALUATION OF DIFFERENT CLASSIFICATION CRITERIA IN SYSTEMIC SCLEROSIS IN A TURKISH COHORT: THE IMPORTANCE OF NON-SKIN MANIFESTATIONS, SEROLOGY AND CAPILLAROSCOPY

Yalçınkaya Y., Amıkıshıyev S., Artım Esen B., Alıyeva N., Gül A., İnanç M.
european congress of rheumatology 2020, Frankfurt, Almanya, 3 - 07 Haziran 2020, ss.416, (Özet Bildiri)

91. INVESTIGATION OF PERMANENT ORGAN DAMAGE IN GIANT CELL ARTERITIS: DISEASE FLARES ARE ASSOCIATED WITH INCREASED DAMAGE SCORES

Ince B., Artan S., Yalçınkaya Y., Artım Esen B., Gül A., Öçal M. L., et al.
European congress of rheumatology 2020, Frankfurt, Almanya, 3 - 07 Haziran 2020, cilt.79, sa.1, ss.1540-1541, (Tam Metin Bildiri)

92. Anca-Assocıated Vasculıtıs: Clınıcal Features, Relapse, Organ Damage And Survıval In 197 Patıents

BEKTAŞ M., İNCE B., AĞARGÜN B. F., GÜZEY D. Y., YALÇINKAYA Y., ARTIM ESEN B., et al.
EULAR 2020, 03 Haziran 2020, (Özet Bildiri)

93. RISK FACTORS FOR ADVERSE PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

ÇETİN Ç., Sarac-Sivrikoz T., Ates-Tikiz M., TORUN E. S., ERSOY A., YALÇINKAYA Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1038, (Özet Bildiri)

94. ANALYSIS OF 89 PATIENTS WITH GIANT CELL ARTERITIS FROM TURKEY: PET-CT AS AN EMERGING METHOD FOR DIAGNOSIS AND HIGH FLARE RATE WITH STANDARD CARE

İNCE B., ARTAN S., YALÇINKAYA Y., Artim-Esen B., GÜL A., ÖCAL M., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1536-1537, (Özet Bildiri) Creative Commons License

95. CLINICAL ASPECTS, LABORATORY CHARACTERISTICS AND TREATMENT RESPONSES OF AA AMYLOIDOSIS: SINGLE CENTER EXPERIENCE WITH 163 PATIENTS

BEKTAŞ M., Koca N., Oguz E., Ince B., Yalcinkaya Y., Artim-Esen B., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.171, (Özet Bildiri)

96. ANCA-ASSOCIATED VASCULITIS: CLINICAL FEATURES, RELAPSE, ORGAN DAMAGE AND SURVIVAL IN 197 PATIENTS

BEKTAŞ M., Ince B., Agargun B. F., Guzey D. Y., Yalcinkaya Y., Artim-Esen B., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1525, (Özet Bildiri)

97. HYDROXYCHLOROQUINE CONTROLS DISEASE ACTIVITY IN SLE AND MULTIMODAL IMAGING TECHNIQUES SHOULD BE USED TO DETECT OCULAR TOXICITY

İNCE B., OĞUREL M. B., CEBECİ Z., Tor Y. B., Ucar B. H., YALÇINKAYA Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1026-1027, (Özet Bildiri)

98. FEATURES AND RISK FACTORS OF SERIOUS INFECTIONS IN ANCA ASSOCIATED VASCULITIS: LONG TERM FOLLOW UP OF 186 PATIENTS

Ince B., BEKTAŞ M., KEMİK F., Aytun A. E., YALÇINKAYA Y., Artim-Esen B., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1069, (Özet Bildiri)

99. AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

GÜL A., KÜRTÜNCÜ M., Erdugan M., OĞUZ E., GÜNDÜZ T., DEMİR G., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1533-1534, (Özet Bildiri) Creative Commons License

100. INVESTIGATION OF PERMANENT ORGAN DAMAGE IN GIANT CELL ARTERITIS: DISEASE FLARES ARE ASSOCIATED WITH INCREASED DAMAGE SCORES

İNCE B., ARTAN S., YALÇINKAYA Y., Artim-Esen B., GÜL A., ÖCAL M., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1536, (Özet Bildiri) Creative Commons License

101. THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND SEVERITY IN SYSTEMIC SCLEROSIS: A PROSPECTIVE ANALYSIS OF 278 PATIENTS

YALÇINKAYA Y., ALIYEVA N., AMIKISHIYEV S., Cagatay Y., Artim-Esen B., GÜL A., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.402, (Özet Bildiri) Creative Commons License

102. VALIDATION OF THE ADJUSTED GLOBAL ANTIPHOSPHOLIPID SYNDROME SCORE AND CORRELATION WITH EXTRA-CRITERIA MANIFESTATIONS

Uludag O., BEKTAŞ M., ÇENE E., Yalcinkaya Y., Gul A., Inanc M., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1058, (Özet Bildiri)

103. THE EFFICACY AND SAFETY OF RITUXIMAB IN 27 CASES OF TREATMENT RESISTANT SYSTEMIC SCLEROSIS WITH SEVERE DISEASE ASSESSED BY ACTIVITY SCORES

YALÇINKAYA Y., Artim-Esen B., AMIKISHIYEV S., ALIYEVA N., GÜL A., Ocal L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1115, (Özet Bildiri)

104. EVALUATION OF DIFFERENT CLASSIFICATION CRITERIA IN SYSTEMIC SCLEROSIS IN A TURKISH COHORT: THE IMPORTANCE OF NON-SKIN MANIFESTATIONS, SEROLOGY AND CAPILLAROSCOPY

YALÇINKAYA Y., AMIKISHIYEV S., ALIYEVA N., Artim-Esen B., GÜL A., Ocal L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.412-413, (Özet Bildiri)

105. THE CORRELATION BETWEEN PREGNANCY, DISEASE ACTIVITY AND ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

ÇETİN Ç., Sarac-Sivrikoz T., Ates-Tikiz M., TORUN E. S., ZARALI S., YALÇINKAYA Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.660, (Özet Bildiri)

106. SİSTEMİK LUPUS ERİTEMATOZUS’TA HASTALIK İLİŞKİLİ HASAR COVİD-19 ENFEKSİYONUNUN SEYRİNİ ETKİLİYOR MU?

Çetin Ç., Alıyeva N., Yalçınkaya Y., Gül A., İnanç M., Artım Esen B.
14.Anadolu Romatoloji Günleri, Ankara, Türkiye, 26 - 30 Mayıs 2020, ss.22-23, (Özet Bildiri) Sürdürülebilir Kalkınma

107. Serum Baff and Aprıl as Candıdate Bıomarkers in Systemıc Lupus Erythematosus (Sle): A Prospectıve Follow-Up Study

SARI S., ÇINAR S., ARTIM ESEN B., GÜL A., ÖCAL L., DENİZ G.
12th European Lupus Meeting, 23 Mart 2020

108. SERUM BAFF AND APRIL AS CANDIDATE BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE FOLLOW-UP STUDY

Sarı S., Çınar S., Artım Esen B., Gül A., Öcal L., Deniz G., et al.
12th European Lupus Meeting, Bruges, Belçika, 23 Mart 2020, ss.74, (Özet Bildiri)

109. A MEFV Gene 3’UTR Region Alu-Repeats May Have an Effecton The Gene Expression

EMRENCE Z., ABACI N., Cosan F., Azakli H., ÇAKİRİS A., Cakar A., et al.
6th International Congress on FMF and SAID,. Autoinflamation 2010, Hollanda, ss.1, (Özet Bildiri)

110. An Insertion Mutation in the MDFIC (MyoD Family Inhibitor Domain Containing) Gene Defines a Novel Autoinflammatory Syndrome Associated with Lymphedema

GÜL A., ÜSTEK D., hatemi g., Azakli H., EMRENCE Z., Cosan F., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Amerika Birleşik Devletleri, ss.60, (Özet Bildiri)

111. Behçet Hastalığı ile takipli ilaç erüpsüyonu ilişkili tekrarlayan oral aft, genital ülser olan hasta

Koca N., Yalçın Dulundu B. Ç., Bektaş E., Oğuz E., Yalçınkaya Y., Artım Esen B., et al.
Cerrahpaşa Behçet Hastalığı Sempozyumu - I, İstanbul, Türkiye, 21 - 22 Şubat 2020, ss.19, (Özet Bildiri)

112. Sistemik Vaskülit Kliniği İle Prezente Olan İnfektif Endokardit Olgusu

Alıyeva N., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.
7. MARMARA ROMATOLOJİ GÜNÜ, İstanbul, Türkiye, 7 - 08 Şubat 2020, ss.6, (Özet Bildiri)

113. AILEVI AKDENIZ ATEŞI VE SCHNITZLER SENDROMU BIRLIKTELIĞI

Aghamuradov S., Kocatürk Göncü E., Amikishiyev S., Çetin Ç., Yalçınkaya Y., Artım Esen B., et al.
XIV. Romatoloji Uzmanlık Öğrencileri ve Uzmanları İçin Eğitim Kursu, Antalya, Türkiye, 9 - 12 Ocak 2020, ss.25, (Özet Bildiri) Creative Commons License

114. Behçet hatalığı patogenezinde doğal lenfoid hücrelerin rolü

GELMEZ M. Y., Özçit G., ÇETİN E., ÇINAR S., Erdugan M., BABUNA KOBANER G., et al.
XXIV. Prof Dr Lütfü Tat sempozyumu, Ankara, Türkiye, 20 - 24 Kasım 2019, ss.152, (Özet Bildiri)

115. Behçet Hastalığı Patogenezinde Doğal Lenfoid Hücrelerin Rolü

GELMEZ M. Y., Özçit G., ÇETİN E., ÇINAR S., ERDUGAN M., BABUNA KOBANER G., et al.
24. Prof. Dr. A. Lütfi Tat Sempozyumu, Ankara, Türkiye, 20 - 24 Kasım 2019, ss.110, (Tam Metin Bildiri)

116. Amiloidoza bağlı guatr saptanan hastaların klinik özellikleri

TORUN E. S., MİRİOĞLU Ş., BEKTAŞ M., CANBAY TORUN B., BAKKALOĞLU H., TÜRKMEN A., et al.
20. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.54-55, (Özet Bildiri)

117. Yayg›n organ tutulumlu sistemik lupus eritematozus hastas› ve geliflen paradoksal emboliler

Ağargün B. F., Koca N., Bektaş M., Kemik F., Yalçınkaya Y., Artım Esen B., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.205-206, (Özet Bildiri) Creative Commons License

118. Tek merkezden izlenen 197 ANCA iliflkili vaskülit hastas›n›n klinik özellikleri, sa¤kal›m, mortalite ve hasar verileri

Bektaş M., İnce B., Ağargün B. F., Güzey D. Y., Yalçınkaya Y., Artım Esen B., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.221-222, (Özet Bildiri) Creative Commons License

119. Yayg›n organ tutulumlu sistemik lupus eritematozus hastas› ve geliflen paradoksal emboliler

Ağargün B. F., Koca N., Bektaş M., Kemik F., Yalçınkaya Y., Artım Esen B., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.205-206, (Özet Bildiri)

120. Ailevi Akdeniz atefli tan›l› hastalarda yüksek transaminaz seyrinin klinik yan›t ile iliflkisi

Şentürk Öztaş N., Deniz R., Oğuz E., Çetin Ç., Bektaş M., Artım Esen B., et al.
Ulusal Romatoli Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.69-70, (Özet Bildiri) Creative Commons License

121. Tek merkezde izlenen 138 ailevi Akdeniz atefline ba¤l› AA amiloidoz hastas›n›n klinik seyir ve tedavi yan›tlar›

Bektaş M., Koca N., Oğuz E., Yalçınkaya Y., Artım Esen B., İnanç M., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.62-64, (Özet Bildiri) Creative Commons License

122. Pankardit ile prezente olan bir SLE olgusu

Kemik F., Bektaş M., Koca N., Ağargün B. F., Kuş F., Artım Esen B., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 20 Ekim 2019, ss.206, (Özet Bildiri) Creative Commons License

123. Sistemik lupus eritematozuslu hastalarda olumsuz gebelik seyri ile iliflkili risk faktörleri

Çetin Ç., Saraç Sivrikoz T., Ateş Tıkız M., Bektaş M., Ersoy A., Yalçınkaya Y., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.203-204, (Özet Bildiri)

124. Antifosfolipid sendromunda uyarlanm›fl Global Antifosfolipid Sendromu Skoru’nun validasyonu ve kriter d›fl› klinik bulgular ile iliflkisi

Uludağ Ö., Bektaş M., Çene E., Yalçınkaya Y., Gül A., Öçal M. L., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.199-200, (Özet Bildiri) Creative Commons License

125. Tek merkezde izlenen 158 AA amiloidoz hastas›n›n demografik ve klinik özellikleri

Koca N., Bektaş M., Oğuz E., Yalçınkaya Y., Artım Esen B., İnanç M., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.70, (Özet Bildiri) Creative Commons License

126. Yayg›n organ tutulumlu sistemik lupus eritematozus hastas› ve geliflen paradoksal emboliler

Ağargün B. F., Koca N., Bektaş M., Kemik F., Yalçınkaya Y., Artım Esen B., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.205-206, (Özet Bildiri) Creative Commons License

127. Sistemik lupus eritematozuslu hastalarda olumsuz gebelik seyri ile ilişkili risk faktörleri

Çetin Ç., Saraç Sivrikoz T., Ateş Tıkız M., Bektaş M., Ersoy A., Yalçınkaya Y., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.203-204, (Özet Bildiri) Creative Commons License

128. Ankilozan spondilit (AS) ve psöriyatik artritte (PSA) sekukinumab deneyimi: Tek merkezden 45 hastan›n analizi

Bektaş M., Çetin Ç., Uğurlu Ç. B., Kemik F., Yalçınkaya Y., Artım Esen B., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.242-243, (Özet Bildiri) Creative Commons License

129. Sistemik lupus eritematozusda gebelik, hastalık aktivitesi ve olumsuz gebelik sonuçlarının ilişkisi

Çetin Ç., Saraç Sivrikoz T., Ateş Tıkız M., Zaralı S., Yalçınkaya Y., Gül A., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.30, (Tam Metin Bildiri) Creative Commons License

130. Silikozis ilişkili otoimmün hastalıklar ve anakinra tedavisinin anti-inflamatuvar etkinliği

Çetin Ç., Altundaş Hatman E., Yalçınkaya Y., İnanç M., Artım Esen B., Kıyan E., et al.
XX.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.151-153, (Özet Bildiri) Creative Commons License

131. Romatoid artrit tanılı› olguda anti-TNF tedavi sonrası gelişen demiyelinizan polinöropati

Aghamuradov S., Amikishiyev Ş., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.192-193, (Özet Bildiri)

132. Romatoid artrit tan›l› olguda anti-TNF tedavi sonras› geliflen demiyelinizan polinöropati

Aghamuradov S., Amikishiyev Ş., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M., et al.
XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.192-193, (Özet Bildiri) Creative Commons License

133. Dev hücreli arteritli 89 hastan›n klinik özellikleri ve takip sonuçları: Erken tanının önemi

İnce B., Artan S., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., GÜL A., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, (Tam Metin Bildiri)

134. Sınırlı sistemik skleroz ile takipli vakada gelişen santral sinir sistemi tutulumu özelliği

Amikishiyev S., Aliyeva N., YALÇINKAYA Y., Charkazzade M., Eraksoy M., ARTIM ESEN B., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.222, (Tam Metin Bildiri)

135. Antifosfolipid sendromunda uyarlanması Global Antifosfolipid Sendromu Skoru’nun validasyonu ve kriter dışı klinik bulgular ile ilişkisi

Uludağ Ö., Bektaş M., Çene E., YALÇINKAYA Y., GÜL A., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.199-200, (Tam Metin Bildiri)

136. Sistemik sklerozda yaygın ve sınırlı deri tutulumunda hastalık aktivitesi ile hastalık şiddeti ilişkisi: 278 hastanın prospektif kesitsel analizi

YALÇINKAYA Y., Aliyeva, N., Amikishiyev S., Çağatay Y., ARTIM ESEN B., GÜL A., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, (Tam Metin Bildiri)

137. Romatoid artrit tanılı› olguda anti-TNF tedavi sonrası gelişen demiyelinizan polinöropati

Aghamuradov S., Amikishiyev S., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., GÜL A., İNANÇ M., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.192-193, (Tam Metin Bildiri)

138. Sistemik lupus eritematozusda gebelik, hastalıkaktivitesi ve olumsuz gebelik sonuçlarının ilişkisi

Çetin Ç., Sivrikoz T. S., Tıkız M. A., Zaralı S., Aghamuradov S., Yalçınkaya (Şahinkaya) Y., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, (Tam Metin Bildiri)

139. Tedaviye dirençli ve şiddetli seyirli 27 sistemik skleroz hastasında rituksimab tedavisinin etkinliği ve güvenilirliği

YALÇINKAYA Y., ARTIM ESEN B., Amikishiyev S., Aliyeva N., GÜL A., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.218, (Tam Metin Bildiri)

140. Tek merkezde izlenen 138 ailevi Akdeniz ateŞine baĞlI AA amiloidoz hastasının klinik seyir ve tedavi yanıtları

Bektaş M., Koca N., Oğuz E., YALÇINKAYA Y., ARTIM ESEN B., İNANÇ M., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.62-63, (Tam Metin Bildiri)

141. Akciğer kanseri tedavisi sonrasında granülomatöz polianjiit gelişen iki olgu

Torun E. S., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., İNANÇ M., ÖÇAL M. L., GÜL A.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.90, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

142. Sistemik sklerozda sınıflandırma kriterlerinin de¤erlendirilmesi: Cilt dışı klinik bulgular, tırnak dibi kapillaroskopisi ve serolojinin önemi

YALÇINKAYA Y., Amikishiyev S., Aliyeva N., ARTIM ESEN B., GÜL A., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.219-220, (Tam Metin Bildiri)

143. Granülomatöz polianjitis hastasında AA-amiloidoz

Aliyeva N., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., İNANÇ M., ÖÇAL M. L., GÜL A.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.136, (Tam Metin Bildiri)

144. Yaygın organ tutulumlu sistemik lupus eritematozus hastası ve gelişen paradoksal emboliler

Ağargün B. F., Koca N., Bektaş M., Kemik F., GÜL A., YALÇINKAYA (Şahinkaya) Y., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.205-206, (Tam Metin Bildiri)

145. Dev hücreli arteritte organ hasarı: Hastalık alevlenmesi ve steroid tedavisinin hasar gelişimindeki önemi

İnce B., Artan S., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., GÜL A., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.90-91, (Tam Metin Bildiri)

146. Tedaviye dirençli ve şiddetli seyirli 27 sistemik skleroz hastasında rituksimab tedavisinin etkinliği ve güvenilirliği

Yalçınkaya Y., Artım Esen B., Amıkıshıyev S., Alıyeva N., Gül A., İnanç M.
20. Ulusal Romatoloji, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.218, (Özet Bildiri)

147. ANCA ilişkili vaskülit hastalarında uzun dönemde ciddi infeksiyon gelişimi ve risk faktörleri

Bektaş M., İnce B., YALÇINKAYA (ŞAHİNKAYA) Y., Altun A. E., ARTIM ESEN B., GÜL A., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.129-130, (Tam Metin Bildiri)

148. Sınırlı sistemik skleroz ile takipli vakada gelişen santral sinir sistemi tutulumu özelliği

Amıkıshıyev S., Alıyeva N., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M.
20.Ulusal Romatoloji, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.222, (Özet Bildiri)

149. Tek merkezden izlenen 197 ANCA ilişkili vaskülit hastasının klinik özellikleri, sağkalım, mortalite ve hasar verileri

BEKTAŞ M., İnce B., Ağargün B. F., YALÇINKAYA (Şahinkaya) Y., Güzey D. Y., ARTIM ESEN B., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.221-222, (Tam Metin Bildiri)

150. Sistemik sklerozda yaygın ve sınırlı deri tutulumunda hastalık aktivitesi ile hastalık şiddeti ilişkisi: 278 hastanın prospektif kesitsel analizi

Yalçınkaya Y., Alıyeva N., Amıkıshıyev S., Artım Esen B., Gül A., İnanç M.
20.Ulusal Romatoloji, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.30-31, (Özet Bildiri)

151. Anti-IL-1 tedavi ihtiyacı olan ailevi Akdeniz ateşi hastalarının özellikleri

Alıyeva N., Yalçın Dulundu B. Ç., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.
20.Ulusal Romatoloji, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.76-77, (Özet Bildiri)

152. Ankilozan spondilit (AS) ve psöriyatik artritte (PSA) sekukinumab deneyimi: Tek merkezden 45 hastanın analizi

BEKTAŞ M., ÇETİN Ç., Uğurlu Ç., Kemik F., YALÇINKAYA Y., ARTIM ESEN B., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.242-243, (Tam Metin Bildiri)

153. Amiloidoza bağlı guatr saptanan hastaların klinik özellikleri

Torun E. S., Mirioğlu Ş., Bektaş M., Canbay Torun B., Bakkaloğlu H., Türkmen A., et al.
20. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.54-55, (Tam Metin Bildiri)

154. Tek merkezde izlenen 158 AA amiloidoz hastasının demografik ve klinik özellikleri

Koca N., BEKTAŞ M., Oğuz E., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., İNANÇ M., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.70, (Tam Metin Bildiri)

155. Sistemik lupus eritematozuslu hastalarda olumsuz gebelik seyri ile iliflkili risk faktörleri

ÇETİN Ç., TIKIZ M. A., Sivrikoz T. S., Bektaş M., YALÇINKAYA Y., Ersoy A., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.203-204, (Tam Metin Bildiri)

156. Silikozis ilişkili otoimmün hastalıklar ve anakinra tedavisinin anti-inflamatuvar etkinli¤i

ÇETİN Ç., Hatman E. A., Amikishiyev S., YALÇINKAYA Y., ÖÇAL M. L., İNANÇ M., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.151-152, (Tam Metin Bildiri)

157. Sistemik sklerozda sınıflandırma kriterlerinin de¤erlendirilmesi: Cilt dışı klinik bulgular, tırnak dibi kapillaroskopisi ve serolojinin önemi

Yalçınkaya Y., Amıkıshıyev S., Alıyeva N., Artım Esen B., Gül A., İnanç M.
20.Ulusal Romatoloji, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.219-220, (Özet Bildiri)

158. Ailevi Akdeniz ateşinde IL-1 tedavisi tek merkez deneyimi

Yalçın Dulundu B. Ç., Alıyeva N., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.
20.Ulusal Romatoloji, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.56, (Özet Bildiri)

159. Ailevi Akdeniz ateŞi, makrofaj aktivasyon sendromu, Melkersson-Rosenthal sendromlu olgu

Amikishiyev S., YALÇINKAYA Y., ARTIM ESEN B., DEMİR S., İNANÇ M., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.59-60, (Tam Metin Bildiri)

160. Anti-IL-1 tedavi ihtiyacı olan ailevi Akdeniz ateşi hastalarının özellikleri

Aliyeva N., Yalçın Dulundu B. Ç., YALÇINKAYA (ŞAHİNKAYA) Y., ARTIM ESEN B., İNANÇ M., ÖÇAL M. L., et al.
XX.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, ss.76-77, (Tam Metin Bildiri)

161. ASSOCIATION OF HLA-DPB1(star)16:01 ALLELE WITH PR3-ANCA POSITIVE GRANULOMATOSIS WITH POLYANGIITIS IN TURKISH PATIENTS

Ince B., Kamali S., Ogret Y., Oguz F., Artim-Esen B., Inanc M., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1469-1470, (Özet Bildiri)

162. Korda rüptürü ile prezente olan relapsing polikondrit vakas›

Bektaş M., Aghamuradov S., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M., et al.
Romatolojide Hedef 2019 Sempozyumu, İstanbul, Türkiye, 17 - 20 Nisan 2019, ss.86, (Özet Bildiri) Creative Commons License

163. Goodpasture hastal›¤› seyrinde tekrarlayan atefl klini¤i ile ortaya ç›kan ailevi Akdeniz atefli olgusu

Amikishiyev S., Bektaş M., Yalçınkaya Y., Artım Esen B., Yazıcı H., İnanç M., et al.
Romatolojide Hedef 2019 Sempozyumu, İstanbul, Türkiye, 17 - 20 Nisan 2019, ss.76, (Özet Bildiri) Creative Commons License

164. ASSOCIATION OF SERUM AND URINE LEVELS OF TWEAK, MCP-1 AND NGAL WITH DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Mirioglu Ş., Cinar S., Yazici H., Gül A., Ocal L., Inanc M., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1166-1167, (Özet Bildiri)

165. SERUM BAFF AND APRIL AS CANDIDATE BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE FOLLOW-UP STUDY

Sari S., Cinar S., Artim-Esen B., Gül A., Ocal M. L., Deniz G., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1724, (Özet Bildiri)

166. THE OMERACT CORE DOMAIN SET FOR CLINICAL TRIALS IN BEHCET'S SYNDROME

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Shea B., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.431, (Özet Bildiri)

167. FAVORABLE RESPONSE TO RITUXIMAB IN A PATIENT WITH HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS ASSOCIATED WITH A HOMOZYGOUS FRAMESHIFT AGBL3 VARIANT

Gül A., Abaci N., Ekmekci S.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1469, (Özet Bildiri)

168. IN BEHÇET’S DISEASE INFLAMMATORY STATUS MIGHT DIRECT ILC CELLS TO ILC3+ SUBSET

GELMEZ M. Y., Özçit G., ÇETİN E., ÇINAR S., ERDUGAN M., BABUNA KOBANER G., et al.
International Molecular Immunology & Immunogenetics Congress IV ( MIMIC IV), Bursa, Türkiye, 27 - 29 Nisan 2019, cilt.PA123, ss.121, (Tam Metin Bildiri)

169. Granülomlu polianjiitin nadir bir prezentasyon flekli: Granülomlu mastit

Aghamuradov S., Nuriyev K., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M., et al.
Romatolojide Hedef 2019 Sempozyumu, İstanbul, Türkiye, 17 - 20 Nisan 2019, ss.83, (Özet Bildiri) Creative Commons License

170. Classification of Idiopathic Inflammatory Myopathies: Assessment of 123 Patients According to 2017 Acr/EULAR Criteria Followed up By a Single Center from Turkey

Oğuz E., Şahin E., Erdugan M., Artım Esen B., Gül A., Öçal M. L., et al.
2018 ACR/ARHP Annual Meeting, Illinois, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, ss.2295, (Tam Metin Bildiri)

171. Tek merkezden izlenen 253 psoriyatik artritli hastanın klinik özellikleri, biyolojik tedavi kullanımı ve sürdürülme oranları

Bektaş M., Oğuz E., Erdugan M., Çetin Ç., Aghamuradov S., Çapar G., et al.
19. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.97-98, (Özet Bildiri) Creative Commons License

172. Santral sinir sistemi tutulumlu granülomatozis polianjitis gibi prezente olan bir lenfomatoid granülomatozis olgusu

Bektaş M., Eren N., Oğuz E., Erdugan M., Çetin Ç., Aghamuradov S., et al.
Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.214, (Özet Bildiri) Creative Commons License

173. Nekrotizan pannikülit ve asimetrik oligoartrit tablosu ile prezente olan alfa-1 antitripsin eksikliği olgusu

Çetin Ç., Kapar C., Ersoy A., Bektaş M., Baykal C., Öçal M. L., et al.
Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.159-160, (Özet Bildiri) Creative Commons License

174. Sistemik lupus eritematozus’lu hastalarda avasküler nekroz: Prevalansı, ilişkileri, risk faktörleri ve seyri

Çetin Ç., Göktaş Aydın S., Çene E., Ersoy A., Kapar C., Bektaş M., et al.
Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.110-111, (Özet Bildiri) Creative Commons License

175. Tek bir merkez tarafından izlenen 90 dermatomiyozit hastasında alt grupların analizi: Amiyopatik dermatomiyozitte yüksek malignite sıklığı

Oğuz E., Dağcı G., Erdugan M., Bektaş M., Çetin Ç., Aghamuradov S., et al.
Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.116, (Özet Bildiri) Creative Commons License

176. Sistemik lupus eritematozusun nadir bir prezentasyonu: Trombotik trombositopenik purpura

Eren N., Aksoy E., Bektaş M., Oğuz E., Erdugan M., Çetin Ç., et al.
Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.199-200, (Özet Bildiri) Creative Commons License

177. Eriflkin Still hastal›¤›: 150 hastan›n klinik bulgular›, laboratuvar özellikleri ve biyolojik ajan kullan›m›

Oğuz E., Tekin Uzman R. D., Dağcı G., Erdugan M., Bektaş M., Aghamuradov S., et al.
Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, ss.34-35, (Özet Bildiri) Creative Commons License

178. Tekrarlayan polikondritte nadir bir klinik bulgu: Dijital nekroz

Şahin E., Oğuz E., Artım Esen B., Gül A., Öçal M. L., İnanç M.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.218-219, (Özet Bildiri)

179. Sistemik Lupus Eritematozuslu Hastalarda Hastalık Aktivitesinin Serum ve İdrar TWEAK, MCP-1 ve NGAL ile Değerlendirilmesi

MİRİOĞLU Ş., ÇINAR S., YAZICI H., GÜL A., ÖÇAL M. L., İNANÇ M., et al.
XIX.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.1, (Özet Bildiri)

180. Erişkin Still hastalığı: 150 hastan›n klinik bulguları, laboratuvar özellikleri ve biyolojik ajan kullanımı

Oğuz E., Tekin R. D., Dağcı G., Erdugan M., Bektaş M., Çetin Ç., et al.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.218-219, (Özet Bildiri)

181. İdiopatik inflamatuar miyopatiler: Tek bir merkez tarafından izlenen 123 hastanın 2017 ACR/EULAR sınıflandırma kriterlerine göre değerlendirilmesi

Oğuz E., Şahin E., Erdugan M., Artım Esen B., Gül A., Öçal M. L., et al.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.33, (Özet Bildiri)

182. Behçet hastalığının seyrinde klinik bulguların kronolojik olarak ortaya çıkışının ve sıklığının değerlendirilmesi

Aydın M., Artım Esen B., İnanç M., Öçal M. L., Gül A.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.74, (Özet Bildiri)

183. Tekrarlayan polikondritte nadir bir klinik bulgu: Dijital nekroz

Şahin E., Oğuz E., Artım Esen B., Gül A., Öçal M. L., İnanç M.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.218-219, (Tam Metin Bildiri)

184. Sistemik lupus eritematozuslu hastalarda hastalık aktivitesinin serum ve idrar TWEAK, MCP-1 ve NGAL ile değerlendirilmesi

MİRİOĞLU Ş., ÇINAR S., YAZICI H., GÜL A., ÖÇAL M. L., İNANÇ M., et al.
19. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.14-16, (Özet Bildiri)

185. Sistemik lupus eritematozuslu (SLE) hastalarda hastal›k aktivitesini belirlemede aday biyobelirteçler olarak serum BAFF ve APRIL

Sarı S., ÇINAR S., ARTIM ESEN B., GÜL A., Ocal L., DENİZ G., et al.
XIX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.13, (Özet Bildiri)

186. İdiopatik inflamatuar miyopatiler: Tek bir merkez tarafından izlenen 123 hastanın 2017 ACR/EULAR sınıflandırma kriterlerine göre değerlendirilmesi

OĞUZ E., ŞAHİN E., ERDUGAN M., ARTIM ESEN B., GÜL A., ÖÇAL M. L., et al.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.33, (Özet Bildiri)

187. Sistemik lupus eritematozus hastalarında kalıcı hasar gelişimi üzerine glukokortikoid tedavinin etkisi

Göktaş Aydın S., Çetin Ç., Çene E., Erdugan M., Oğuz E., Gül A., et al.
19.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, ss.112, (Özet Bildiri)

188. Sistemik lupus eritematozuslu hastalarda hastalık aktivitesinin serum ve idrar TWEAK, MCP-1 ve NGAL ile değerlendirilmesi

MİRİOĞLU Ş., ÇINAR S., YAZICI H., GÜL A., ÖÇAL M. L., İNANÇ M., et al.
19. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.14-16, (Özet Bildiri)

189. Type 3 Innate Lymphoid Cells might have an impact in active Behçet’s Disease

Gelmez M. Y., Özçit G., Çetin E., Çınar S., Erdugan M., Babuna Kobaner G., et al.
5th European Congress of Immunology-ECI 2018, Amsterdam, Hollanda, 2 - 05 Eylül 2018, ss.447-448, (Özet Bildiri)

190. RABIOPRED, AN INNOVATIVE THERANOSTIC TOOL TO ASSIST CLINICIANS SELECT AN OPTIMAL ANTI-TNF ALPHA BIOLOGICAL THERAPY FOR RHEUMATOID ARTHRITIS PATIENTS

Danilin S., Schordan E., Coq M., Abbinazi S. A., Mehdi M., Firat H., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.857, (Özet Bildiri)

191. ASSESMENT OF PERSISTENT ORGAN DAMAGE ACCORDING TO IMACS (INTERNATIONAL MYOSITIS ASSESMENT AND CLINICAL STUDIES) MYOSITIS DAMAGE INDEX IN 92 PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOSITIS

Oguz E., Sahin E., Erdugan M., Esen B. A., Gul A., Ocal L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1101-1102, (Özet Bildiri)

192. IDIOPATHIC INFLAMMATORY MYOPATHIES: CLINICAL CHARACTERISTICS, SURVIVIAL AND POOR PROGNOSTIC FACTORS OF 110 PATIENTS FROM TURKEY

Oguz E., Erdugan M., Esen B. A., Gul A., Ocal L., Inanc M.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.750, (Özet Bildiri)

193. NEW AUTOINFLAMMATORY PHENOTYPE MANIFESTING AS HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS AND ASSOCIATED WITH HOMOZYGOUS AGBL3 VARIANT

Gul A., Abaci N., Ekmekci S. S.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1151-1152, (Özet Bildiri)

194. Assesment Of Organ Damage Accordıng To Imacs(Internatıonal Myosıtıs Assesment And Clınıcal Studıes)Myosıtıs Damage Index In 92 Patıents Wıth Idıopathıc Inflammatory Myosıtıs

OĞUZ E., ŞAHİN E., ERDUGAN M., ARTIM ESEN B., GÜL A., ÖÇAL M. L., et al.
XVII Mediterranean Congress of Rheumatology, Genoa, İtalya, 12 - 14 Nisan 2018, ss.4-6, (Tam Metin Bildiri)

195. IgG4 iliflkili hastal›k: Aortit/periaortit ve akalkülöz kolesistit olgusu

Oğuz E., Abbasgholı Zadeh A., Bektaş M., Çetin Ç., Artım Esen B., Gül A., et al.
Romatolojide Hedef 2018 Sempozyumu, Antalya, Türkiye, 7 - 10 Mart 2018, ss.47-48, (Özet Bildiri) Creative Commons License

196. Dermatomiyozit/antisentetaz sendromun nadir bir klinik bulgusu: Palmoplantar keratoderma

Dağcı G., Oğuz E., Eren N., Tekin Uzman R. D., Bektaş M., Artım Esen B., et al.
Romatolojide Hedef 2018 Sempozyumu, Antalya, Türkiye, 7 - 10 Mart 2018, ss.45-47, (Özet Bildiri) Creative Commons License

197. Kaposi sarkomunun efllik etti¤i otoimmün hemolitik anemi ile prezente bir sistemik lupus eritematozus olgusu

Bektaş M., Yağcı M. A., Artım Esen B., Gül A., İnanç M., Öçal M. L.
Romatolojide Hedef 2018 Sempozyumu, İstanbul, Türkiye, 7 - 10 Mart 2018, ss.54, (Özet Bildiri) Creative Commons License

198. New Autoinflammatory Phenotype Associated with Homozygous AGBL3 Variant

GÜL A., ABACI N., SIRMA EKMEKCİ S.
2017 ACR/ARHP Annual Meeting, San Diago, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, cilt.69, ss.169, (Tam Metin Bildiri)

199. Klinik bulguları ağır seyreden ailevi Akdeniz ateşi hastalarında MEFV mutasyonu bulunmayan ailelerde tüm exom dizileme analizi

ABACI N., SIRMA EKMEKCİ S., SARIMAN M., EMRENCE Z., Salman B., PAÇAL F., et al.
XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.199, (Tam Metin Bildiri)

200. ‘SLCO2A1 mutasyonuna bağlı gelişen ve yüksek inflamasyon yanıtı ile jüvenil idiyopatik artriti taklit eden pakidermoperiostoz vakaları’

SIRMA EKMEKCİ S., ABACI N., sariman m., EMRENCE Z., salman b., PAÇAL F., et al.
XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Mardin, Türkiye, 26 - 29 Ekim 2017, ss.194, (Tam Metin Bildiri)

201. Tekrarlayan polikondrit: Tanıda gecikme ve takip sırasında alevlenmelerin önemi

Oğuz E., Erdugan M., Artım Esen B., Gül A., Öçal M. L.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.92, (Özet Bildiri)

202. İdyopatik inflamatuvar miyopatilerde kalıcı organ hasarı: 110 hastanın IMACS (‘International myositis assessment and clinical studies’) miyozit hasar indeksine göre uzun dönem kalıcı organ hasarının değerlendirilmesi

Oğuz E., Şahin E., Erdugan M., Artım Esen B., Gül A., Öçal M. L., et al.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.151-152, (Özet Bildiri)

203. PET/BT’de artmış FDG tutulumu gösteren kronik peritonitli ailevi akdeniz ateşi hastası ve anti-IL1 tedavisine yanıt

Oğuz E., Erdugan M., Artım Esen B., İnanç M., Öçal M. L., Gül A.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.31-32, (Özet Bildiri)

204. Ankilozan spondilit ve okronozis birlikteliği

Erdugan M., Oğuz E., Artım Esen B., Gül A., İnanç M., Öçal M. L.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.170, (Özet Bildiri)

205. İdyopatik inflamatuvar miyopatiler: 110 hastanın klinik özellikleri, sağ kalım analizi ve kötü prognoz faktörleri

Oğuz E., Erdugan M., Artım Esen B., Gül A., Öçal M. L., İnanç M.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.9-10, (Özet Bildiri)

206. TNF reseptörü ile ilişkili periyodik sendrom (TRAPS): Aynı aileden 3 olgunun klinik özellikleri ve anakinra tedavisine yanıtı

Oğuz E., Erdugan M., Artım Esen B., İnanç M., Öçal M. L., Gül A.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.33-34, (Özet Bildiri)

207. IgG4 ilişkili hastalığın tedavisi için Rituksimab: 10 hastanın tedavi sonuçları

Oğuz E., Erdugan M., Artım Esen B., Gül A., Öçal M. L., İnanç M.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.92-93, (Özet Bildiri)

208. Koroner arter trombozunun eşlik ettiği Kimura hastalığı

Erdugan M., Oğuz E., Artım Esen B., Gül A., İnanç M., Öçal M. L.
18.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, ss.96-97, (Özet Bildiri)

209. CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40

De Benedetti F., Gattorno M., Frenkel J., Calvo I., Moutschen M., Quartier P., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.77, (Özet Bildiri)

210. CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS

Tesser J., Gul A., Olech E., Oelke K., Lukic T., Murray C. W., et al.
Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR), Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.276-277, (Özet Bildiri)

211. BUDD-CHIARI SYNDROME IN BEHCET'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY

Akyol L., Toz B., Bayindir O., Zengin O., ÜSKÜDAR CANSU D., Yigit M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.327-328, (Özet Bildiri)

212. DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTER COHORT OF 240 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)

İnanç M., Artım Esen B., Pehlivan Ö., Yalçınkaya Y., Gül A., Öçal M. L.
37th KCR Annual scientific meeting and the 11th international symposium, Seoul, Güney Kore, 19 - 20 Mayıs 2017, cilt.24, ss.198, (Tam Metin Bildiri)

213. Behçet Hastalarında Aktive Edici Doğal Öldürücü Reseptörler

Sallakci N., KÜÇÜKSEZER U. C., TAHRALI İ., ÇETİN E., GÜL A., DENİZ G.
XXIV. Ulusal İmmünoloji Kongresi, İstanbul, Türkiye, 27 - 30 Nisan 2017, ss.66, (Tam Metin Bildiri)

214. A single center experience of rituximab treatment in 79 patients with systemic lupus erythematosus

Artım Esen B., Çetin Ç., Mastanzade M., Erdugan M., Oğuz E., Gül A., et al.
LUPUS17 & ACA 2017, Melbourne, Avustralya, 26 - 29 Mart 2017, cilt.4, ss.157, (Tam Metin Bildiri)

215. PET/CT IMAGING IN VASCULAR BEHCET DISEASE

Gül A., Ozkan Z. G., Esen B. A., Inanc M., Ocal L.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.90, (Özet Bildiri)

216. IDENTIFYING CORE DOMAINS FOR BEHCETS SYNDROME TRIALS BY A DELPHI EXERCISE

Meara A. S., Ozguler Y., Mahr A., Direskineli H., Gül A., Yazici Y., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.95, (Özet Bildiri)

217. Utility of Vascular Findings By PET/CT Scan in the Diagnosis and Activity Assesment of Takayasu Arteritis

Toz B., Artım Esen B., Özkan Z. G., Erer B., Kamalı S., Gül A., et al.
American College of Rheumatology Annual Meeting, Washington, Amerika Birleşik Devletleri, 11 - 14 Kasım 2016, cilt.68, sa.10, ss.1-2, (Tam Metin Bildiri)

218. Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis

Toz B., Tecer S., Oğuz E., Erdugan M., Artım Esen B., Kamalı S., et al.
American College of Rheumatology Annual Meeting 2016, Washington, Amerika Birleşik Devletleri, 11 - 16 Kasım 2016, cilt.68, sa.10, ss.1-2, (Tam Metin Bildiri)

219. a Singlecenter Experience of Rituximab Treatment in 86 Patients with Systemic Lupus Erythematosus

Artım Esen B., Toz B., Erer B., Kamalı S., Gül A., Öçal M. L., et al.
American College of Rheumatology Annual Meeting, Washington, Amerika Birleşik Devletleri, 11 - 16 Kasım 2016, cilt.68, sa.10, ss.1, (Tam Metin Bildiri)

220. Tek merkeze ait sistemik lupus eritematozuslu 79 hastada rituksimab tecrübesi

Artım Esen B., Çetin Ç., Mastanzade M., Erdugan M., Oğuz E., Kamalı S., et al.
17.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 24 - 30 Ekim 2016, ss.155, (Özet Bildiri)

221. TEK MERKEZE AİT 240 ANTİFOSFOLİPİD SENDROMLU HASTANIN HASTALIK ÖZELLİKLERİ, SAĞKALIM ANALİZİ VE MORTALİTESİ

Artım Esen B., Pehlıvan O., Yalçınkaya (Şahinkaya) Y., Yüce T., Bektaş M., Kamalı S., et al.
XVII. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 24 - 30 Ekim 2016, ss.7, (Tam Metin Bildiri)

222. Disease Characteristics, survival analysis, and mortality in a single center cohort of 240 patients with Antiphospholipid Syndrome

Artım Esen B., Pehlıvan O., Yalçınkaya (Şahinkaya) Y., Yüce T., Kamalı S., Gül A., et al.
15th International Congress of Antiphospholipid Antibodies, Girne, Kıbrıs (Kktc), 21 - 24 Ekim 2016, cilt.25, ss.78, (Tam Metin Bildiri)

223. Disease characteristics, survival analysis and mortality in a single center cohort of patients with antiphospholipid syndrome

Artım Esen B., Pehlivan Ö., Yalçınkaya Y., Yüce T., Kamalı S., Gül A., et al.
10th European Lupus Meeting, Venice, İtalya, 5 - 08 Ekim 2016, ss.1-2, (Tam Metin Bildiri)

224. Autoimmune hemolytic anemia and thrombocytopenia in a single center cohort of patients with systemic lupus erythematosus from Turkey: Clinical associations and effect on disease damage and survival

Artım Esen B., Kamalı S., Gül A., Öçal M. L., İnanç M.
10th European Lupus Meeting, Venice, İtalya, 5 - 08 Ekim 2016, ss.1-2, (Tam Metin Bildiri)

225. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility

Takeuchi M., Mizuki N., Meguro A., Ombrello M., Tugal-tutkun I., Ozyazgan Y., et al.
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Washington, Amerika Birleşik Devletleri, 1 - 05 Mayıs 2016, cilt.57, (Özet Bildiri)

226. Natural kilIer activating receptors in Behcet disease

Şallakçı N., Çetin E., Tahralı İ., Küçüksezer U. C., Yılmaz A., Gül A., et al.
Abstracts of IAl 2016 internatiünal Gongress of lnımunology, Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.173, (Özet Bildiri)

227. Natural killer activating receptors in Behcet disease International Congress of Immunology ECI

SALLAKCI N., ÇETİN E., TAHRALI İ., KÜÇÜKSEZER U. C., YILMAZ A., GÜL A., et al.
International Congress of Immunology (ECI), Avustralya, 21 - 26 Ağustos 2016

228. Natural killer activating receptors in Behcet disease

Sallakci N., Cetin A. E., Tahrali I., Kucuksezer U. C., Yilmaz A., Gul A., et al.
International Congress of Immunology (ICI), Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.173, (Özet Bildiri)

229. COGAN SYNDROME: DIFFERENTIAL RESPONSE TO BIOLOGIC AGENTS AND ROLE OF PET-CT IN THE INCREASED DIAGNOSIS OF AORTITIS

Toz B., Erer B., Kamali S., Tugal-Tutkun I., Ocal L., Gul A.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1208-1209, (Özet Bildiri)

230. UTILITY OF VASCULAR FINDINGS BY PET/CT SCAN IN THE DIAGNOSIS AND ACTIVITY ASSESSMENT OF TAKAYASU ARTERITIS

Toz B., Ozkan Z. G., Alcin G., Kamali S., Esen B. A., Erer B., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.791, (Özet Bildiri)

231. DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF 240 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

ARTIM-ESEN B., Sahinkaya Y., YUCE T., PEHLIVAN O., Bektas M., TOZ B., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1055, (Özet Bildiri)

232. AUTOIMMUNE HEMOLYTIC ANEMIA AND THROMBOCYTOPENIA IN A SINGLE CENTRE COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM TURKEY: CLINICAL ASSOCIATIONS AND EFFECT ON DISEASE DAMAGE AND SURVIVAL

Artim-Esen B., Erdugan M., Oguz E., Toz B., Erer B., Kamali S., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.775, (Özet Bildiri)

233. EFFICACY OF COLCHICINE AND IL-1 INHIBITORS IN AMYLOIDOSIS ASSOCIATED WITH FAMILIAL MEDITERRANEAN FEVER: A RETROSPECTIVE ANALYSIS

Toz B., Tacar S., Oguz E., Erdugan M., Esen B. A., Kamali S., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.611-612, (Özet Bildiri)

234. BIOLOGIC AGENTS IN REFRACTORY ADULT STILL'S DISEASE: BETTER RESPONSE RATES AND ACCEPTABLE SAFETY WITH ANAKINRA AND TOCILIZUMAB

Toz B., Inanc M., Senturk N., Erer B., Esen B. A., Kamali S., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.620, (Özet Bildiri)

235. Salivary IL-1 Alpha and IL-1 Beta Levels Are Associated with Oral Mucosal Activity in Behcet’s Disease

Gül A.
2015 ACR/ARHP Annual Meeting, California, Amerika Birleşik Devletleri, 6 - 11 Kasım 2021, cilt.67, sa.3224, ss.10, (Özet Bildiri) Creative Commons License

236. ANCA ilişkili vaskülit kohortunda artmış avasküler nekroz sıklığı: Vaskülit bir risk faktörü olabilir mi?

Toz B., Erer B., Alpay Kanıtez N., Artım Esen B., Gül A., İnanç M., et al.
16.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 28 Ekim - 01 Kasım 2015, ss.41-42, (Özet Bildiri)

237. COST OF FAMILIAL MEDITERRANEAN FEVER (FMF) DISEASE IN TURKEY

AKSU K., DOKUYUCU O., ERTENLİ A. İ., Gül A., KARAASLAN Y., Kasapcopur O., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri)

238. TEK MERKEZE AİT BİR SLE KOHORTUNDA OTOİMMUN HEMOLİTİK ANEMİ VE TROMBOSİTOPENİ : KLİNİK ÖNEMLERİ, HASTALIK HASARI VE SAĞKALIM ÜZERİNDEKİ ETKİLERİ

ARTIM ESEN B., YALÇINKAYA (ŞAHİNKAYA) Y., TOZ B., Erer B., KAMALI S., GÜL A., et al.
XVI. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 28 Ekim - 01 Kasım 2015, (Tam Metin Bildiri)

239. PATIENT JOURNEY AND TREATMENT ROUTE TO USE OF FIRST BIOLOGIC IN RARE AUTOINFLAMMATORY DISEASES: AN INTERNATIONAL RETROSPECTIVE CHART REVIEW

Ozen S., Kuemmerle-Deschner J., Cantarini L., Cimaz R., Quartier P., Gul A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.106, (Özet Bildiri)

240. SMALL BOWEL MUCOSAL FINDINGS IN FAMILIAL MEDITERRANEAN FEVER

Demir A., Akyuz F., Gokturk S., Evirgen S., Gulluoglu M., Erer B., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, ss.307, (Özet Bildiri)

241. FAVOURABLE RENAL OUTCOME IN AAV NEPHRITIS: A CASE SERIES REPORTED FROM A TERTIARY REFERRAL CENTER

Sari M., Ince B., Ozluk Y., Erer B., Gul A., Inanc M., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.1002, (Özet Bildiri)

242. ACUTE PHASE REACTANTS AND THEIR CORRELATION WITH CLINICAL ACTIVITY IN BEHCET'S DISEASE

Toz B., Alpay-Kanitez N., Erer B., Polat N., Kamali S., Ocal L., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.547, (Özet Bildiri)

243. Evaluation of Small Bowel Mucosal Damage by Capsule Endoscopy in Familial Mediterranean Fever Patients

Demir A., Besisik F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)

244. EFFECTS OF SMOKING IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING TNF INHIBITORS

Pehlivan O., Yalcinkaya Y., Huseyinsinoglu N., Kanitez N. A., Esen B. A., Erer B., et al.
Annual Meeting of the British-Society-for-Rheumatology and British-Health-Professionals-in-Rheumatology, Liverpool, Birleşik Krallık, 29 Nisan - 01 Mayıs 2014, cilt.53, ss.145, (Özet Bildiri)

245. Effects Of Smoking In Patients With Axial Spondyloarthritis - Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis - Receiving Anti-TNF therapy

Pehlivan O., Yalcinkaya Y., Huseyinsinoglu N., Kanitez N. A., Erer B., Kamali S., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

246. Predictivity Of Serum Biomarkers For Disease Activity In a Prospectively Followed-Up Takayasu Arteritis Cohort: Is Serum Amyloid A Protein Better Than Conventional Acute Phase Markers?

Omma A., Erer B., Alpay N., Polat N. G., Gül A., Inanc M., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

247. High Density Genotyping Of Immune-Related Disease Genes Identifies 7 New Susceptibility Loci For Behcets Disease

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Satorius C., Kirino Y., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

248. Starting Time Of Inflammatory Attacks In Patients With Familial Mediterranean Fever

Berktas F., Kanitez N. A., Toz B., Bakkaloglu K., Erer B., Gül A.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

249. Major Histocompatibility Complex Class I Molecules Contribute To Behcet's Disease Risk Through Both Innate and Adaptive Immune Interactions

Ombrello M. J., Kirino Y., de Bakker P., Gül A., Remmers E. F., Kastner D. L.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

250. BİYOLOJİK TEDAVİ ALAN AKSİYAL SPONDİLOARTRİTLİ HASTALARDA SİGARANIN HASTALIKLA AKTİVİTESİ VE YAŞAM KALİTESİNE ETKİSİ

PEHLIVAN O., YALÇINKAYA (Şahinkaya) Y., HÜSEYİNSİNOĞLU N., Alpay Kanıtez N., Erer B., KAMALI S., et al.
XIV.Ulusal Romatoloji kongresi, İzmir, Türkiye, 11 - 15 Eylül 2013, (Tam Metin Bildiri)

251. BİYOLOJİK TEDAVİALAN AKSYİAL SPONDİLOARTRİTLİ HASTALARDA SİGARANIN HASTALIK AKTİVİTESİ VE YAŞAM KALİTESİNE ETKİSİ

PEHLİVAN Ö., YALÇINKAYA Y., HÜSEYİNSİNOĞLU N., ALPAY KANITEZ N., ERER S. B., KAMALI S., et al.
XIV. ULUSAL ROMATOLOJİ KONGRESİ, İzmir, Türkiye, 11 - 15 Eylül 2013

252. SAPHO Syndrome- A Case Report

Ramazanoğlu M., Kenan S., Sofiyev N., Akçım E., Duymaz B., Aktaş Ş., et al.
Türk Oral Maksillofasiyal Cerrahi Derneği 20. Uluslararası Kongresi, Antalya, Türkiye, 1 - 04 Mayıs 2013, ss.96, (Özet Bildiri)

253. Takayasu Arteritinde Gebelik ve Gebelikle İlişkili Hastalık Prognozu:Tek Merkez Deneyimi

ALPAY-KANıTEZ N., OMMA A., Erer B., Güzel M., YALÇINKAYA Y., GÜL A., et al.
XIII.Ulusal Romatoloji kongresi, Antalya, Türkiye, 13 - 17 Ekim 2012, ss.55, (Özet Bildiri)

254. Takayasu arteritinde gebelik ve gebelikle iliskili hastalık prognozu Tek merkez deneyimi

ALPAY KANITEZ N., OMMA A., ERER S. B., GÜZEL M., ŞAHİNKAYA Y., GÜL A., et al.
XIII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.1-214

255. Granülomlu Polianjitiste Hepatit B aşısı ile Zayıf İmmunizasyon ve Kadınlarda daha Yüz Güldürücü Aşı Yanıtı

Kara E., Erer B., ARTIM ESEN B., OMMA A., YALÇINKAYA Y., KANITEZ N. A., et al.
XIII.Ulusal Romatoloji kongresi, Antalya, Türkiye, 13 - 17 Ekim 2012, ss.110-111, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

256. Sistemik Lupus Eritematozusta Metabolik Sendrom Kardiyovasküler Risk Faktörü Olmasının Yanısıra Kümülatif Organ Hasarı İle ilkşkilidir:311 hastanın Kesitsel Analizi

DEMİR (Ertan) S., ARTIM ESEN B., YALÇINKAYA (Şahinkaya) Y., PEHLIVAN O., KANITEZ N. A., OMMA A., et al.
XIII.Ulusal Romatoloji kongresi, Antalya, Türkiye, 13 - 17 Ekim 2012, ss.81-82, (Tam Metin Bildiri)

257. Genome-Wide Analysis Reveals a Recessive Association of ERAP1 Variants with Behcet's Disease and Epistasis Between ERAP1 and HLA-B*51.

REMMERS E. F., KIRINO Y., BERTSIAS G., ISHIGATSUBO Y., KIM Y., OMBRELLO M. J., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

258. CROSS-Sectional Assessment of Damage in Takayasu Arteritis with A Validated Tool.

Omma A., Erer B., KARADAĞ Ö., Yilmaz N., ALİBAZ ÖNER F., Yildiz F., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

259. Tuberculosis and Tofacitinib Therapy in Patients with Rheumatoid Arthritis

Winthrop K. L., Park S. -., Gul A., Cardiel M., Gomez-Reino J. J., de Leon D. P., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri) Sürdürülebilir Kalkınma

260. Metabolic Syndrome Is Not Only a Risk Factor for Cardiovascular Events in Systemic Lupus Erythematosus but Also Associated with Cumulative Organ Damage: A Cross-Sectional Analysis of 311 Patients.

Ertan-Demir S., Artim-Esen B., Sahinkaya Y., Pehlivan O., Alpay-Kanitez N., Omma A., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

261. Targeted Deep Re-Sequencing Implicates Rare and Low Frequency Coding Variants in IL23R, MEFV, TLR4, and NOD2 in Behcet's Disease

KIRINO Y., ZHOU Q., ISHIGATSUBO Y., MIZUKI N., TUGAL-TUTKUN I., Seyahi E., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

262. Efficacy and Safety of Canakinumab in Adults with Colchicine Resistant Familial Mediterranean Fever

Gul A., Ozdogan H., Erer B., Ugurlu S., Davis N., Sevgi S., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

263. The Identification of Pathway Markers in Behcet's Disease Using Genomewide Association Data From Two Different Populations.

Bakir-Gungor B., Remmers E., Kastner D. L., Meguro A., Mizuki N., Gül A., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

264. POOR IMMUNIZATION WITH HEPATITIS B VACCINATION IN PATIENTS WITH GRANULOMATOSIS WITH POLIANGIITIS WEGENER S AND MORE FAVORABLE ANTIBODY RESPONSE IN FEMALES

KARA E., ERER S. B., ARTIM ESEN B., OMMA A., ŞAHİNKAYA Y., NİLÜFER K., et al.
EULAR 2012, Berlin, Almanya, 6 - 09 Haziran 2012, cilt.71, ss.385 Sürdürülebilir Kalkınma

265. An Insertion Mutation in the MDFIC (MyoD Family Inhibitor Domain Containing) Gene Defines a Novel Autoinflammatory Syndrome Associated with Lymphedema

GÜL A., ÜSTEK D., HATEMİ G., AZAKLI H., EMRENCE Z., COŞAN F., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, (Özet Bildiri)

266. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center

ARTIM ESEN B., ÇENE E., ŞAHİNKAYA Y., ERTAN S., PEHLİVAN Ö., KAMALI S., et al.
ACR 2011 ( American College of Rheumatology & Association of Rheumatology Health Professionals, 2011 Annual Scientific Meeting), CHICAGO, 4 - 09 Kasım 2011, cilt.63, ss.1-1041

267. Anti-TNF tedavi alan ankilozan spondilit olgularının cinsiyete göre farklılıkları

YALÇINKAYA (Şahinkaya) Y., PEHLIVAN O., ARTIM ESEN B., Coşan F., Erer B., HÜSEYİNSİNOĞLU N., et al.
XII.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2011, ss.114, (Tam Metin Bildiri)

268. Sistemik Lupus eritematozuslu hastalarda otoantikor kümlereinin klinik öneminin incelenmesi

ARTIM ESEN B., Çene E., YALÇINKAYA (Şahinkaya) Y., DEMİR (Ertan) S., PEHLIVAN O., OMMA A., et al.
XII.Ulusal Romatoloji kongresi, Antalya, Türkiye, 16 - 20 Ekim 2011, ss.24-25, (Özet Bildiri)

269. Gender Differences of Ankylosing Spondylitis Patients receivivng anti-TNF therapy

YALÇINKAYA Y., OMMA A., PEHLIVAN O., ARTIM ESEN B., Erer B., HÜSEYİNSİNOĞLU N., et al.
5th Turkish-Greek Rheumatology Days, Antalya, Türkiye, 14 - 16 Ekim 2011, ss.12, (Tam Metin Bildiri)

270. Cluster Analysis of Autoantibodies in 852 Patients with Systemic Lupus Erythematosus From a Single Center: Four Main Clusters with Prognostic Implications

Artim-Esen B., ÇENE E., Sahinkaya Y., Ertan S., Pehlivan O., Kamali S., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

271. Major Histocompatibility Complex Class II Gene Cluster Harbors Systemic Juvenile Idiopathic Arthritis Susceptibility Locus

Ombrello M. J., Remmers E., Grom A. A., Thomson W., Martini A., Gattorno M., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

272. A Retrospective Analysis of Anti-TNF Treatment of 146 Ankylosing Spondylitis Patients According to Gender

Yalcinkaya Y., Pehlivan O., Omma A., Artim-Esen B., Erer B., Huseyinsinoglu N., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

273. Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Behcet's Disease.

KIRINO Y., BERTSIAS G., OMBRELLO M. J., Ustek D., SATORIUS C., LE J., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

274. An Insertion Mutation in the MDFIC (MyoD Family Inhibitor Domain Containing) Gene Defines a Novel Autoinflammatory Syndrome Associated with Lymphedema

Gül A., Ustek D., Hatemi G., Azakli H., Emrence Z., Cosan F., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

275. GENDER DIFFERENCES OF ANKYLOSING SPONDYLITIS PATIENTS RECEIVING ANTI TNF THERAPY

ŞAHİNKAYA Y., COŞAN F., PEHLİVAN Ö., OMMA A., ARTIM ESEN B., ERER S. B., et al.
EULAR 2011, Londrina, Brezilya, 25 - 28 Mayıs 2011, cilt.70, ss.341

276. Disease Characteristics of spondyloarthropaties associated with anti-TNF therapy

YALÇINKAYA (Şahinkaya) Y., Coşan F., PEHLIVAN O., OMMA A., ARTIM ESEN B., Erer B., et al.
EULAR 2011, Londra, Birleşik Krallık, 25 - 28 Mayıs 2011, cilt.70, (Tam Metin Bildiri)

277. Disease activity, damage and survival analysis of WG: long-term single-centre experience from Turkey

Kamali S., Erer B., Esen B. A., Gül A., Ocal L., Aral O., et al.
15th International Vasculitis/ANCA Workshop, North Carolina, Amerika Birleşik Devletleri, 15 - 18 Mayıs 2011, cilt.164, ss.118, (Özet Bildiri)

278. CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES

Hawkins P. N., Kuemmerle-Deschner J. B., Hachulla E., Cartwright R., Kone-Paut I., Hoyer J., et al.
Annual Meeting of the British-Society-for-Rheumatology 2011, Brighton, Birleşik Krallık, 12 - 14 Nisan 2011, cilt.50, ss.53-54, (Özet Bildiri)

279. Anti-TNF tedavi alan Ankilozan Sponndilitli Olguların Değerlendirilmesi

YALÇINKAYA (Şahinkaya) Y., PEHLIVAN O., ARTIM ESEN B., Coşan F., Erer B., HÜSEYİNSİNOĞLU N., et al.
XI.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, ss.84, (Tam Metin Bildiri)

280. Ankilozan Spondilitli 370 Olgunun değerlendirilmesi

YALÇINKAYA (Şahinkaya) Y., PEHLIVAN O., Coşan F., ARTIM ESEN B., Erer B., HÜSEYİNSİNOĞLU N., et al.
XI.Ulusal Romatoloji Kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, ss.83, (Tam Metin Bildiri)

281. Wegener Granülomatozlu 82 Olgunun Analizi:Türkiye Deneyimi

KAMALI S., Erer B., ARTIM ESEN B., YALÇINKAYA (Şahinkaya) Y., GÜL A., ÖÇAL M. L., et al.
XI.Ulusal Romatoloji kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, ss.31, (Tam Metin Bildiri)

282. Poliartiküler Tutulumlu Erişkin still Hastalarının Yeni ACR/EULAR Artrit Kriterleri İle Sınıflandırılması

Erer B., OMMA A., Hatipoğlu E., ARTIM ESEN B., YALÇINKAYA (Şahinkaya) Y., PEHLIVAN O., et al.
XI.Ulusal Romatoloji kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, ss.116, (Tam Metin Bildiri)

283. Poliartiküler Tutulumlu Erişkin Still HastalarInIn Yeni ACR EULAR Romatoid Artrit Kriterleri ile Sınıflandırılması

ERER S. B., OMMA A., ARTIM ESEN B., ŞAHİNKAYA Y., PEHLİVAN Ö., İNANÇ M., et al.
XI. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 13 - 17 Ekim 2010, cilt.2, ss.16-39

284. Tek merkezden Takip Edilen 902 Sistemik Lupus Eritematozuslu Hastanın Analizi

ARTIM ESEN B., DEMİR (Ertan) S., YALÇINKAYA (Şahinkaya) Y., PEHLIVAN O., Erer B., KAMALI S., et al.
XI.Ulusal Romatoloji kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, ss.20, (Özet Bildiri)

285. Tek Merkezden Takip Edilen 902 Sistemik Lupus Eritematozus lu HastanIn Analizi

ARTIM ESEN B., ERTAN S., ŞAHİNKAYA Y., PEHLİVAN Ö., ERER S. B., KAMALI S., et al.
XI. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 13 - 17 Ekim 2010, cilt.2, ss.16-39

286. Analysis of 641 patients with systemic lupus erthematosus: a single center experience from Turkey

Artım Esen B., Ertan S., Yalçınkaya Y., Pehlivan Ö., Kamalı S., Erer B., et al.
The 9th international congress of SLE, Vancouver, Kanada, 24 - 27 Haziran 2010, cilt.19, ss.74, (Tam Metin Bildiri)

287. Outcome of mycophenolate mophetil treatment in patients with proliferative lupus nephritis.

ARTIM ESEN B., ÖZLÜK M. Y., KILIÇASLAN I., HİNDİLERDEN F., KAMALI S., GÜL A., et al.
The 19th International Congress on SLE, Vancouver, Kanada, 24 - 27 Haziran 2010, ss.169, (Tam Metin Bildiri)

288. Systemic lupus erythematosus (SLE)in Turkey:Analysis of 708 patients from a single center

ARTIM ESEN B., DEMİR (Ertan) S., PEHLIVAN O., YALÇINKAYA (Şahinkaya) Y., Erer B., KAMALI S., et al.
EULAR 2010, Londra, Birleşik Krallık, 16 - 19 Haziran 2010, cilt.69, ss.390, (Tam Metin Bildiri)

289. A NOVEL TNFRSF1 GENE MUTATION IN A TURKISH FAMILY: REPORT OF THREE CASES

Cosan F., YAZICI A., ÇEFLE A., GÜL A.
30th European Workshop for Rheumatology Research, Bamberg, Almanya, 4 - 07 Mart 2010, cilt.69, (Özet Bildiri)

290. Common Variants of the Class I Major Histocompatibility Complex, IL10, CPLX1, and IL23R Genes Predispose to Behcet's Disease in the Turkish Population

Yang B., Remmers E., Cosan F., Kirino Y., Ombrello M., O'Shea J., et al.
10th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, Massachusetts, Amerika Birleşik Devletleri, 24 - 27 Haziran 2010, cilt.135, (Özet Bildiri)

291. Büyük Damar Tutulumu ile Seyreden Cogan Sendromu:Tanıda PET taramanın Katkısı

Kaya Ö., PEHLIVAN O., ARTIM ESEN B., Ekinci Ö., Tufan A. N., YALÇINKAYA (Şahinkaya) Y., et al.
X.Ulusal Romatoloji kongresi, Antalya, Türkiye, 30 Ekim - 03 Kasım 2009, ss.129, (Tam Metin Bildiri)

292. BÜYÜK DAMAR TUTULUMU İLE SEYREDEN COGAN SENDROMU TANIDA PET TARAMANIN KATKISI

KAYA Ö., PEHLİVAN Ö., ARTIM ESEN B., EKİNCİ Ö., TUFAN A. N., ŞAHİNKAYA Y., et al.
X.ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 30 Ekim - 03 Kasım 2009

293. Behçet Hastalığına Bağlı Tedaviye Dirençli Abdominal Aort Anevrizmasının Anakinra Tedavisine Yanıtı

PEHLIVAN O., ARTIM ESEN B., YALÇINKAYA (Şahinkaya) Y., Coşan F., KAMALI S., İNANÇ M., et al.
X.Ulusal Romatoloji kongresi, Antalya, Türkiye, 30 Ekim - 03 Kasım 2009, ss.124, (Tam Metin Bildiri)

294. BEHÇET HASTALIĞINA BAĞLI TEDAVİYE DİRENÇLİ ABDOMİNAL AORT ANEVRİZMASININ ANAKİNRA TEDAVİSİNE YANITI

PEHLİVAN Ö., ARTIM ESEN B., ŞAHİNKAYA Y., COŞAN F., KAMALI S., İNANÇ M., et al.
X.ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 30 Ekim - 03 Kasım 2009

295. Distribution of Killer Immunoglobulin-like Receptor 3DL1 Alelles in Behçet’s Disease

DUYMAZ J., UĞURLU A., UYAR F. A., SARUHAN DİRESKENELİ G., GÜL A.
2nd European Congress of Immunology, Berlin, Almanya, 13 - 16 Eylül 2009, (Özet Bildiri)

296. Increased diameter of tuberculin skin test induration in patients receiving TNF-alpha antagonists

ÇAĞATAY T., KILIÇASLAN Z., Aydin M., ÇAĞATAY P., GÜLBARAN Z., Yildiz R., et al.
ERS Anual congress, Berlin, Almanya, 4 - 08 Ekim 2008, ss.428, (Özet Bildiri)

297. The MEFV gene 3 '-UTR alu repeat Polymorphisms in patients with familial Mediterranean

Ustek D., Ekmekci C. G., Oku B., Cosan F., Cakiris A., Abaci N., et al.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)

298. Distribution of killer immunoglobulin-like receptor 3DL1/3DS1 alelles in Behcet's disease

Tozkir J. D., Uyar A. F., Norman P. J., Parham P., Direskeneli G. S., Gül A.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)

299. Behçet Hastalığında KIR3DL1 3DS1 Alel Dağılımı

DUYMAZ J., UYAR F. A., SARUHAN DİRESKENELİ G., GÜL A.
XIX. Ulusal İmmünoloji Kongresi, Türkiye, 21 - 24 Kasım 2007

300. Eular recommendations for the management of Behvet's disease

Hatemi G., Bang D., Bodaghi B., Chamberlain A. M., Gul A., Houman M. H., et al.
Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.44-45, (Özet Bildiri)

301. Analysis of baseline and cumulative damage in 51 patients with Wegener's granulomatosis

Kamali S., Erer B., Gul A., Inanc M., Ocal L., Konice M., et al.
Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.378-379, (Özet Bildiri)

302. Synovial fluid T1/T2 cytokine expression in Behcet’s Disease

Çetin E., Bilgiç Gazioglu S., Çağatay Y., Küçüksezer U. C., Gül A., Deniz G.
12. Uluslararası Behçet Hastalığı Konferansı,, Lisbon, Portekiz, 19 - 23 Eylül 2003, ss.9, (Özet Bildiri)

303. Granzyme B gene polymorphism in Behcet’s disease

Küçüksezer U. C., Duymaz J., Gül A., Saruhan Direskeneli G.
12. Uluslararası Behçet Hastalığı Konferansı, Lisbon, Portekiz, 19 - 23 Eylül 2006, ss.9, (Özet Bildiri)

304. Synovial fluid T1 T2 cytokine expression in Behcet s Disease 12th International Conference on Behcet s Disease

ÇETİN E., BİLGİÇ GAZİOĞLU S., ÇAĞATAY Y., KÜÇÜKSEZER U. C., GÜL A., DENİZ G.
12th International Conference on Behcet’s Disease, Portekiz, 19 - 23 Eylül 2006, (Tam Metin Bildiri)

305. No association of the TNF receptor superfamily 1A gene R92Q mutaiton with Behçet s Disease

DUYMAZ J., UYAR F. A., SARUHAN DİRESKENELİ G., GÜL A.
12th INTERNATIONAL CONFERENCE ON BEHCET'S DISEASE, 19 - 23 Eylül 2006

306. Intracytoplasmic cytokine levels of NK cells in Behcet’s Disease patients with uveitis.

Küçüksezer U. C., Çetin E., Bilgiç Gazioğlu S., Ornek O., Tuğal Tutkun İ., Gül A., et al.
16. Avrupa İmmünoloji Kongresi (EFIS 2006), Paris, Fransa, 6 - 09 Eylül 2006, ss.448, (Özet Bildiri)

307. T1 T2 cytokine levels in Behcet s Disease

ÇETİN E., BİLGİÇ GAZİOĞLU S., CAGATAY Y., KÜÇÜKSEZER U. C., GÜL A., DENİZ G.
EFIS 2006, 6 - 09 Eylül 2006

308. Natural Killer cell surface receptors and neutrophil functions in Behcet’s Disease with peripheral arthritis

Çetin E., Bilgiç Gazioğlu S., Çağatay Y., Küçüksezer U. C., Erten G., Gül A., et al.
16. European Congress of Immunology (EFIS 2006), Paris, Fransa, 6 - 09 Eylül 2006, ss.152, (Özet Bildiri)

309. Association of familial mediterranean fever-related MEFV gene M694V mutation with ankylosing spondylitis.

Cosan F., Tozkir J. D., Ustek D., Ocal L., Aral O., Gul A.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)

310. Response observed during treatment for amyloid a (AA) amyloidosis with eprodisate (NC-503; 1,3-propanedisulfonate) after 2 years in patients with familial mediterranean fever in comparison to patients with rheumatoid arthritis.

Livneh A., Gorevic P. D., DİRESKENELİ R. H., GÜL A., Ozdogan H., Hawkins P. N., et al.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)

311. Long-term outcome of patients randomized in the euro-lupus nephritis trial: Further evidence that a low-dose IV cyclophosphamide induction regimen achieves good results

Houssiau F. A., Vasconcelos C., D'Cruz D., Sebastiani G., De Ramon Garrido E., Danieli M., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.64, (Özet Bildiri)

312. Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial

Hazenberg B. P., Hawkins P. N., Butrimiene I., Lesnyak O., Livneh A., Nasonov E. L., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.101, (Özet Bildiri)

313. Behçet Hastalığında KIR3DL1 3DS1 Polymorfizmi ve HLA Bw4 ile ilişkisi

DUYMAZ J., UYAR F. A., SARUHAN DİRESKENELİ G., GÜL A.
10.Ulusal Behçet Hastalığı Kongresi, Türkiye, 31 Mart - 01 Nisan 2006

314. Periferik Artritli Behçet Hastalarının Kan ve Eklem Sıvılarında İmmünolojik Parametreler

ÇETİN E., BİLGİÇ GAZİOĞLU S., CAĞATAY Y., KÜÇÜKSEZER U. C., GÜL A., DENİZ G.
X.Ulusal Behçet Hastalığı Kongresi, Türkiye, 31 Mart - 01 Nisan 2006

315. Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503).

Gorevic P., Hawkins P., Butrimiene I., Lesnyak O., Livneh A., Filipowicz-Sosnowska A., et al.
69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 12 - 17 Kasım 2005, cilt.52, ss.4108-4109, (Özet Bildiri)

316. Behçet Üveitinde Doğal Öldürücü Hücre İçi Sitokin Düzeyleri

KÜÇÜKSEZER U. C., ÇETİN E., BİLGİÇ GAZİOĞLU S., ÖRNEK O., TUĞAL A., GÜL A., et al.
XVIII.Ulusal İmmünoloji Kongresi, Türkiye, 7 - 10 Eylül 2005

317. Periferik artritli Behçet hastalarının aktif döneminde Th1/Th2 sitokin düzeyleri

Çetin E., Molo K., Bilgiç Gazioğlu S., Küçüksezer U. C., Çağatay Y., Gül A., et al.
XVIII. Ulusal İmmünoloji Kongresi, Bursa, Türkiye, 7 - 10 Eylül 2005, ss.195-196, (Özet Bildiri)

318. Periferik Artritli Behçet Hastalarında Lenfosit Yüzey Molekülleri NK Hücre Reseptör Ekspresyonu ve Nötrofil Fonksiyonları

ÇETİN E., MOLO K., BİLGİÇ GAZİOĞLU S., KÜÇÜKSEZER U. C., CAĞATAY Y., GÜL A., et al.
XVIII. Ulusal İmmünoloji Kongresi, Türkiye, 7 - 10 Eylül 2005

319. Reduced expression of MEFV gene in peripheral blood leukocytes during acute inflammation.

Selcukbiricik F., Ustek D., Vural B., Yanar H. T., Taviloglu K., Ozbek U., et al.
69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 12 - 17 Kasım 2005, cilt.52, (Özet Bildiri)

320. KIR3DL1 homozygosity increases the susceptibility to Behcet's disease in HLA-BW4 positive individuals

Duymaz-Tozkir J., Uyar F. A., Saruhan-Direskeneli G., Gul A.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.122-123, (Özet Bildiri)

321. Psödotümör serebri tablosuyla başvuran Behçet Hastalığı.

Can E., Keser M., Kara B., Somer A., Hatipoğlu N., Salman N., et al.
4.Ulusal Çocuk Enfeksiyon Hastalıkları Kongresi, İstanbul, Türkiye, 11 - 13 Mayıs 2005, ss.234, (Özet Bildiri)

322. A new mouse model for Behcet's disease

Ustek D., Gul A., Ozbek U.
2nd European Conference and Practical Course on Towards Clinical Gene Therapy - Preclinical Gene Transfer Assessment, Bellaterra, İspanya, 1 - 14 Şubat 2004, cilt.11, (Özet Bildiri)

323. Efficacy of infliximab in the treatment of uveitis resistant to the combination of azathioprine and cyclosporin in Behcet's disease: Preliminary results of an open-label trial.

Gul A., Tutkun I., Mudun B., Inanc M., Kamali S., Kasapoglu E., et al.
68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Antonio, Kuzey Mariana Adaları, 16 - 21 Ekim 2004, cilt.50, (Özet Bildiri)

324. Clinical patterns and treatment characteristics of Turkish patients with psoriatic arthritis: A single center prospective study

Kasapoglu E., Kamali S., Gul A., Ocal L., Aral O., Konice M., et al.
Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.419, (Özet Bildiri)

325. M694V variant of the MEFV gene is strongly associated with secondary amyloidosis in Turkish patients

Cefle A., Vural B., Kamali S., Inanc M., Ocal L., Aral O., et al.
Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.118-119, (Özet Bildiri)

326. Anti-CCP and anti-keratin antibodies in rheumatoid arthritis, primary Sjogren's syndrome and Wegener's granulomatosis

Kamali S., Polat N., Kasapoglu E., Gul A., Ocal L., Aral O., et al.
Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.199-200, (Özet Bildiri)

327. Early response to immunosuppressive therapy predicts good long-term renal outcome in proliferative lupus glomerulonephritis: Lessons from the Euro-Lupus Nephritis Trial

Houssiau F., Vasconcelos C., D'Cruz D., Sebastiani G., Garrido E., Daniell M., et al.
Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.111-112, (Özet Bildiri)

328. Efficacy of infliximab in the treatment of uveitis resistant to the combination of azathioprine and cyclosporin in Behcet's disease: Preliminary report of an open trial

Tugal-Tutkun I., Gul A., Mudun A., Inanc M., Kamali S., Urgancioglu M.
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology, Florida, Amerika Birleşik Devletleri, 24 - 29 Nisan 2004, cilt.45, (Özet Bildiri)

329. Long-term course of deep venous trombosis in patients with Behcet's disease.

Kahraman O., Celebi-Onder S., Kamali S., Inanc M., Ocal L., Aral O., et al.
67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, ORLANDO, FLORIDA, 23 - 28 Ekim 2003, cilt.48, (Özet Bildiri)

330. Comparison of argon laser photocoagulation induced cutaneous inflammation and skin pathergy test in Behcet's disease

Sayarlioglu M., Calka O., Cinal A., Sayarlioglu H., Akdeniz N., Topcu N., et al.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.217, (Özet Bildiri)

331. Survival analysis, organ damage and predictors of early mortality in patients with Wegener's granulomatosis: A single center experience

Kamali S., Inanc M., Gul A., Ocal L., Aral O., Konice M.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.453, (Özet Bildiri)

332. Impaired endothelium-dependent flow-mediated dilation in Behcet's disease: More prominent endothelial dysfunction in patients with vascular involvement

Oflaz H., Karaman O., Kamali S., Erer B., Tunaci A., Mercanoglu F., et al.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.214, (Özet Bildiri)

333. Assessment of Europian Spondylarthropathy Study Group and Amor criteria: A prospective study in consecutive patients

Kasapoglu E., Ocal L., Kamali S., Gul A., Inanc M., Aral O., et al.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.468-469, (Özet Bildiri)

334. A prospective study of disease severity and functional status in systemic sclerosis

Kalender M., Inanc M., Kamali S., Ocal L., Gul A., Aral O., et al.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.227, (Özet Bildiri)

335. Whole genome screening of multicase families with Behcet's disease.

Karasneh J., GÜL A., Ollier W., Silman A., Worthington J.
66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Louisiana, Amerika Birleşik Devletleri, 24 - 29 Ekim 2002, cilt.46, (Özet Bildiri)

336. The role of procoagulant mutations on the type and site of thrombosis in Behcet's disease.

Celebi-Onder S., Ozbek U., Akman-Demir G., Kamali S., Inanc M., Ocal L., et al.
66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Louisiana, Amerika Birleşik Devletleri, 24 - 29 Ekim 2002, cilt.46, (Özet Bildiri)

337. Polymorphisms of CXCR-2 in Behcet’s Disease.

YILMAZ V., DUYMAZ J., UYAR F. A., GÜL A., SARUHAN DİRESKENELİ G.
10th International Conference on Behcet’s Disease, 27 - 29 Haziran 2002, (Özet Bildiri)

338. Behçet Hastalığında CXCR 2 Polimorfizmleri

YILMAZ V., DUYMAZ J., UYAR F. A., GÜL A., SARUHAN DİRESKENELİ G.
XVI. ULUSAL İMMÜNOLOJİ KONGRESİ, Türkiye, 9 - 13 Mayıs 2001

339. RISK-FACTORS FOR VITAL ORGAN INVOLVEMENT IN BEHCETS-DISEASE

DILSEN N., KONICE M., ARAL O., OCAL L., INANC M., GUL A.
6th International Conference on Bechcets Disease, Paris, Fransa, 30 Haziran - 01 Temmuz 1993, cilt.1037, ss.165-169, (Tam Metin Bildiri)

340. IMPORTANT IMPLICATIONS OF SKIN PATHERGY TEST IN BEHCETS-DISEASE

DILSEN N., KONICE M., ARAL O., INANC M., GUL A., OCAL L.
6th International Conference on Bechcets Disease, Paris, Fransa, 30 Haziran - 01 Temmuz 1993, cilt.1037, ss.229-233, (Tam Metin Bildiri)

341. IMMUNOHISTOLOGY OF SKIN PATHERGY REACTION IN BEHCETS-DISEASE

GUL A., ESIN S., DILSEN N., KONICE M., WIGZELL H., BIBERFELD P.
6th International Conference on Bechcets Disease, Paris, Fransa, 30 Haziran - 01 Temmuz 1993, cilt.1037, ss.343-347, (Tam Metin Bildiri)
Kitaplar 2

1. Ürtikeryal Lezyonlar ile Seyreden Otoinflamatuar Sendromlar

Amikishiyev S., Bektaş M., Gül A.
Ürtiker ve Anjiyoödem, Semra Demir, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.51-57, 2022 Creative Commons License

2. Ürtikeryal Lezyonlar ile Seyreden Otoinflamatuar Sendromlar

AMİKİSHİYEV S., BEKTAŞ M., GÜL A.
İMMÜNOLJİ ALERJİ-ÜRTİKER VE ANJİYOÖDEM, Doç. Dr. Semra DEMİR, Editör, TÜRKİYE KLİNİKLERİ, ss.51-57, 2022
Metrikler

Yayın

759

Yayın (WoS)

501

Yayın (Scopus)

396

Atıf (WoS)

15457

H-İndeks (WoS)

62

Atıf (Scopus)

17332

H-İndeks (Scopus)

64

Atıf (Scholar)

38

H-İndeks (Scholar)

4

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Sobiad)

1

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

5

Proje

40

Fikri Mülkiyet

3

Tez Danışmanlığı

1

Açık Erişim

40
BM Sürdürülebilir Kalkınma Amaçları
SDG 1: AMAÇ 1: YOKSULLUĞA SON
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 8: AMAÇ 8: İNSANA YAKIŞIR İŞ VE EKONOMİK BÜYÜME
SDG 9: AMAÇ 9: SANAYİ, YENİLİKÇİLİK VE ALTYAPI
SDG 16: AMAÇ 16: BARIŞ VE ADALET
SDG 17: AMAÇ 17: AMAÇLAR İÇİN ORTAKLIKLAR